Development of a multi-distance, multi-channel broadband near-infrared spectroscopy system to investigate the spatial variation in cellular oxygen metabolism in the healthy and injured adult human brains by Phan, Phong Thanh
Development of a multi-distance,
multi-channel broadband near-infrared
spectroscopy system to investigate the
spatial variation in cellular oxygen
metabolism in the healthy and injured
adult human brains
Phong Thanh Phan
A thesis submitted to University College London
for the Degree of Doctor of Philosophy (Ph.D)
University College London (UCL)
Department of Medical Physics and Biomedical Engineering
August, 2017
Declaration
I, Phong Thanh Phan, confirm that the work presented in this thesis is my own. Where
information has been derived from other sources, I confirm that this has been indicated
in the thesis.
1
Abstract
This PhD thesis describes the progressive development of a multi-channel, multi-distance
broadband NIRS system designed to measure the concentration changes in oxygenated
haemoglobin (HbO2), deoxygenated haemoglobin (HHb), and especially the oxidation
state of cytochrome-c-oxidase (oxCCO) across multiple regions of the adult human brain.
The system was developed using an iterative approach, through two major iterations. At
each iteration, in vivo tests in healthy adult volunteers were performed to test the sys-
tem capability. The first iteration was the pseudo broadband diffuse optical tomography
system, achieved by physically moving one source fibre and eight detector fibres across
multiple positions in a fixed 3D printed probe holder. A functional activation task involv-
ing the visual cortex was used as an in vivo test of this approach. The second iteration
was the full multi-channel, multi-distance broadband NIRS system, achieved by increas-
ing the number of source and detector fibres and integrating a time-multiplexing mecha-
nism for the sources. The capability of this system was tested using functional activation
tasks involving both the visual and frontal cortices. The final version of the system was
then used in the neurointensive care unit to monitor the frontal regions of patients with
acute brain injury, demonstrating the capability for monitoring the temporal and spatial
variations in cerebral haemodynamics and oxygen metabolism.
The multi-channel, multi-distance broadband NIRS measurements acquired from var-
ious functional activation studies and the clinical study have provided evidence for the
existence of a spatially dependent ∆[oxCCO] signal. More importantly, they show that
the spatial variation in ∆[oxCCO] can be monitored using a multi-channel broadband
NIRS approach. The measurements collected during various stages of system develop-
ment have allowed the implementation of the oxCCO image reconstruction algorithm,
reconstructing 3D tomographic images of oxCCO for the first time. The combined de-
velopments in hardware engineering, data acquisition, clinical studies and image recon-
struction open up a whole new avenue for the investigation of cerebral oxygen metabolism
in the healthy and injured adult human brain.
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sult of this PhD can be used for future neuroscience research to investigate the spatial
variation of cerebral oxygen metabolism during cognitive processes or for future clinical
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In term of clinical practice, this work has demonstrated the potential benefits of having
multi-regional measurements of cerebral oxygen metabolism in that it can provide a
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Chapter 1
Introduction
This chapter introduces the technique of near-infrared spectroscopy, its clinical relevance
and the motivation and objectives behind the work presented in this thesis. The main
motivation of this work emerges from the benefits of having a non-invasive instrument
that can monitor changes in cerebral oxygen metabolism across multiple regions in the
adult human brain. This instrument can potentially be used to monitor the spatial vari-
ation in cerebral metabolism in the injured brain to provide relevant clinical information
to guide targeted therapy that can improve clinical outcomes.
1.1 Near-infrared spectroscopy introduction
Near-infrared spectroscopy (NIRS) is a non-invasive, non-ionising optical technique that
uses light in the near-infrared (NIR) region of the spectrum to interrogate biological tis-
sue. Within this region of the spectrum, three compounds absorb light strongly: oxy-
genated haemoglobin (HbO2), deoxygenated haemoglobin (HHb) and cytochrome c oxi-
dase (CCO). The measurements derived from the changes of HbO2 and HHb can provide
information about the changes in cerebral haemodynamics and oxygenation while the
measurement derived from the changes of CCO can provide insights into the changes in
cerebral cellular oxygen metabolism. NIRS has for many years been used to investigate
changes in haemodynamics and metabolism of various types of biological tissues [1], [2].
To date, most commercial NIRS devices rely on a dual wavelength approach, limiting
their capabilities to the measurements of HbO2 and HHb [3]. These measurements are
not directly related to changes in metabolic activity during neuronal activation. Over
recent decades the Biomedical Optics Research Laboratory (BORL) at UCL has been de-
veloping novel optical systems and methods with a particular focus on the measurement
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of CCO to inform on cellular oxygen metabolism. Simultaneous measurements of CCO
and haemoglobin signals may provide complementary information on the haemodynam-
ics, oxygenation and metabolism of biological tissue.
In order to accurately monitor changes in CCO, a compound that exists in a much
lower concentration in tissue compared to haemoglobin, a broadband NIRS system mea-
suring the intensity changes over more than 100 wavelengths is needed. Our group has
expertise in building these systems and we have developed and used several broadband
NIRS devices to investigate the measurement of CCO in the animal brain, the adult brain
and the neonate brain. [4]–[16]. However, these systems only have the capability of mon-
itoring the CCO signal over one or two areas. Given that NIRS measurements are only
sensitive to the brain area directly below the locations of the source-detector pairs, this
limits the brain areas that can be monitored and more importantly, the result is criti-
cally dependent on the placement of these single source-detector probes. Moreover, if
only a limited number of measurement channels is used, inadequate data are acquired
to allow image reconstruction of spatial changes in any of the chromophores. In this
thesis, a new multi-channel, multi-distance broadband NIRS system will be presented
to overcome these issues and provide, for the first time, the capability to provide images
of localised measures of CCO.
1.2 Clinical introduction
There is significant interest in using NIRS in the clinical setting following studies showing
that treatment guided by NIRS can improve clinical outcomes in specific clinical scenar-
ios where there is an increased risk of cerebral ischemic injury [17]. In the case of acute
brain injury (ABI) where there is significant morbidity and mortality, multi-modal con-
tinuous monitoring is necessary to understand the multi-factorial and complex nature
of the pathophysiology. Two components in particular have been identified as having key
importance in brain injury: reduction in substrate delivery below critical thresholds and
failing cellular metabolism characterised by the inability of the mitochondria to utilize
the delivered oxygen and glucose, resulting in profound energy crisis within the injured
brain [18]. This failure of oxygen metabolism may occur without cerebral ischemia and
be spatially varying [19]. As a result, there is a clinical need to simultaneously monitor
the oxygenation, haemodynamics and metabolism in the injured brain across multiple
regions to identify the time critical windows for an individual patient to deliver targeted
treatments to prevent secondary injury and improve outcomes.
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However, as mentioned earlier, most commercial NIRS devices do not have the ca-
pability to measure CCO and in-house systems optimised for the measurement of CCO
provide only a limited number of channels, limiting the measurement of metabolism to
one or two areas of the brain. This project is aimed at filling that unmet clinical need of
monitoring the brain of patients with acute brain injury with a system that can moni-
tor oxygenation, haemodynamics and metabolism across multiple areas simultaneously.
Spatially resolved CCO may provide useful insights into the heterogeneity of the cellular
metabolic processes in the injured brain and help identify regions with metabolic crisis.
Those insights can be used to optimise treatments for every individual patient and as a
result, improve clinical outcomes.
1.3 The iterative development process
We have taken an iterative approach in the development process of the multi-channel,
multi-distance broadband NIRS system. The final iteration of the system is the result of
developments in hardware, data acquisition, data analysis and image reconstruction. At
each iterative step, functional activation tasks were used as a testing platform to evaluate
the capability of the system to monitor changes in oxygenation, haemodynamics and
metabolism in the adult brain.
1.4 Motivations and objectives
This work was motivated by both the clinical and research need for a NIRS system that
has the capability of measuring the changes in CCO over multiple regions as described
earlier. It is important to state that the work presented in this thesis brings together
and expands the previous work on developing NIRS instrumentation and monitoring the
adult human brain during functional activation and brain injury studies. This work
requires overcoming both the technical and clinical challenges with innovative analysis
to investigate the feasibility of monitoring the spatial variation of CCO signal across the
adult human brain. Therefore, the focus of this PhD is to develop a novel multi-channel,
multi-distance broadband NIRS system to monitor the variation in the CCO signal across
multiple regions of the healthy and injured adult human brains. With that in mind, the
specific objectives of this PhD are:
• To develop a pseudo broadband diffuse optical tomography system to validate the
feasibility of monitoring the spatial variation of CCO response.
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• To design and develop a multi-channel, multi-distance broadband NIRS system that
can simultaneously monitor changes in the CCO signal across multiple areas of the
adult human brain together with changes in oxygenation and haemodynamics.
• To demonstrate the use of the multi-channel system to monitor the variation in CCO
response in healthy volunteers during functional activation tasks and in patients
with acute brain injury.
• To develop signal processing methods to extract insights from the multi-channel
data sets collected from patients with brain injury.
• To facilitate the development of an image reconstruction algorithm for CCO using
the multi-channel, multi-distance broadband NIRS data collected by the system.
1.5 Thesis overview
This thesis describes the progressive evolution of a broadband NIRS system into a multi-
channel, multi-distance system with the capability of monitoring concentration changes
of oxidised CCO together with the changes in haemoglobin concentrations. At each step
of development, specific experiments with a small number of subjects were done to test
the working of the system. This is similar to what has previously been done in the field
of NIRS, with proof of principle studies requiring a small number of subjects.
For the background information, Chapter 2 provides the details about the functional
anatomy of the human brain with focus on the neurovascular unit, the regulation of cere-
bral blood flow and the metabolic processes in the brain. Neuromonitoring techniques
will also be discussed to provide the background on brain monitoring techniques. Chap-
ter 3 provides the fundamentals of NIRS, a brief review on NIRS instrumentation that
can measure CCO signal, a summary of NIRS studies investigating the measurement of
CCO in the adult brain and the technical details of a broadband NIRS system that was
used to develop the multi-channel, multi-distance system of this thesis.
Chapter 4 covers the first iterative step of the development process, resulting in the
pseudo broadband diffuse optical tomography system. That system was then used to
validate the feasibility of monitoring the spatial variation in the response of CCO to a
visual functional activation task. Chapter 5 covers the whole development of the multi-
channel, multi-distance broadband NIRS system from the upgrade of the hardware and
software to the development of the analysis algorithm. It also describes the testing of
the system with phantom studies, the in vivo experiments with cuff occlusion studies,
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visual functional activation study and prefrontal cortex functional activation study.
Chapter 6 provides the results from a pilot clinical study investigating the use of
the multi-channel, multi-distance broadband system to monitor changes in oxygenation,
haemodynamics and metabolism in patients with acute brain injury. The thesis closes
with a brief summary of the current experiments and planned future experiments util-
ising the capability of the system and a discussion of the future continuation of this
work.
1.6 Personal Statement
The work presented in this thesis can be separated in four parts: the development of
the instrumentation, the design of functional activation tasks and its data collection,
the clinical data collection and the analysis of the data. This requires the collaborative
effort of a number of individuals and it is important to acknowledge the effort of those
individuals and to highlight the work that I carried out.
The development of the instrumentation was carried out by myself with the guidance
of my colleagues and supervisors. This involved modifying the working of the system with
additional optical components, designing optical fibres and probe holders and integrat-
ing the new functionality into existing software to bring together the modified hardware
and software. Preliminary testing and characterisation of the system were also done by
myself.
The design of the functional activation tasks and its data collection were done by my-
self while the clinical data collection required the help of my clinical colleague Dr David
Highton, an anaesthetics registrar. Dr Highton and I, with the guidance of our supervi-
sors (Dr Ilias Tachtsidis, Professor Clare Elwell and Professor Martin Smith) integrated
the multi-channel, multi-distance broadband NIRS system into the neurocritical care
unit to collect multi-modal data sets from brain injured patients . As well as data collec-
tion, I was responsible for the quality of the optical data, the synchronising of the data
and the development of analysis algorithm.
All the data analysis presented in this thesis were done by myself with the exception of
the image reconstruction which required the expertise of Dr Sabrina Brigadoi. I collected
and pre-processed the multi-distance, multi-channel broadband data before passing it to
Dr Brigadoi to run it through an image reconstruction algorithm to produce tomographic
images of concentration changes. The development of this reconstruction algorithm was
facilitated by the work presented in this thesis.
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Some results from the work presented in this thesis have been published in peer-
reviewed journals. I have written two first-authored papers and assisted in another three
papers published by my colleagues, the details of which are presented in the previous
section.
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Chapter 2
Functional anatomy and
physiology of the adult human
brain
This chapter describes the fundamental functional anatomy and physiology of the healthy
adult human brain. These background information is essential to assist the understand-
ing and interpretation of NIRS parameters. This chapter begins with a brief overview of
the functional anatomy of the human brain and its functional unit, before exploring
different mechanisms regulating cerebral blood flow (CBF) and metabolism. Finally, dif-
ferent neuroimaging techniques that can be used to investigate the functioning brain are
discussed to put NIRS technology into perspectives.
2.1 Functional anatomy of the brain and the regulation
of cerebral blood flow
The brain is the most complex and active organ of the human body. It has a constantly
high metabolic demand for nutrients and oxygen for normal functionality. In a nor-
mal healthy adult, the brain receives more than 15% of blood flow from cardiac output
despite taking up only 2% of body weight [20]. However, the brain has a limited capac-
ity to store energy and it relies on the change in CBF for the delivery of nutrients and
oxygen to match its varying demand and for the removal of carbon dioxide and other
waste products. Although there is some degree of homeostasis in most body systems,
homeostasis in the brain is extraordinary with many overlapping mechanisms to ensure
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the matching of CBF and metabolic demand as the brain is extra-sensitive to under
or overperfusion. Any mismatch in supply and demand can result in severe metabolic
consequences [21] and pathologies [22], [23]. The control of CBF is complex and not
fully understood. However, previous studies have identified three key mechanisms that
ensure that the transport of nutrients and oxygen is continuous and in an organised
manner to fulfil the demand of neural tissue. These are cerebral pressure autoregula-
tion, maintaining a relatively constant CBF in the face of changing perfusion pressure,
functional hyperaemia (or flow-metabolism coupling), increasing CBF to active regions
of the brain, and neurogenic regulation, modulating CBF directly in the face of changing
activity [24]. These overlapping mechanisms work closely with each other using some
key structural components to create a coordinated regulation of CBF. In this section of
the thesis, those key structural components, that together constitute the neurovascu-
lar unit, will be discussed in detail before investigating individual mechanisms of CBF
regulation.
2.1.1 Neurovascular Unit
Neurovascular unit (NVU) is a group of cells that are in intimate anatomical and chemi-
cal relationship with each other to establish a functional whole that can detect changes
in neural tissue and trigger necessary responses to regulate CBF to meet metabolic de-
mands [25]. The key components of the NVU are neurons, astrocytes and endothelial
cells that interact with each others through positive and negative feedback mechanisms
[26]. Each component seems to have a specific but not fully established role but they
maintain dynamic linkages among themselves under normal physiological conditions.
Neurons and astrocytes work closely with each other during signal transduction to me-
diate the release of neurotransmitters and their re-uptake at synapses whereas astro-
cytes and endothelial cells work closely with each other at the blood-brain barrier (BBB)
to maintain its integrity (Figure 2.1 ). Neurons, astrocytes and endothelial cells work
closely with each other to regulate CBF to meet metabolic demand.
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Figure 2.1: Schematic showing the interactions between fundamental components of the
NVU ([27]).
2.1.1.1 Neurons
Neurons are the basic working unit of the brain. All neurons are electrically excitable
and they can transmit and receive signals through electrochemical processes. These
cells can transmit information to other neurons, glial cells, muscle cells and gland cells.
A typical neuron has a cell body, dendrites and an axon. Dendrites are thin structures
that arise from the cell body to receive signals from axons of other neurons via synapses.
An axon is an elongated cellular extension from the cell body to transmit an electrical sig-
nal. Neurons are considered the central component of the NVU as they can detect small
variations in the availability of nutrients, oxygen and other metabolic wastes in their
surrounding microenvironment and transform these signals into electrical and chemical
signals to other neurons or other components of the NVU to turn on corresponding ad-
justment mechanisms [28]. There is evidence showing that neurons can directly control
the vascular tone of blood vessels via the innervation of smooth muscle cells (SMCs) or
indirectly through the interaction with astrocytes, endothelial cells and other interneu-
rons to control blood flow to their surrounding environment (Figure 2.2) [29], [30].
2.1.1.2 Astrocytes
Astrocytes are an important type of glial cells that play the central supporting role in
the NVU. Astrocytes have a characteristic star-shaped morphology due to the presence
of multiple processes, some of which envelop synapses made by neurons while others
are in close contact with the vascular tree. Astrocytes also have end-feet that are closely
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applied to the wall of cerebral microvessels (Figure 2.2). Therefore, astrocytes provide
the link between the cells in the vasculature and the neurons, facilitating the coupling
between neural activity and change in CBF. Astrocytes perform several roles, many of
which are still not fully elucidated. Within the NVU, astrocytes do not only support
endothelial cells to form the BBB, a selective barrier formed by endothelial cells that line
cerebral microvessels, but also assist neurons to perform their functions [31].
2.1.1.3 Endothelial cells
Endothelial cells are squamous cells that form the vascular endothelium, the inner lin-
ing of blood vessels, and provide a single cell barrier between the blood and the wall
of the vessels. Adjacent endothelial cells are linked with each other by complex tight
junctions, forming the BBB that forces molecules from the bloodstream to take the tran-
scellular route to get through the BBB rather than the paracellular route through the
junctions (Figure 2.2) [26]. This mechanism allows strict regulation of substance move-
ment to the brain tissue. Apart from being the physical barrier between the bloodstream
and the brain tissue, endothelial cells are in constant communication with neurons and
astrocytes to regulate CBF via the release of vasoactive substances. These vasoactive
substances can have direct effects on vascular SMCs to initiate vasoconstriction or va-
sodilation to control CBF.
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Figure 2.2: Key components of the NVU that regulate CBF along the vascular tree. There
are three cell types that play the key roles in the regulation of CBF. They are neurons,
astrocytes and endothelial cells. Neurons (red) are the central component of the NVU with
the ability to sense small variations in the availability of nutrients, oxygen and other
metabolic waste products. They are in constant communication with other neurons,
astrocytes (green) and endothelial cells (light red in b-d) to regulate CBF. Astrocytes have
end-feet that are in close contact with the wall of cerebral microvessels as demonstrated
in b,c and d. Endothelial cells are connected with each other via tight junctions to form
the BBB. ([32]).
2.1.2 Regulation of cerebral blood flow
As mentioned above, CBF is tightly regulated by several overlapping mechanisms that
are interplayed with each other to produce a characteristic haemodynamic response to
the increase in neuronal activity. Components of the NVU play the central role in these
homeostatic mechanisms. In this section, we will describe two fundamental mechanisms
of the regulation of CBF.
2.1.2.1 Cerebral pressure autoregulation
Cerebral pressure autoregulation (CA) is the process by which cerebral arteries main-
tain a constant blood flow in the cerebral circulation in the face of changing perfusion
pressure, ensuring that in normal physiological conditions, neural tissue can receive
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sufficient nutrients and oxygen for normal activity [33]. Alternatively, it can be defined
by the ability of the cerebral vasculature to change its calibre in response to changes in
arterial blood pressure. A fall in perfusion pressure causes rapid vasodilation of cerebral
blood vessels while a rise in perfusion pressure leads to vasoconstriction [34]. This is
critical to the normal functionality of the brain in different physiological conditions as
neural tissue is intolerant to ischemia. CA operates within a wide but limited range of
cerebral perfusion pressure (CPP), where CPP is equivalent to the difference between arte-
rial blood pressure (ABP) and intracranial pressure (ICP). Early studies have convincingly
documented that when CPP is within the range of 50 to 160 mmHg, CBF is maintained
at a relatively constant level [24]. When CPP gets below or above these limits, CA may
be impaired and CBF becomes pressure-dependent [35], [36]. This phenomenon is sum-
marised by a classic sigmoidal curve in Figure 2.3. Although CA occurs over a short
time scale, it is not instantaneous. Previous studies have suggested that when there are
step changes in ABP, the restoration of blood flow to the pretest level can take more than
four seconds ([33]). This means that even when CA is intact, an abrupt drop in ABP can
result in a transient drop in CBF before autoregulation brings it back to normal level.
Figure 2.3: An idealised curve demonstrating the basis of CA. In an ideal situation,
there is little variation in CBF when CPP is within 50 to 150 mmHg. Above or below
these values, a small change in CPP results in a large change in CBF. (Taken from [24]).
Several mechanisms have been proposed to explain CA. As we view CA as a metabolic
independent control of CBF (metabolic dependent control i.e functional hyperaemia will
be discussed later), only mechanisms that cause changes in cerebral vascular tone as
a result of changes in CPP are considered here. These include myogenic response and
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endothelial contribution. These mechanisms act together to modulate and fine-tune the
response of the cerebral vasculature to changing blood pressure.
Myogenic response, first described by Bayliss in 1902 [37], is considered an intrin-
sic property of SMCs characterised by the constriction of the vessel in response to an
increase in transmural pressure and its dilatation in response to decrease in pressure
[38], [39]. Using isolated vessel techniques, the response has been established to depend
mainly on the reaction of SMCs in the wall of small arteries and arterioles and not on
either nerves or endothelium [40], [41]. The myogenic response exists in several net-
works of small arteries and arterioles; its response varies with vessel diameter and it is
different in different vascular beds [42]. The mechanism behind the myogenic response
is not fully elucidated but there is evidence suggesting that the increase in transmural
pressure may activate non-selective stretch-activated ion channels present on the SMCs,
resulting in the depolarisation of SMC membrane which leads to the opening of voltage-
gated calcium (Ca2+) channels on SMCs. The influx of extracellular Ca2+ results in an
increase in the concentration of intracellular Ca2+ and the contraction of SMCs, a re-
sponse that disappears in the presence of voltage-gated Ca2+ channel inhibitors. A more
detailed discussion of cellular mechanisms of individual events of the myogenic response
can be found in [42].
The cerebrovascular endothelium plays a central role in the regulation of CBF through
the production and the release of vasoactive molecules that can lead to vasoconstric-
tion or vasodilatation, constantly modulating the vascular tone [43]. Furthermore, it
can respond to or modify circulating vasoactive substances in the bloodstream to have
vascular effect. Two main factors that have been proposed to activate the activity of
cerebrovascular endothelium. These are the change in shear stress and the change in
transmural pressure. The increase in shear stress (or flow velocity) was shown to re-
sult in vasodilation [44] while the increase in transmural pressure was demonstrated to
result in vasoconstriction [45]. The mechanisms of these responses are not fully under-
stood but accumulating evidence suggests that there is a mechanoreception mechanism
present in the endothelial cells that detects the changes in shear stress and transmu-
ral pressure. These lead to the release of endothelium-derived relaxing factor (EDRF) or
endothelium-derived contracting factor (EDCF) that can diffuse to the vascular SMCs to
result in their relaxation or contraction [46].
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2.1.2.2 Functional hyperaemia
Functional hyperaemia is the process characterised by the microscopic local increase
in CBF to specific regions of active neural tissue. This increase in CBF delivers nutri-
ents and oxygen to the neural tissue and washes out metabolic waste products and car-
bon dioxide via a complex and highly developed vascular system. However, the increase
in CBF far exceeds the local requirement, especially for oxygen, resulting in regions of
hyperoxygenation [47], [48]. This oversupply of oxygen is the basis for haemodynamic-
based functional neuroimaging techniques such as functional magnetic resonance imag-
ing (fMRI), detecting the decrease in the concentration of deoxygenated haemoglobin,
functional near-infrared spectroscopy (fNIRS) which detects the increase in concentra-
tion of HbO2 and the decrease in concentration of HHb or positron emission tomography
(PET) which detects the increase in blood flow of a biologically active labelled tracer in
the body (See Figure 2.4). These functional imaging modalities will be discussed in detail
in section 2.2. The rationale behind the over supplying of oxygen to regions of activation
is not fully understood and is an active area of research.
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Figure 2.4: A typical haemodynamic response in the rat somatosensory cortex after four
seconds of forepaw stimulation [49]. Dark grey trace shows the calcium response. Green
trace shows an increase in the total haemoglobin corresponding to the dilation of blood
vessels. A typical response of functional activation was recorded with an increase in
concentration of oxygenated haemoglobin (red trace) and a decrease in concentration of
deoxygenated haemoglobin (blue trace), indicating a net overoxygenation of the tissue.
There are some specific vascular features evidenced during functional hyperaemia.
Capillaries are suggested to expand physically during functional hyperaemia [50] which
may explain the increase in total capillary concentration of haemoglobin observed in
various studies [49], [51]. Specific arteriolar branches of pial arteries dilate rapidly,
extending up to more than one mm away from the centre of the activated region [52],
[53]. There is evidence of propagation of vasodilation from small specific vessels to a
larger number of nearby larger vessels [52], [53]. Veins do not change diameter during
functional activation but the velocity of blood flow in veins is increased during this event.
The primary process underlying functional hyperaemia is termed neurovascular cou-
pling, which describes the close temporal and regional linkage of neuronal activity and
CBF responses [54]. This process is still under active investigation but the fundamental
sequence of events can be summarised as followed [55]. An increase in neuronal activ-
ity leads to an increase in adenosine triphosphate (ATP) consumption and the release
of metabolic waste products. Neurons replenish this energy by the process of oxidative
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metabolism which requires nutrients and oxygen. These are supplied by a coordinated
increase in CBF. Although the investigation of the mechanism underlying neurovascu-
lar coupling is a complex matter, several candidates are thought to be involved in the
sequence of coordinated events. These are the components of the neurovascular unit
discussed earlier: endothelial cells, neurons, astrocytes [56].
There are several proposed mechanisms suggesting the concerted sequences of events
carried out by these components of the NVU to bring about the localised increase in CBF
following neuronal activation. Some popular mechanisms of neurovascular coupling are
discussed individually before they are brought together using an integrated model trying
to describe the sequence of events underlying neurovascular coupling.
Metabolic hypothesis: CBF is directly controlled by energy demand. Blood flow is
controlled by feedback mechanisms that are sensitive to variation in the concentration
of ionic and molecular metabolic by-products of cellular metabolism. These metabolic
by-products of neuronal activity (including but not limited to postassium ion (K+), nitric
oxide (NO), adenosine, carbon dioxide (CO2) and arachidonic acids) may directly or indi-
rectly trigger vasodilation or vasoconstriction via depolarisation or hyperpolarisation of
the vascular SMCs. One specific molecule to consider is CO2 as CBF is highly sensitive
to changes in arterial partial pressure of CO2 (pCO2) [57]. When pCO2 is higher than
normal, CBF increases to attenuate the rise and when pCO2 is lower than normal, CBF
decreases to attenuate the fall. This may be explained by the effect of CO2 on pH. In-
crease in pCO2 leads to a decrease in pH which in turn opens K+ channels on vascular
endothelial cells [57]. This leads to hyperpolarisation of the endothelial cells due to the
eﬄux of the cation. The hyperpolarisation can be transmitted from endothelial cells to
SMCs and neighboring endothelial cells via myoendothelia and gap junctions respec-
tively resulting in the closure of voltage-gated Ca2+ channels in SMCs and vasodilation.
Furthermore, the change in pH due to change in pCO2 can also initiate the release of
vasoactive molecules from endothelial cells to cause vasoconstriction/vasodilation.
Neurogenic hypothesis: this is a feed-forward mechanism where neurovascular cou-
pling is mediated by neuronal mechanisms using the glial pathway or using the direct
influence of neurons on SMCs rather than by mechanisms that sense energy consump-
tion. In the glial pathway, astrocytes have been widely believed to have significant in-
volvement in neurovascular coupling after a study showed that the uncaging of Ca2+ in
astrocytic end-feet resulted in the dilatation of adjacent arterioles [58]. It was suggested
that the buildup of glutamate from local neural activity may act on metabotropic glu-
tamate receptors (mGluR5s) on astrocytes to result in the increased intracellular Ca2+
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concentration. This can result in the generation of arachidonic acid derivatives, such
as prostaglandins (PGs) capable of causing vasodilation by their direct action on SMCs.
However, recent studies have shown evidence that questions the role of astrocytes in
neurovascular coupling. Firstly, the measureable increases in astrocytic Ca2+ occurs
after the onset of arteriolar dilation [59]. Secondly, mice lacking receptors for intracel-
lular Ca2+ signalling still exhibit functional hyperaemia [59]. Thirdly, astrocytes do not
express mGluR5s receptors in the adult brain which play the key role in the pathway for
glutamate-mediated astrocyte activation [60]. And lastly, astrocytes are not directly in
contact with pial arteries above the cortical surface [61]. In the direct pathways, neurons
act directly on SMCs (direct neuronal innervation of SMCs) or products of neural activity
diffuse directly to have effect on SMCs. There is evidence suggesting that acetylcholine
released by the basal forebrain can modulate regional blood flow [62], [63] and cortical
interneurons are able to release vasoactive substances such as VIP, NO (dilation) and
NPY, SOM (constriction) that can cause changes in blood flow [64]. These mechanisms
provide alternative routes to local coupling within the cortex.
Propagated vasodilation: Endothelial cells are hyperpolarised after being activated
and this hyperpolarisation can propagate electrically within the endothelium to cause
dilation of a selected group of vessels to create a defined area of functional hyperaemia.
Another view is that after being activated, there is a calcium wave that can propagate
slowly causing dilation of SMCs via endothelial release of NO and prostagnoids.
As a result of multiple hypotheses, an integrated model can be used to explain neu-
rovascular coupling [65]. Initiation of functional hyperaemia can be at the level of capil-
lary endothelial cells via the actions of astrocytes, pericytes, neurons or the direct diffu-
sion of products of neural activity to the blood vessels. After the initial spark via different
mechanisms, the wave of vascular dilation travels retrograde from the focal point of ac-
tivation along the selective vascular route, recruiting specific arterial branches to create
an optimally localised area of functional hyperaemia.
This localised area of functional hyperaemia can be measured by fMRI as an in-
crease in the blood-oxygen-level-dependent (BOLD) signal as the concentration of HHb
decreases, and by fNIRS as an increase in concentration of HbO2 and a decrease in con-
centration of HHb. However, these signals only measure the changes in CBF secondary
to neuronal activation. It should be emphasised that there is a clear difference between
the concept of neuronal activation and the focal increase in CBF. In the next section, the
metabolic process of neuronal activation, the actual process of neuronal activity will be
discussed.
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2.1.3 Cellular mechanisms in neuronal activity
At the cellular level, it is the group of neurons that is activated during functional acti-
vation. To understand the basis of the process, resting potential of neuron needs to be
discussed.
2.1.3.1 Resting membrane potential of neurons
Neurons at rest have a resting membrane potential around -65mV. This is the result of
a combination of many equilibrium potentials but most important is the action of K+
ions. Sodium/Potassium pumps (Na+/K+ pumps) utilise an ATP to pump 3 sodium ions
(Na+) out of the cell to the extracellular matrix (ECM) and 2K+ into the cell cytosol to
create a chemical gradient where K+ is more concentrated inside the membrane and Na+
is more concentrated outside the membrane (Figure 2.5). Additionally, the membrane
is selectively permeable to ions; its permeability to K+ is extremely high compared to
other ions. As a result, there is a large movement of K+ from cytosol to ECM, going
down the concentration gradient. This outward movement of K+ also makes the inner
side of the membrane more negative. The negatively charged inner membrane creates
an electrical gradient across the membrane, preventing the escape of positively charged
ions from the cytosol. The movement of K+ occurs until the chemical gradient is balanced
by electrical gradient created by the build-up of negative charge on the inner surface of
the membrane. This is the reason why the resting potential of neurons is close to the
equilibrium potential of K+ (-80mV). Similar process can be applied to Na+ ion, another
principle ion playing an important role in establishing the resting membrane potential
(Figure 2.5).
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Figure 2.5: Ionic exchange processes that establish the resting membrane potential in
neurons. Sodium/Potassium pump (purple) pumps 3Na+ out of the cell in exchange to
2K+ into the cell. Due to the selective permeability of the cell membrane to different ions
and the balancing between the electrical gradient and the chemical gradient, the inner
side of the membrane becomes negative. [66]
2.1.3.2 Action potential
When a neuron is activated, the resting potential is disrupted and an action potential
is generated. Action potentials propagate along the axon of the neuron to its terminal
end where it is in contact with other neurons via synapses or with motor cells via neuro-
muscular junctions. An action potential is a short-lasting event in which the membrane
potential rises and falls to communicate with other neurons. During an action potential,
Na+ channels are opened, allowing an influx of Na+ ions into the cell cytosol, causing
the membrane potential to depolarise. Depolarisation of the membrane causes more
Na+ channels to open and further influx of Na+ ions causing the membrane potential to
be positive. At a threshold potential, Na+ channels close and K+ channels open, allow-
ing the eﬄux of K+ to repolarise the membrane. Repolarisation also requires the action
of Na+/K+ pumps, pumping 3Na+ out of the cell and 2K+ into the cell. The membrane
potential overshoots the resting potential by a small amount (hypepolarisation) before
getting back to the resting potential.
2.1.3.3 Cellular metabolic processes
The action of Na+/K+ pumps plays the vital role in re-establishing the resting potential for
neurons after an action potential, making them ready for the next wave of action poten-
tials. This explains why a large amount of ATP utilised by the brain is expended in this
process. The ATP needed for this process is generated by the oxidative phosphorylation
of glucose in cells. In brief, the process can be summarised in the equation:
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C6H12O6 + 6O2 + 38ADP + 38Pi → 6CO2 + 6H2O + 38ATP (2.1)
One glucose molecule is converted into two pyruvate molecules through glycolysis,
generating two ATP and two nicotinamide adenine dinucleotide (NADH). When there is
adequate oxygen in the cells, the majority of pyruvates will enter the citric acid cycle – a
highly efficient aerobic process to generate energy. The rates of glycolysis and citric acid
cycle are tightly coupled with the ATP requirement of the cell; in the case of a neuron,
it is mainly to re-establish the resting potential after the wave of action potentials. The
outputs of the citric acid cycle are mostly potent electron donors – NADH and flavin
adenine dinucleotide (FADH2) that have the ability to generate ATP through the electron
transport chain (ETC).
The ETC takes place in the inner membrane of the mitochrondia and it comprises of a
series of compounds embedded in the membrane to carry out redox reactions to transfer
electrons from electron donors (mainly NADH and FADH2) to electron acceptors (oxygen)
(Figure 2.6). This transfer of electrons is coupled with the transfer of protons (H+) across
the membrane to create a proton gradient that can be used to synthesise ATP from ADP
and Pi through the activity of ATP synthase [67]. This process accounts for most of the
ATP production in cells.
Figure 2.6: Series of redox reactions in the mitochondrial electron transport chain that
transfer electrons from electron donors (NADH/FADH2) to oxygen to generate a proton
gradient across the inner membrane of the mitochondria. This proton gradient can be
used by the ATP synthase to produce ATP for cellular activity. [67]
In the ETC, electrons pass successively from NADH to NADH dehydrogenase, ubiquinone,
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cytochrome b-c1, cytochrome c, CCO and then oxygen [67]. The transfer of electrons
through NADH dehydrogenase, cytochrome b-c1 complex and CCO is coupled with the
transport of H+ from the matrix to the intermembrane space, generating a proton gradi-
ent across the inner membrane of the mitochondria [68]. In the case of FADH2, electrons
are first passed to ubiquinone rather than NADH dehydrogenase and then follows a sim-
ilar path.
The rate of flow of electrons through the ETC is dependent on three main factors:
changes in substrate supply, changes in energy demand (ATP turnover), and changes in
oxygen level, and each of these factors affects the oxidation status of components of the
ETC differently [69]. In general, it is assumed that an increase in substrate supply leads
to an increase in the electron flux and a decrease in the oxidation level of all members
of the ETC; an increase in oxygen level causes an increase in the electron flux and an
increase in oxidation level of all members of the ETC; an increase in ATP turnover results
in an increase in flux and has a various effects on the oxidation status [69].
During functional activation where there is a change in energy demand, the change in
oxidation status of components within the ETC is not theoretically simple [11]. Consider-
ing the oxidation status of CCO, the terminal member of the ETC and therefore responsi-
ble for more than 95% of oxygen metabolism, there is experimental evidence suggesting
that the oxidation status of CCO increases during functional activation [70], [71]. How-
ever, there is also evidence suggesting that CCO can be either reduced or oxidised during
functional activation [11]. More work needs to be done to investigate the changes in the
oxidation status of CCO during functional activation and broadband near-infrared spec-
troscopy with the ability to measure the redox changes of CCO non-invasively, appears to
be the only feasible method. This will be discussed in chapter 3 of this thesis. The next
section will summarise currently available brain monitoring/neuroimaging techniques
that can monitor brain function.
2.2 Functional neuroimaging techniques
Functional neuroimaging is used to investigate and understand various aspects of brain
function. It is usually used with the aim to understand the relationship between brain
areas and specific mental functions. In this thesis, the basis of some common neu-
roimaging techniques as well as their advantages and disadvantages will be discussed.
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2.2.1 Electroencephalography
Electroencephalography (EEG) is an electrophysiological monitoring technique to record
electrical activity of the brain. By placing electrodes on the scalp, the technique mea-
sures the variation in electrical potential difference produced as a result of synchronous
electrical activity of thousands of neurons across a given brain volume. EEG is therefore
considered a direct measure of brain activity. The fundamental principle of EEG is based
on the fact that neurons are constantly exchanging ions with the extracellular matrix to
maintain their resting membrane potential and to propagate action potentials. Provided
that ions of the same charge repel each other, ionic exchange by thousands of neurons
that are synchronised in activity produces an electrical potential difference that is large
enough to be detected at the scalp. Pyramidal neurons on the cerebral cortex are be-
lieved to be the main source of EEG activity as they are aligned to each other and they
work synchronously during brain activity [72]. Event-related potential (ERP) is a specific
pattern of brain electrophysiological response measured by EEG as a direct result of a
specific stimulus presented to the subject. This pattern is distinctive from spontaneous
background potentials and can be resolved using signal averaging techniques. As the
ERP is time-locked to the stimulus, the block averaging process will average out the ran-
dom noise and reveal the ERP caused by the stimulus. This provides a direct measure of
brain activity during functional activation with a very high temporal resolution up to one
millisecond as there is no measurable conduction delay between brain activity generated
inside the head and the potential difference recorded from the scalp [73]. EEG has cer-
tain advantages and disadvantages in comparison with other neuroimaging techniques.
Despite having a very poor spatial resolution, EEG offers very high temporal resolution
with common sampling rates varying between 250 to 2000 Hz. With significantly low
hardware cost compared to other techniques, it is not restricted to specialised facilities
and can be used in a clinical environment with other monitoring techniques such as
fNIRS. EEG measurements do not involve the use of high intensity magnetic fields (as in
fMRI) or the use of radioligands (as in PET). However, EEG has a poor signal to noise ratio
that requires sophisticated data analysis techniques and a large number of subjects to
derive useful information.
2.2.2 Positron Emission Tomography
Positron emission tomography is a nuclear medicine functional imaging technique that is
commonly used for the imaging of glucose metabolism of tissue. It detects pairs of gamma
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rays moving in opposite directions emitted by the annihilation between a positron emitted
from the radioactively labelled tracer and an electron in the tissue. The most commonly
used tracer in PET is fluorodeoxyglucose (FDG), an analog of glucose. This tracer is
taken up and accumulated in cells that have high rate of glucose metabolism, resulting
in the intense radiolabelling of tissues with high glucose uptake such as the brain, liver
and tumour cells. Before the widespread use of functional magnetic resonance imaging,
PET was the popular method for functional brain imaging. However due to the fact that
positron emitting radioisotopes have short half-lives, PET facilities have to be placed in
proximity to a cyclotron where these radioisotopes are produced. This poses the issue
of practicality and in conjunction with the use of radioactive tracer, PET is now mostly
limited to research facilities. The greatest benefit of PET is that different tracers can be
used to investigate different parameters of the working brain. Oxygen-15 can be used in
PET to enable the measurement of CBF and cerebral metabolic rate of oxygen while FDG
can be used to investigate cerebral glucose metabolism.
2.2.3 Singe photon emission computed tomography
Single photon emission tomography (SPECT) is a nuclear medicine tomographic imaging
technique that requires the injection of gamma-emitting tracer into the bloodstream of
the patient. The gamma rays emitted from the tracer are detected by a gamma cam-
era. The tracer commonly used in SPECT functional brain imaging is technitium-99m
hexamethylpropylene amine oxime (99mTc-HMPAO) that is taken up by brain tissue in a
manner that is proportional to blood flow, allowing CBF to be estimated. As change in
CBF in the brain during functional activation is coupled with local neural metabolism,
SPECT with 99mTc-HMPAO tracer can be used to assess brain metabolism regionally. In
this sense, 99mTc-HMPAO SPECT scanning is similar to FDG PET scanning, both of which
can assess regional brain metabolism. In comparison to PET, SPECT requires less ex-
pensive equipment; the radioisotopes used as tracers are less expensive and have longer
half-lives, allowing them to be delivered to hospitals weekly. As a result, SPECT is more
widely available.
2.2.4 Magnetoencephalography
Magnetoencephalography (MEG) is a functional neuroimaging technique that records
the magnetic fields produced by the naturally occurring electrical activity in the brain
by the use of magnetometers. The technique is based on the fact that synchronised neu-
ronal activity induces a weak magnetic field. However, this magnetic field is considerably
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smaller than the magnetic noise in the urban environment. As a result, to detect this
signal, magnetic shielding and a very sensitive magnetometer are required which limits
the use of the technique outside special research facilities. MEG has the advantage of
being a non-invasive technique, using no ionising radiation and measuring brain activity
directly with high temporal resolution. MEG has been used to study cognitive processes
such as vision, language processing in fetuses and newborns.
2.2.5 Functional magnetic resonance imaging
fMRI is the most common functional neuroimaging technique that is used to detect brain
activity by measuring the changes in the magnetic resonance signal associated with the
increase in blood flow to the active regions of the brain. The technique relies on the
coupling of neuronal activity and cerebral blood flow as discussed in previous section.
To generate a magnetic resonance signal (MR signal), a strong, static magnetic field is
applied to align the nuclei in the brain. Gradient magnetic fields are then applied to spa-
tially locate nuclei in the field of view before a radiofrequency (RF) pulse is used to excite
the nuclei to a higher magnetization state. After the RF pulse is removed, nuclei slowly
go back to their original state emitting energy that can be measured by a radiofrequency
coil that surrounds the subject. In the case of fMRI, hyperoxygenation at the active
brain region due to functional hyperaemia leads to a decrease in the concentration of
deoxygenated haemoglobin. Given that deoxygenated haemoglobin is paramagnetic, its
decrease in concentration leads to an increase in MR signal at the active brain region
which is the fundamental basis of fMRI blood oxygen level dependent signal (BOLD sig-
nal). fMRI has the advantage of having a very high spatial resolution that can enable
visualisation of both structural and functional information simultaneously. It does not
involve ionising radiation and is a non-invasive technique. However, the drawbacks of
the technique are that it has a low temporal resolution, is expensive and requires the
scanning subject to be transported to the MR facility.
2.2.6 Functional near-infrared spectroscopy
fNIRS is a non-invasive, optical functional neuroimaging technique that uses NIR light
to investigate changes in haemodynamics associated with neuronal activity. Tradition-
ally, fNIRS instrumentation allows the calculation of changes in the concentration of
HbO2 and HHb by measuring the attenuation of NIR light through the human brain.
This method relies on the principle of neurovascular coupling, which is similar to the
fMRI BOLD technique. However, in additional to the measurement of HbO2 and HHb,
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fNIRS can measure the concentration changes of oxidised CCO which can be used as a
biomarker for cellular oxygen metabolism. During functional activation, the increase in
CBF to the active brain regions creates regions of hyperoxygenation as discussed above.
This is reflected in fNIRS by an increase in concentration of oxygenated haemoglobin and
a decrease in the concentration of deoxygenated haemoglobin (Figure 2.7). fNIRS has
several advantages over other functional imaging techniques. Firstly it is a non-invasive
technique that does not require the subjects to be in a restricted environments as in the
case of PET, SPECT and fMRI. As a result, it can be used at bedside to monitor critically
ill patients. Moreover, it does not involve the use of radioisotopes or contrasts agents
to produce functional images which proves to be favourable for neuroscience studies. It
has a high temporal resolution, allowing measurements to be acquired at high sampling
rate up to 250 Hz [3]. Last but not least, its simple set up allows miniaturization of the
equipment towards wireless, portable fNIRS systems [74].
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Figure 2.7: A typical haemodynamic response to functional activation measured by fNIRS
showing an increase in concentration change in oxygenated haemoglobin (red trace),
a decrease in concentration change in deoxygenated haemoglobin (blue trace) and an
increase in concentration change of total haemoglobin.
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Chapter 3
Near-infrared spectroscopy and
imaging
This chapter describes the fundamentals of NIRS including light tissue interaction pro-
cesses, different techniques to retrieve tissue information in NIRS, an overview of dif-
ferent types of NIRS instrumentation, an overview of NIRS CCO instrumentation and
previously published studies investigating the CCO signal. The image reconstruction
process using NIRS data will also be discussed. This information on the NIRS technique
with a special focus on NIRS broadband instrumentation is the basis for the next three
original chapters of this thesis describing the iterative development process and the ap-
plication of the multi-channel, multi-distance broadband NIRS system to monitor the
CCO signal across multiple brain regions.
3.1 Fundamentals of near-infrared spectroscopy
Near-infrared spectroscopy is a non-invasive, non-ionising technique to assess the changes
in haemodynamics and metabolism of biological tissue using light in the NIR region of
the electromagnetic spectrum (650-950 nm) [75]. The technique is based on the fact
that the diffusely scattered NIR light through tissue contains information about tissue
that can be retrieved by a variety of NIRS techniques. In this thesis, the instrumentation
was developed using the continuous-wave (CW) NIRS technique. With CW technique, it
is possible to monitor changes in the concentration of three physiologically interesting
chromophores: HbO2, HHb and oxidised cytochrome c oxidase (oxCCO) which will be
discussed in detail in later sections. NIRS techniques exploit the facts that:
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• biological tissues have relatively low absorption in the NIR region, creating a window
of transparency in the electromagnetic spectrum;
• NIR light is either absorbed by chromophores, optical absorbers, or scattered by
biological tissues;
• NIR light can penetrate deep enough into biological tissue as the amount of light
being scattered is much larger than the amount of light being absorbed;
• most of the attenuation of NIR light is due to chromophores in small blood vessels
(< 1mm in diameter).
To better understand and interpret NIRS signals, the process of light transport in
tissue has to be discussed in detail.
3.1.1 Light Transport in Tissue
Light transport in tissue is a complex process; however, it can be simplified using ap-
proximations and assumptions with theoretical models to have two individual processes:
absorption and scattering, both of which attenuate the light as it passes through the tis-
sue. These effects depend on both the wavelength of light and the complexity of tissue
structure. In these next sections, the basics of light absorption and light scattering will
be discussed individually before the combined effect that determines light attenuation
in tissue is considered.
3.1.1.1 Light Absorption
The simplest case of absorption happens when light travels through a non-scattering, ho-
mogeneous absorbing medium. In 1729, Pierre Bouguer described his observation that
successive layers of a non-scattering, homogeneous medium of equal thickness absorb
the same fraction of light intensity I incident upon them. In 1760, Johann Henry Lam-
bert mathematically described the relationship in his book on the measurement of light,
Photometria:
δI
I
= −µa · δd (3.1)
δI
I is the fraction of incident light being absorbed by the medium. µa (cm
−1) is the
absorption coefficient of the medium and is defined as the probability that a photon gets
absorbed in the medium per unit length it travels. δd is the thickness of the medium.
Integration of equation 3.1 gives the Lambert-Law:
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I = I0e
−µa·d. (3.2)
I is the transmitted light intensity after it has passed through d (cm) thickness of a
non-scattering, homogeneous, absorbing medium having an absorption coefficient of µa
(cm−1). I0 is the incident light intensity (Figure 3.1).
Figure 3.1: Cuvette model for an absorbing, non-scattering, homogeneous medium
where the Lambert Law can be used to describe the attenuation of light.
Equation 3.2 can be expressed in terms of log to the base 10 as:
I = I010
−k·d (3.3)
where k (cm−1) is the extinction coefficient and is related to µa by equation 3.4
µa = k ln 10. (3.4)
August Beer established the proportional relationship between the concentration, c
(molar), of the absorbing compound in a non-absorbing solution and the absorption
coefficient, µa.
µa = α · c (3.5)
For base 10, the relationship is
k =  · c (3.6)
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α is the specific absorption coefficient (molar−1 · cm−1) and  is the specific extinction
coefficient (molar−1 · cm−1). Combining equations from Lambert’s Law (equation 3.2 and
3.3) and Beer’s Law ( equation 3.5 and 3.6 ) results in the Beer-Lambert Law for both
natural log and base 10 log:
I = I0e
−α·c·d (3.7)
I = I010
−·c·d (3.8)
Transmittance T is defined as the ratio between the transmitted intensity I and the
incident intensity I0. Attenuation A of a non-scattering, absorbing medium is defined as
the −log10 of transmittance:
T =
I
I0
(3.9)
A = − log10 T = log10 (
I0
I
) =  · c · d (3.10)
Equation 3.10 can be expanded to n absorbing compounds in a non-absorbing so-
lution. The absorbance of a solution containing a mixture of absorbing compounds is
the sum of the absorbances of individual attributed compounds each with a specific
extinction coefficient and a concentration:
A = 1 · c1 · d+ 2 · c2 · d+ ... =
∑
i
i · ci · d. (3.11)
The Beer-Lamber Law assumes that the incident light is monochromatic, perfectly
collimated and all the light incident on the material is either transmitted or absorbed.
Light loss due to scattering and reflection at tissue interfaces, prominent phenomena
in biological tissue, are not taken into account. These issues will be discussed in later
section. In the next section, optical absorbers in biological tissue usually referred to as
chromophores will be discussed.
3.1.1.2 NIR chromophores in biological tissue and NIR window of transparency
Chromophores are compounds that absorb light in the spectral region of interest. Each
chromophore has its own individual absorption spectrum describing the level of absorp-
tion at each wavelength. Biological tissue can be approximated as a mixture of many
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different chromophores, each of which has its own absorption spectrum and concen-
tration. The overall absorption or attenuation of light due to biological tissue depends
mostly on the consisting chromophores and their concentrations. In NIRS, the chro-
mophores of interest are those whose absorption spectra vary with oxygenation status.
However, it is important to notice that other principle tissue chromophores that remain
at a constant concentration (at least during the period of the experiment) also contribute
to the total light loss. In the following sections, absorption characteristics of principle
chromophores and of chromophores that change their absorption spectra due to oxy-
genation will be discussed.
Water Water is a chromophore that is present at the highest concentration in biolog-
ical tissue. Typically, 60 − 90% of the total body mass is comprised of water [76]. As
a result, it is considered the dominant tissue chromophore in NIRS and its absorption
spectrum determines the spectral region that can be used for spectroscopic measure-
ment. From Figure 3.2, it can be seen that beyond 900 nm, absorption by water rises
sharply as wavelength λ increases. The high absorption of water in this region of the
spectrum causes the photons at these wavelengths to travel only a short distance in tis-
sue, limiting the tissue thickness through which light can penetrate. From 650 to 900
nm, the absorption of light by water is relatively low, creating a window of transparency
in the tissue across which light can penetrate to a certain depth to produce meaningful
spectroscopic measurements.
Figure 3.2: Specific extinction coefficient of water from 650 nm to 1000 nm. Spectral
data were taken from UCL BORL website [77].
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Lipids Distribution of lipids varies greatly among tissue types. Lipids can be considered
as constant absorbers, contributing to total attenuation as their concentration in tissue
tend to remain constant during the course of a clinical measurement. The absorption
spectrum of lipids is approximately similar to water with low absorption in the NIR region.
Superficial tissues Superficial tissues such as skin, bone and muscles are also impor-
tant in spectroscopic measurements. Although the absorption spectra of these tissues
are not dependent on oxidation status, they contribute to total light attenuation.
Skin The human skin typically has three layers: epidermis, dermis and hypoder-
mis. The epidermis is the outermost layer of the skin, containing no blood vessels, and
melanocytes. The chromophore that needs to be considered in the epidermis is melanin.
Melanin, produced by melanocytes, is a natural pigment and an effective absorber of
light. Although the absorption of light due to melanin is constant, its concentration in
the epidermis determines the amount of light that can be transmitted through the skin
to the underlying layers of tissue. The dermis is the layer underneath the epidermis con-
sisting of mostly connective tissue. In the dermis, there are hair follicles, sweat glands,
sebaceous glands, apocrine glands, lymphatic vessels and subcutaneous blood vessels.
Tissues in this layer contain the three main NIRS absorbers i.e. haemoglobins in the
blood vessels and CCO. Changes in the oxygenation of these NIRS absorbers in this layer
may contaminate NIRS measurements of changes of chromophores in the brain. Hair
follicles in the dermis play a similar role as melanin in the epidermis as an attenuator
of light. This issue is important to consider when making spectroscopic measurements
in regions of the head that are usually covered by hair. The hypodermis is the layer
beneath the dermis and its main role is to act as a fat storage, containing lobules of fat
and blood vessels that give branches to the vessels in the dermis. Haemoglobins in the
blood vessels in the hypodermis also contribute to the attenuation of NIR light through
the head.
Bone and Muscles The absorption of NIR light by bone is very little in comparison
to other tissues and most of that absorption is due to the haemoglobin present in the
tiny blood vessels supplying the bone tissue. Muscles, especially facial muscles such as
frontalis and temporalis, contain myoglobin and supplying blood vessels that may also
contribute to the attenuation of NIR light when measurements of cerebral haemodynam-
ics are recorded from the frontal lobe or the temporal lobe.
Although constant attenuation of light due to these superficial tissue layers is not
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of particular interest in NIRS, it is worth remembering that changes in blood flow and
oxygenation in the superficial tissue layers may contaminate NIRS measurements of the
underlying changes in cerebral haemodynamics and metabolism.
Haemoglobin Haemoglobin is one of the most important absorbers of NIR light in NIRS.
Haemoglobin is the oxygen-transport protein in the red blood cells. It carries oxygen from
the lungs, in the form of oxygenated haemoglobin, to all other tissues in the body through
a dense network of blood vessels and carries the deoxygenated form of haemoglobin back
to the lungs. As discussed in chapter 2, an increase in neuronal activity in an area of
the brain results in an increase in blood flow to that area via the process of neurovas-
cular coupling. This brings a surplus supply of oxygenated haemoglobin to the tissue,
creating changes in the concentration of different species of haemoglobin. Therefore, the
ability to measure changes in the concentration of these different species will give us an
insight into how different areas of the brain behave in response to certain conditions.
The two main species of haemoglobin are oxygenated (HbO2) and deoxygenated (HHb)
haemoglobin. This is because oxygen binds to haemoglobin in a reversible manner:
HbO2 +H
+ 
 HHb+O2 (3.12)
The binding of oxygen to haemoglobin induces a conformational change in the molec-
ular structure of the protein and a resulting change in its absorption spectrum. The
absorption spectra of HbO2 and HHb are shown in Figure 3.3. In the NIR region of the
spectrum from 650 to 900 nm, there are significant differences in the absorption spectra
of the two chromophores. It is these differences that are fundamental to NIR biomedical
techniques, allowing the contribution of each chromophore to the overall attenuation to
be separated and quantified.
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Figure 3.3: Specific extinction coefficient of oxygenated (red) and deoxygenated (blue)
haemoglobins from 650 nm to 1000 nm. Spectral data were taken from UCL BORL
website [77].
Cytochrome c oxidase Cytochrome c oxidase (CCO) is the terminal enzyme of the ETC,
catalysing the electron transfer from cytochrome c to oxygen in the inner membrane of
cellular mitochondria. It is responsible for more than 95% of cellular oxygen metabolism
in tissue [78]. The role of CCO in the ETC has been briefly discussed in chapter 2. There-
fore, the biochemistry of CCO is the focus here. CCO has four redox active centres: two
haem groups (a and a3) and two copper centres (Cua and Cub). Haem a3 group and Cub
centre form a binuclear unit that is the oxygen binding site of CCO. It is the donation of
electrons from this unit to oxygen that accounts for most of the oxygen consumption in
biological tissue. The two remaining redox centres, Cua and haem a group, donate elec-
trons to haem a3 group and Cub centre. When electrons pass between these redox active
centres through a series of redox reactions, changes in optical property occur. However,
the absorption of NIR light from CCO is primarily due to the Cua centre, with a strong
peak centred around 830 to 840 nm in the oxidised form [75]. The difference absorption
spectrum between the oxidised and reduced versions of CCO is shown in Figure 3.4. As
the total concentration of CCO remains constant during the period of clinical measure-
ment, the difference in the absorption spectrum between the oxidised and the reduced
states of the enzyme can be utilised to obtain the concentration changes of oxidised CCO,
or the oxCCO signal which is a measure of the redox state of the enzyme, reflecting the
balance between cerebral energy supply and demand [18]. As can be seen from Fig-
ure 3.4, the difference absorption spectrum of CCO has the same magnitude of those
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for haemoglobin species. However, the concentration of CCO in tissue is approximately
10% of that of haemoglobin [79], making it more challenging to resolve concentration
changes of this chromophore with high accuracy.
Figure 3.4: Specific extinction coefficient of the difference spectrum between the oxidised
and reduced CCO. Spectral data was taken from UCL BORL website [77].
NIR Window of transparency As water and haemoglobin are present in very high con-
centrations in tissue, their absorption spectra determine the wavelengths of light that
can penetrate through the tissue. As can be seen from Figure 3.5, water absorbs strongly
at wavelengths greater than 900 nm and lower than 200 nm. Similarly, haemoglobin is
a strong absorber at wavelengths below 600 nm. The spectroscopic window between 600
nm to 900 nm with the characteristics of low absorption of both water and haemoglobin
allows light to penetrate through superficial tissues to reach tissues at sufficient depth
(e.g. brain tissue and capillaries on the surface of grey matter) to have meaningful spec-
troscopic measurements. Within this NIR window of transparency, light scattering is the
most dominant light-tissue interaction in biological tissue and as a result, the incident
light diffuses rapidly through biological tissue. This process will be discussed in the next
section.
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Figure 3.5: Absorption spectra (natural logarithm base) for different chromophores in
human tissues from 100 nm to 10,000 nm. Spectra are given with the specific concen-
tration in mM. Chromophores included are HbO2, HHb, CCO, proteins, water, collagen
and fat. Taken from [3]
3.1.1.3 Light scattering
Light scattering is the process during which the direction of travel or the energy of the in-
cident photon is altered due to the interaction with matter. In biological tissue, scattering
is the dominant type of light-tissue interaction, accounting for most of the attenuation
of incident light. Scattering events can be divided into two types: elastic scattering and
inelastic scattering. Elastic scattering is the process in which energy of the incident pho-
ton is reserved and the scattered photon has the same frequency as the incident photon
but with a different direction. Inelastic scattering, on the other hand, is characterised by
the increase or decrease in energy level of the incident photon due to the interaction with
matter and as a result the scattered photon has a different frequency than the incident
photon. In biological tissue, virtually all scattering events are elastic with no change in
energy and the photon only changes direction. Inelastic scattering is generally neglected
in biomedical optics. The type of elastic scattering events that occur in biological tissue
is determined by the size of the scattering particle, the wavelength of the incident light
and the refractive indices of the scattering medium.
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Rayleigh scattering When the diameter of the scattering particle is much smaller than
the wavelength of the incident light λ >> pid, Rayleigh scattering occurs during which
the arrival of the incident photon momentarily raises the energy of the particle. The
particle, at the higher energy state, radiates a photon with the same energy but in a
different direction. For NIR light of wavelengths of about 1000 nm, a scattering particle
must be smaller than 100 nm to be considered as a Rayleigh scattering particle. This is
the size of cell organelles such as mitochondria. Rayleigh scattering intensity is inversely
proportional to the fourth power of the wavelength; has a strong dependency on the size
of the particles and the intensity of the scattered radiation is identical in the forward
and reverse directions.
Rayleigh-Gans-Debye Approximation Rayleigh theory can be extended to a scattering
particle of larger diameter as long as the refractive index of the particle is close to that
of the background. In this case, larger scattering particles (λ > pid|n − 1| , |n − 1| < 1,
n is the refractive index) can be treated as a collection of Rayleigh scattering particles
and the overall scattering is the sum of all individual scattering events of each Rayleigh
scattering particle.
Mie Theory of Scattering Rayleigh theory breaks down when the size of the particle
gets larger than 10% of the wavelength of the incident radiation. In those cases, Mie
theory can be used to model light scattering. Mie scattering is independent of wave-
length and larger in the forward direction. The greater the particle size, the more light
is scattered in the forward direction.
Estimation of light scattering The attenuation of the incident light by scattering alone
(Figure 3.6) can be described similarly to the case of absorption in equation 3.2:
I = I0e
−µs·d. (3.13)
Where µs (mm−1) is the scattering coefficient, representing the probability that a photon
will be scattered per unit length travelled in the scattering medium. Similar to µa in
equation 3.5, µs is the product of total scattering cross section of a particle and the
number density of those particles in the scattering medium.
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Figure 3.6: Cuvette model for scattering medium
However, equation 3.13 is only valid for the case of single scattering event, and it can-
not be used for the multiple scattering event scenarios. However, due to the complexity of
biological tissue with a mixture of different types of particles, each with different shapes
and sizes and either homogeneous or heterogeneous, multiple scattering is the dominant
event. In that case, it is difficult to estimate the total light attenuation due to scattering
which is dependent on various factors. Therefore, the calculation of the absolute con-
centration of chromophores in tissue is a complex matter and is out of the scope of this
thesis. However, light loss due to both absorption and scattering (total light attenuation)
has to be taken into account in spectroscopic measurements in order to resolve changes
in optical properties accurately.
3.1.1.4 Light attenuation
When light travels through biological tissue, it is attenuated by both absorption and
scattering and the effect of both processes has to be taken into account when consid-
ering spectroscopic measurement. For an absorption-only medium, equation 3.10 and
equation 3.11 can be used to describe light attenuation by one or more chromophores re-
spectively in tissue. However, given that biological tissue is a highly scattering medium,
these equations cannot be applied directly as they do not account for light loss due to
scattering. The modified Beer-Lambert law (MBLL) developed by Delpy [80] takes into ac-
count light loss due to scattering and increased optical pathlength of scattered photons.
As a result, the attenuation of light can be approximated using the following equation:
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A =
∑
i
i · ci · d ·DPF +G. (3.14)
A: total attenuation of light through an inhomogeneous tissue (OD)
DPF: differential pathlength factor to account for the increase in the distance trav-
elled by photons due to multiple scattering (dimensionless)
d · DPF is the differential pathlength or the effective optical pathlength (cm)
G is the total light loss due to scattering and other boundary losses.
i is the specific extinction coefficient of chromophore i (molar−1.cm−1)
ci is the concentration of chromophore i (molar)
G is a geometry-dependent factor and is difficult to estimate. As a result, using con-
ventional spectroscopy methods it is not possible to measure absolute attenuation in a
scattering medium and so absolute concentrations of chromophores cannot be resolved.
However, the attenuation due to scattering can be assumed to be constant at any given
wavelength (but it is wavelength–dependent i.e. different at different wavelengths). This
allows the use of MBLL to estimate the changes in concentrations of chromophores in
biological tissues based on the change in attenuation measured. This is the basis for
differential spectroscopy which will be discussed in the next section. DPF values de-
pend highly on the degree of light scattering and weakly on the µa of the tissue. The
relationship between DPF and µa can be demonstrated using theoretical attenuation
data generated using a diffusion equation model as a function of µa in a scattering and
non-scattering medium. The attenuation of light as a function of µa with four different
scattering media is shown in Figure 3.7. The DPF can be determined as the slope of the
curve.
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Figure 3.7: Theoretical relationship between attenuation and the absorption coefficient.
The local gradient of the curve is equal to the optical pathlength d ·DPF in the scattering
medium µs > 0. The gradient of the line in the non-scattering medium (µs =0) is equal to
the geometric pathlength. Taken from [81]
Based on this theoretical data, DPF appears to increase with increasing µs and de-
crease with increasing µa. As µa and µs are wavelength-dependent, DPF is also wavelength-
dependent. As in Figure 3.7, if the change in attenuation measured is small enough
compared to the total attenuation, the DPF can be assumed to be constant for a given
tissue.
It is important to stress the three strong assumptions that are made to derive the
MBLL [1] to understand the limitations as well as to be aware when interpreting NIRS
parameters:
• scattering stays constant or changes negligibly during the period of measurement.
This assumption allows the subtraction of light loss due to scattering when consid-
ering the change in attenuation. Moreover, it also allows the assumption that the
DPF at a certain wavelength is constant. This assumption, in the case of cerebral
haemodynamics, is plausible as the change in blood flow due to neural activity will
change the absorption coefficient (due to changes in proportion of different species
of haemoglobin and CCO) of the tissue more strongly than it does to the scattering
coefficient (due to changes in the scattering particles or the structure of the sam-
pling volume- the neuronal tissue). However, there are cases where this assumption
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is unrealistic such as in brain injury where there are changes in scattering of the
tissue [82].
• the change in absorption in the sampling volume is homogeneous. This assumption
is often invalid given that absorbers are non uniformly distributed in tissue. Two
kinds of errors can arise where the limitation of this assumption is not taken into
account: 1) partial volume effect where the estimated concentration change by the
MBLL is an underestimate of the real concentration change [83] and 2) cross-talk
between chromophores where the estimated change in one chromophore is influ-
enced by the change of another chromophore [71].
• the medium in which the changes in absorption are monitored is homogeneous.
This is certainly wrong in biological tissues where the tissue is a complex mixture
of different substances and NIR light passes through several tissue layers both
before and after passing through the brain tissue.
Even though there are limitations in the MBLL, its development has made a significant
advance in NIRS and as a result, most commercial NIRS instrumentation rely on this
method [3].
3.2 Differential spectroscopy
As mentioned above, due to the fact that the value of G is unknown and is dependent on
the measurement geometry and the scattering characteristics of the tissue interrogated,
absolute concentrations cannot be derived from the MBLL (equation 3.14). However, if
G does not change during the period of measurement, changes in the concentration of
chromophores can be calculated from the measured changes in attenuation. For simplic-
ity’s sake, consider the medium with only one chromophore, at time t1, its concentration
in the medium is c1 and at time t2, its concentration is c2. The measured attenuation at
two time points is A1 and A2 respectively. Using the MBLL, we have:
A1 =  · c1 · d ·DPF +G (3.15)
A2 =  · c2 · d ·DPF +G (3.16)
The ∆ in concentration of the chromophore (∆c = c2 − c1) can be calculated from the
change in measured attenuation (∆A = A2 −A1) where G cancels out.
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∆A =  ·∆c · d ·DPF (3.17)
Expanding the equation 3.17 to i number of chromophores
∆A =
∑
i
i ·∆ci · d ·DPF (3.18)
Expanding the equation 3.18 to j number of wavelengths
∆Aλj =
∑
i,λj
i,λj ·∆ci · d ·DPF (3.19)
Equation 3.19 is the basis of differential spectroscopy, the technique that can be
used to calculate concentration changes of tissue chromophores such as HbO2, HHb
and oxCCO. To solve for concentration changes of two chromophore, HbO2 and HHb,
measurements of changes in attenuation at two wavelengths are needed:
∆Aλ1
∆Aλ2
 =
HbO2,λ1 HHb,λ1
HbO2,λ2 HHb,λ2

∆cHbO2
∆cHHb
 · d ·DPF (3.20)
Solving equation 3.20 for concentration changes of HbO2 and HHb:
∆cHbO2
∆cHHb
 = 1
d ·DPF
HbO2,λ1 HHb,λ1
HbO2,λ2 HHb,λ2

−1 ∆Aλ1
∆Aλ2
 . (3.21)
3.3 Broadband near-infrared spectroscopy
In theory, it should be possible to resolve concentration changes of three chromophores,
HbO2, HHb and oxCCO using three wavelengths. However, there are some specific is-
sues that need to be considered regarding resolving the oxCCO signal. Although the
difference absorption spectrum of CCO is similar in magnitude to those of HbO2 and
HHb, the concentration of CCO in the brain is approximately one order of magnitude
less than that of the other two chromophores [84]. This makes the measurement of CCO
more challenging and raises the question whether the CCO signal is a crosstalk artefact
resulting from the insufficient separation of chromophores from algorithm errors [71],
[85]–[87]. Several studies have demonstrated the independence of the oxCCO signal from
the haemoglobin signals, and that fitting the CCO spectrum results in a better fit of the
measured attenuation data [6], [12], [71]. Moreover, the CCO signal demonstrates a
brain specificity characteristic that is not seen in the haemoglobin signals [12]. Mod-
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elling work has suggested that measuring light attenuation at multiple wavelengths can
minimise the errors from the algorithm and result in more accurate measurements [88].
As a result, measurement of ∆[oxCCO] is usually acquired by broadband spectroscopy
system, measuring light attenuation across a continuous portion of the spectrum. In
this thesis, the UCLn algorithm [88] is used to analyse that measured broadband spec-
trum to resolve concentration changes of chromophores. The UCLn equation is given
below:

∆cHbO2
∆cHHb
∆coxCCO
 = 1d.DPF

HbO2,λ1 HHb,λ1 oxCCO,λ1
HbO2,λ2 HHb,λ2 oxCCO,λ2
...
...
...
HbO2,λn HHb,λn oxCCO,λn

−1 
∆Aλ1
∆Aλ2
...
∆Aλn

(3.22)
The MBLL only allows calculation of concentration changes of chromophores from
an arbitrary baseline, not the absolute concentration. Its measurement is sensitive to
changes in the coupling between optodes and tissue and changes in the tissue surface –
such as subcutaneous skin circulation. In addition to the MBLL, there is another NIRS
technique to resolve an absolute index of tissue oxygenation which will be discussed in
the next section.
3.4 Spatially resolved spectroscopy
Spatially resolved spectroscopy (SRS) is a technique based on light attenuation being
measured at several different source-detector distances to derive the ratio between HbO2
and (HbO2 + HHb), also known as the tissue oxygenation index (TOI) (3.23) [89]. The tech-
nique uses the solution to the diffusion equation which is a special case of the radiative
transfer equation to derive the scaled absolute concentration of HbO2 and HHb which
will be discussed in detail later.
TOI =
kHbO2
k(HbO2 +HHb)
× 100%. (3.23)
SRS assumes that the coupling between the optodes and the tissue is the same for
different source-detector distances and the superficial layers of tissue affect all the mea-
surements of attenuation in the same way so that their effects cancel out. This means
that SRS measurements are more sensitive to cerebral changes. Using the technique dur-
ing carotid endarterectomy, Al-Rawi concluded that the TOI value measured by the NIRO
300 reflects changes in cerebral tissue oxygenation and it was predominantly associated
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with internal carotid clamping [90]. To understand the nature of the SRS technique, a
closer look at the diffusion equation is necessary.
Propagation of photons in tissue can be described using the diffusion equation [91].
For a semi-infinite half-space geometry, the intensity of the reflected light R from an
impulse input can be expressed using the following equation:
R(ρ, t) = (4piDct)−3/2
1
µ′s
t(−5/2)exp(−ρ
2 + µ′−2s
4Dct
− µact). (3.24)
R is the reflected intensity;
ρ , t are the distance and time from the impulse input;
µa is the absorption coefficients;
µ′s is the reduced scattering coefficients which is a product of µs and a factor per-
taining to the anisotropy of tissue scattering.
D = 1/3(µa + µ
′
s) is the diffusion coefficient and c is the velocity of light.
For continuous wave systems, the intensity I(ρ) is the integral of R over time and the
attenuation is the negative log of I(ρ)
A(ρ) = −log10
∫ ∞
0
R(ρ, t)δt (3.25)
Substituting the expression derived for R(ρ) in equation 3.24 into equation 3.25, dif-
ferentiating with respect to ρ and letting µ′s ≈ µ′s + µa (from µ′s  µa) gives:
δA
δρ
=
1
ln(10)
(
√
3µaµ′s +
2
ρ
). (3.26)
µ′s can be assumed to be constant. However, to increase accuracy, the decrease of
µ′s(λ) over wavelength is taken into account by the equation:
µ′s = k(1− hλ) (3.27)
where k is an unknown constant and h is the slope of the wavelength dependency of
µ′s and is set to 8.5 x 10−4 nm−1 [82].
Combining equations 3.27 and 3.26 to solve for k · µa:
kµa(λ) =
1
3(1− hλ) (ln(10)
δA(λ)
δρ
− 2
ρ
)2. (3.28)
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Given that µa = ln(10)··c, equation 3.28 can be used to solve for scaled concentrations
of HHb and HbO2 using two wavelengths:
kµa,λ1
kµa,λ2
 = ln(10)
HbO2,λ1 HHb,λ1
HbO2,λ2 HHb,λ2

kcHbO2
kcHHb
 . (3.29)
Solving for scaled concentrations of HbO2 and HHb
kcHbO2
kcHHb
 = 1
ln(10)
HbO2,λ1 HHb,λ1
HbO2,λ2 HHb,λ2

−1 kµa,λ1
kµa,λ2
 . (3.30)
When calculating TOI, the scaling factor k is cancelled out as shown in equation 3.31.
TOI =
HbO2
(HbO2 +HHb)
× 100%. (3.31)
3.5 NIRS instrumentation
There are three different types of NIRS instrumentation, each of which utilises a different
approach to resolve the specific tissue information [92] (Figure 3.8). Continuous-wave
(CW) NIRS system is the focus here; however, frequency domain (FD) NIRS system and
time-resolved (TR) NIRS system are summarised briefly for completeness. CW systems
measure the variation in the light intensity passing through the tissue. FD systems mea-
sure the change in the intensity and the phase shift of the modulated intensity injected
into the tissue. TR systems measure the variation in both the intensity of light and the
time of flight of photons through the tissue. In this thesis, all of the data presented was
acquired using CW systems. As a result, detailed discussion about CW systems will be
provided and only brief introductions will be given for the other two techniques.
Figure 3.8: Three different types of NIRS systems. a) Continuous wave NIRS system emits
light at constant intensity to the tissue and measure the intensity of diffusely reflected
light reemerging from the tissue. b) Frequency domain NIRS emits light at modulated
intensity and frequency and measures the intensity and the phase shift of the reflected
light. The latter corresponds to the time of flight. c) Time domain NIRS system emits an
extremely short pulse of light to the tissue and measures the intensity and the time of
flight of photons which constitute a temporal point spread function. Taken from [3]
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3.5.1 Frequency Domain Systems
Frequency domain systems modulate the light intensity delivered to tissue at high fre-
quency (5 MHz to 1GHz) and measure both the intensity of the diffusely reflected light
and the phase shift (corresponding to the time of flight of photons through tissue). By de-
tecting the changes in amplitude and the phase shift of the reflected intensity, absorption
coefficients (µa), scattering coefficients (µs) and DPF can be calculated continuously.
3.5.2 Time Resolved Systems
Time-resolved systems deliver short impulses of light (a few picoseconds) through the tis-
sue and measure the time of flight of individual photons through the tissue. This results
in the temporal point spread distribution of photons (TPSF). TPSF has a characteristic
shape spanning to several nanoseconds because of the effect of light scattering on the
optical pathlength of photons – a histogram of the number of photons on the y axis and
their arrival times on the x axis. This histogram can be used to calculate the absorption
(µa) and the reduced scattering coefficients (µ′s). The absorption coefficient can be used
later to calculate the absolute concentration of chromophores in tissues.
3.5.3 Continuous Wave System
CW systems deliver light at a constant intensity to the tissue of interest and measure the
intensity of the light re-emerging from it. This allows changes in attenuation, ∆A, due
to changes in optical properties of tissue to be recorded continuously. Usually, at least
two different wavelengths are used to obtain spectral information. Using appropriate
algorithms [88], the changes in concentration of different chromophores present in the
tissue can be calculated. CW systems are the simplest, the least expensive of all NIR
systems and they are stable and allow a remarkable amount of useful information to be
obtained. As a result, most commercial NIRS systems use this approach [3] and there
are many clinical successes as detailed in [1].
The most basic CW NIRS system has one source-detector pair that can probe one
region of tissue of interest. This setup has been employed successfully in numerous
clinical studies [1]. However, planar arrays of sources and detectors can be used to mon-
itor multiple regions of interest simultaneously to enable both high spatial resolution and
large coverage. In this case, due to the density of measurement channels and the fact
that each NIR source and detector may support multiple measurements, illumination
by sources has to be encoded and decoded while detectors acquire data continuously.
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Three popular encoding techniques that are employed by CW NIRS systems are spatial,
temporal and frequency encoding. With spatial encoding, sources are located at suf-
ficient distance apart such that there is a minimal level of double illumination to any
single detector when both sources are illuminated. In temporal encoding, sources are
illuminated sequentially in certain time steps that can provide the balance of delivering
sufficient amount of light to tissue and sufficient sampling rate. In frequency encoding,
sources can be illuminated in parallel but they are intensity-modulated at different fre-
quencies. The detected intensity from each source can be separated by frequency using
Fourier Transform or lock-in amplifiers. Multiple encoding methods have been utilised
to increase the density of measurement channels to acquire high density diffuse optical
tomography images of oxygenated and deoxygenated haemoglobin using two wavelengths
as demonstrated by Eggebrecht and colleagues [93].
Despite having the advantages of easy setup, low cost and yielding a tremendous
amount of useful information, CW systems have two fundamental drawbacks that need
to be considered. First of all, CW systems are highly sensitive to any changes in source
detector coupling to the subject. The variation in pressure applied to both source and
detector fibres during a clinical experiment can introduce a significant change in the
intensity measurement. Sweating, frowning or any actions that introduce movements
to the sources and detectors independently can also create a large change in intensity.
The variation in the distribution of hair when the measurements are acquired in regions
apart from the frontal cortex also poses challenges for the optode coupling. However,
these variations can be minimised by having a good headgear and probe holder design.
The other limitation of CW technique is that it is only sensitive to the tissue immediately
below the source-detector pair as described by the photon measurement density function
(PMDF) [94]. In general. increasing the distance between the source and the detector
will increase the number of photons passing through deeper tissues, therefore increase
the sensitivity of the channel to brain tissue. However, increasing the source detector
distance is at the expense of signal-to-noise (SNR) ratio, simply because fewer photons
can reach the detector. In the adult population, source detector separation of 30 mm
is a good compromise between having a reasonable sensitivity to the cortex and having
enough light to have a reasonable SNR.
Although there are certain limitations, CW systems have found widespread use due
to their simplicity and the amount of useful physiological information that can be ob-
tained. As a result, there is a wide range of commercially available CW NIRS systems on
the market [3]. System complexity ranges from devices with a single source-detector pair
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to devices that have the capability of full head imaging. Some manufacturers have devel-
oped integrated boards housing both sources and detectors that can be coupled directly
to the scalp [95] while others depend on the use of optical fibres to transmit light and
receive light. Most systems have a compact design and are transportable on carts; how-
ever, there are some systems that are designed to be fully portable, wirelessly transport
the data to a PC or store them in an SD card. Most commercial NIRS systems that use
two or three wavelengths generated by lasers or LEDs only have the capability to resolve
the haemoglobin concentration changes (∆[HbO2] and ∆[HHb] ). Most systems that have
the capability to measure changes in oxCCO were built in-house and those systems only
have one or two channels. More information regarding CW NIRS instrumentation can be
found in a review by Scholkmann [3].
This thesis focuses on the CW technique to resolve changes in the concentration of
oxCCO in the adult human brain. This requires a special type of CW system called broad-
band NIRS spectroscopy system. Before discussing the explicit details of a broadband
NIRS system, it is essential to understand the basic components of a CW system.
3.5.4 Components of a CW NIRS instrumentation
CW NIRS instrumentation is, in principle, the simplest among the three types of NIRS
instrumentation. A basic setup for a CW system consists of (1) a NIR light source, (2) light
transporting medium from the light source to the tissue and from tissue to photodetector
and (3) photodetector to detect the reflected light from the tissue. Each of these compo-
nents will be discussed in detail in the following session to give a basic understanding
of the specifications of a standard CW NIRS system. Some specific focus will be given to
the optimisation of the system for the measurement of oxCCO.
3.5.4.1 Light source
Most commercial CW systems utilise LEDs or lasers at specific discrete wavelengths as
sources. These sources typically have two wavelengths to resolve ∆[HbO2] and ∆[HHb]
[3]. However, to resolve ∆[oxCCO] accurately, broadband light sources emitting light
from a continuous portion of the spectrum from 650 nm to 900 nm is the gold standard.
This can typically be achieved using a thermally-stable white light source with optical
filters attenuating light with wavelengths below 650 nm and above 900 nm. A typical
broadband spectrum with high intensity in the NIR region is shown in Figure 3.9.
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Figure 3.9: Typical broadband source output with high intensity in the NIR region of the
spectrum
Two of the most important characteristics of a CW NIRS broadband light source are
optical power and optical stability. Ideally, optical power is chosen to maximise the in-
tensity at the detector, resulting in high signal to noise ratio and the ability to probe
deep tissues. However, high irradiation may lead to tissue heating causing changes in
the tissue architecture which may lead to discomfort and damage. For safety reasons,
the amount of light output from sources of most NIR systems operating in continuous
mode is kept below 2mW/mm2. Source stability is an important feature for the NIRS light
source. This is because any variation in the intensity due to the light source itself will
introduce more noise to the signals measured at the detector. Instability can be acciden-
tally introduced by noisy power supply or due to temperature effects on the light source.
These factors can be mitigated by careful design of the light source.
3.5.4.2 Photodetector
Most commonly used photodetectors in commercial CW NIRS systems are photodiodes
(Figure 3.10a) and avalanche photodiodes. Both of these use the principle of the pho-
toelectric effect to convert light to electrical signals. However, for broadband CW NIRS
systems, charge-coupled devices (CCDs) (Figure 3.10b) are commonly used in combina-
tion with a spectrograph and series of lenses. This is because these systems need to
record the intensity of the diffusely reflected light across a continuous portion of the
spectrum. The incoming light to the spectrometer is directed through a series of lenses
before being separated into its wavelength components by a diffraction grating. The spec-
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trum is collected by the CCD camera. Because light loss occurs during these processes,
the spectrometer must be designed to ensure a high throughput of light and a low noise
characteristic. CCD cameras are usually cooled to reduce the thermal dark count.
(a) Hamamatsu S12158-01CT photodiode (b) Pixis:1024f CCD camera
Figure 3.10: Commonly used photodetectors for CW NIRS systems.
3.5.4.3 Light transport medium
Optical fibres are commonly used as the light transport medium for broadband NIRS
systems. They carry light from the source to the subject (source fibres) and collect the
reflected light from the subject to the spectrometer (detector fibres). Detector fibres are
usually designed to have high numerical aperture to increase the amount of light col-
lected. When using optical fibres, it is important to ensure that light coupling at both
the sources and the detectors to the scalp is optimal. This is important because, as
mentioned in the previous section, CW technique is highly sensitive to changes in opti-
cal coupling and any changes may introduce artefacts to spectroscopic measurements.
Achieving good optical coupling is challenging when carrying out experiments on the
hairy region of the head as hair has to be moved away from all the detectors and the
sources to ensure high intensity. Moreover, light intensity, in this case, is highly depen-
dent on hair colour, hair density and skin pigmentation. Regarding the design of optical
fibres, the subject ends of all fibres have to be carefully designed so as to make sure that
they can be easily coupled to the skin through the use of probe holders which will be
discussed in the next section.
The advantages of using optical fibres as the transport medium are that they allow
flexibility in source detector arrangements; they are inherently safe as there are no elec-
tronics coming into contact with the subject. They also allow the system to be further
away from the subject. However, optical fibres may become bulky and heavy as the
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number of sources and detectors increases. Some form of weight bearing system must
be used to mitigate this shortcoming to ensure good optical coupling and comfort for the
subject. Because of those features of optical fibres, some commercial NIRS systems have
a design where sources and detectors are integrated on a single chip. As a result, these
can be coupled directly to the skin without the need of using optical fibres.
3.5.4.4 Probe holders - head gear
For broadband NIRS systems with optical fibres, probe holders must be used to fix these
fibres in place during clinical experiments to ensure good optical coupling (an example is
shown in Figure 3.11). Holder design has to be optimised for each specific clinical exper-
iment and each subject type. For example, in infant studies, movements are unavoidable
and therefore any probe holder design has to ensure that both sources and detectors are
tightly coupled to the scalp to minimise artefacts generated by movements (Figure 3.12).
In some other experiments, probe holder design has to allow clearance of hair from be-
neath the sources and detectors. Another important function of probe holders is to fix
the distance between source-detector pairs. This can be achieved by making the probe
holder with a material with suitable flexibility or introducing fixed-distance connections
between the source-detector pairs.
Figure 3.11: A 3D printed probe holder designed to hold one central source and eight
surrounding detectors.
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Figure 3.12: Head gear design for clinical experiment with babies (image from Centre for
Brain and Cognitive Development, Birkbeck)
to hold sources and detectors tightly to the scalp to prevent movement artefacts.
3.5.5 CW-NIRS instrumentation with the capability of measuring
changes in oxCCO concentration
Current commercial systems do not have the capability to measure ∆[oxCCO] accurately
[3] (as of August 2017). Most CW-NIRS systems with the capability of measuring changes
in oxCCO were developed in-house with only a limited number of channels. Table 3.1
provides a brief summary of NIRS instrumentation that has the capability of investigating
the ∆[oxCCO] signals. Most of the systems to date only have a limited number of chan-
nels populated within one or two regions to monitor the haemodynamic and metabolic
changes. However, investigation of localisation of functional brain activity or localised
brain injury requires monitoring over multiple regions of the brain. There is an un-
met need for a non-invasive multi-channel broadband NIRS system that can monitor the
haemodynamic changes and cellular oxygen metabolism over multiple areas of the adult
human brain.
84
3.5. NIRS INSTRUMENTATION
Table 3.1: Brief summary of NIRS oxCCO instrumentation as of August 2017
NIRS Systems Number of
λ
Number of
source(s)
Number of
detector(s)
Number of
channels
used
Multi-
distance/TOI
Duke 1 [96] 3 1 1 1 No/No
Duke 2 [97] 4 1 1 1 No/No
UCL 1 [98] 4 1 1 1 No/No
Keele 1 [99] 3 1 1 1 No/No
Keele 2 [100] 4 1 1 1 No/No
NIRO 1000 [101] 6 1 1 1 No/No
NIRO 500 [102] 4 1 1 1 No/No
NIRO 300 [90] 4 1 3 1 Yes/Yes
UCLn [6], [7], [103] Broad-band 1 1 1 No/No
UCLn - CYRIL [13] Broad-band 2 8 2 Yes/Yes
UCL Hydrid [12] Broad-band 2 8 2 Yes/Yes
Humboldt 1 [70] Broad-band 1 1 1 No/No
Humboldt 2 [71] Broad-band 1 4 4 No/No
Ryerson 1 [104] Broad-band 2 2 2 No/No
3.5.6 The multi-distance broadband NIRS system in BORL
This section gives the specifications of the dual-channel multi-distance broadband in-
strument (MDBBS) built previously in BORL [11], [105]. The system has two channels,
each of which has the three typical components of a broadband CW NIRS system: a white
light source, a CCD camera that is incorporated into the spectrograph and optical fibres
(Figure 3.13).
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Figure 3.13: Schematic diagram showing the components of the MDBBS system built in
BORL.Taken from [106].
Each channel of the MDBBS system utilises a 50W halogen bulb as a white light
source emitting broadband light which is band-pass filtered to remove wavelengths below
504 nm and above 1068 nm to reduce the temperature effect. All the main components
of the light source are given in Figure 3.14. The light from each light source is directed
to the subject via a single light source fibre with a fibre diameter of 4 mm. The diffusely
reflected light from the subject is collected using four detector fibres placed at four dif-
ferent distances away from the light source. Detector fibres at 20 mm and 25 mm have
a fibre diameter of 1mm, whereas detector fibres at 30 mm and 35 mm have a diameter
of 2 mm and 3 mm respectively as shown in Figure 3.15. The light from the detector
fibres is passed to a lens-based spectrograph (Figure 3.16). The spectrograph contains
Minolta MC Rokkor lenses with a focal length of f= 58 mm and a f-number of f/# = 1:12
to provide a higher throughput of light. A diffraction grating (Thorlabs GR50-0310) with
300 grooves per mm that is blazed at 1000 nm is used optimise the reflection in NIR
region of the spectrum. The light spectrum is detected by a CCD camera (PIXIS:512f,
Princeton Instruments) with chip dimension of 12.3 mm x 12.3 mm corresponding to 512
x 512 pixels. The CCD camera is cooled to -70◦C to reduce thermal noise and increase
sensitivity.
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Figure 3.14: In-house built light source.1) Ventilator. 2) Gold plated concave mirror. 3)
Halogen bulb. 4) Metal plate. 5) Optical lenses. 6) Magnetic shutter. 7) Entrance for
source fibre. 8) Band-pass filter. Taken from [106].
Figure 3.15: One channel of the MDBBS system. a) A source fibre and four detector
fibres, each with different diameters placing at 20, 25, 30 and 35 mm away from the
source. b) Ferule (spectrometer end) of the detector fibres showing the oval crossed
section with different diameters. Taken from [106].
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Figure 3.16: The spectrograph and camera of a channel of the MDBBS system. Taken
from [106].
Overall, the MDBBS has two channels, each of which has its own light source fibre,
detector fibres, a spectrograph and a CCD camera. With this arrangement of optical
fibres, the system can be used to monitor two brain regions simultaneously. Each region
is monitored by one source and four detector fibres. As mentioned earlier, the main
objective of this thesis is to develop a system that can monitor cellular oxygen metabolism
across multiple regions of the adult human brain. As a result, iterative development was
introduced to this MDBBS system to develop it into a multi-channel system with the
capability of measuring oxCCO across multiple regions. However, before discussing the
process of system development, it is important to have an overview of in vivo human
studies investigating the oxCCO signal and their results. This will give the foundations
for the understanding and interpretation of the spatial changes in oxCCO in the next few
chapters.
3.6 CCO studies in the healthy adult brain
This section provides an overview of NIRS studies using broadband instrumentation to
investigate the change in CCO redox state reflected by the ∆[oxCCO] signal in the adult
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human brain. Given the position of CCO in the electron transport chain, the redox state
of CCO reflects the balance between electron supply from cytochrome c and electron
demand from oxygen molecules. Although there are many factors that can influence
this supply and demand, the most significant is the availability of molecular oxygen [85].
This is the reason that the BORL group at UCL has performed several volunteer studies
during which changes in cerebral oxygen delivery was manipulated through systemic
physiological challenges and functional activation tasks. The details of those will be
discussed here.
3.6.1 Volunteer studies with systemic challenges
In this section, published studies that investigated the response of oxCCO signal to chal-
lenges that cause an increase in cerebral oxygen delivery (hyperoxia and hypercapnia)
and those that cause a decrease in cerebral oxygen delivery (hypoxia and hypocapnia)
in the healthy adult volunteers will be discussed. The hypothesis for these studies was
that challenges which increase cerebral oxygen delivery would result in an increase in
the ∆[oxCCO] signal measured by broadband NIRS and challenges that decrease cerebral
oxygen delivery would result in a decrease in the ∆[oxCCO] signal.
Early studies of this kind were done in the 1990s by Jobsis’s group at Duke Univer-
sity, North Carolina, USA. Sustained isocapnic hypoxia challenge during which arterial
oxygen saturation (SaO2) was maintained at 80% was used to assess the change in the
oxidation state of CCO. Four wavelength NIR instrumentation using a single channel with
source detector separation of 35 mm was used to collect the optical data. A significant
decrease in oxCCO signal was evidenced during the challenge [107]. Much later in 2007,
Tisdall et al. [5] used a broadband spectroscopy system having one channel with the
same source detector separation and the UCLn algorithm to evaluate the concentration
changes of HbO2, HHb and oxCCO during hypoxemia [5]. A significant decrease in the
∆[oxCCO] signal was again observed. Moreover, distinct differences between the oxCCO
signal and the haemoglobin signals were demonstrated in individual and group data.
A significant correlation was found between a measure of cerebral oxygen delivery and
∆[oxCCO] but not with either ∆[HbT] or ∆[HbDiff]. As a result, the author suggested
that ∆[oxCCO] signal has clinical relevance and is a more reliable marker of reduced
cerebral oxygen delivery during hypoxemia than the other two NIRS signals. A later
study by Kolyva et al. confirmed this decrease in ∆[oxCCO] signal by using a hybrid
optical spectrometer (pHOS), combining multi-distance frequency and broadband spec-
trometers [11]. The pHOS was designed to address the technical issues hindering the
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accuracy of oxCCO measurements [10], notably the changes in optical scattering [85],
[86] and insufficient separation of chromophores by the resolving algorithm [6], [71],
[85]–[87].
During hyperoxia, the expected increase in cerebral oxygen delivery is hypothesised
to result in an increase in the ∆[oxCCO] signal. This was demonstrated in a study by
Tachtsidis and colleagues where hyperoxia was achieved by increasing the inspired frac-
tion of oxygen (FiO2) to greater than 90% [108]. They measured ∆[oxCCO], ∆[HbO2],
∆[HHb] and TOI using a broadband NIRS system having one channel with source detec-
tor separation of 35 mm. Mean blood flow velocity in the middle cerebral artery (Vmca)
was measured using transcranial Doppler. There was significant positive correlation be-
tween ∆[oxCCO] and TOI and between ∆[oxCCO] and ∆[HbDiff] while negative correlation
was found between ∆[oxCCO] and Vmca/∆[HbT]. The author concluded that ∆[oxCCO]
increased during the challenge and it was highly associated with brain tissue oxygena-
tion. Later, Kolyva et al. repeated the study using the pHOS and the same result was
found [12]. Moreover, the author also showed that the magnitude of ∆[oxCCO] decrease
was dependent on the source detector separation, the first evidence of its kind showing
the brain specificity of the ∆[oxCCO] signal.
The response of the ∆[oxCCO] signal to changes in partial pressure of carbon dioxide
(PaCO2) was investigated in 2009 by Tachtsidis and colleagues through a hypercapnia
study [108]. In this study, the percentage of inspired CO2 was increased by mixing 6% of
CO2 to the inspired gas and the subjects were monitored using a broadband system hav-
ing one channel with SDS of 35 mm. The authors demonstrated increases in ∆[oxCCO],
TOI, ∆[HbDiff], ∆[HbT] and Vmca during hypercapnia challenge and they concluded that
the increase in ∆[oxCCO] is highly correlated with the increase in brain tissue oxygena-
tion. Later, Kolyva et al. confirmed the increase of ∆[oxCCO] during hypercapnia using
the pHOS system [12]. Moreover, the author also found a decrease in ∆[oxCCO] during
hypocapnia induced by hyperventilation.
Thanks to technological advances in the pHOS system, Kolyva et al. were able to
measure ∆[HbO2], ∆[HHb] and ∆[oxCCO] at multiple source detector separations (20,
25 ,30 and 35 mm) simultaneously during challenges that increase cerebral oxygen de-
livery (hyperoxia and hypercapnia) and challenges that decrease cerebral oxygen delivery
(hypoxia and hypocapnia) [12]. The authors concluded that ∆[oxCCO] increased during
challenges that increased cerebral oxygen delivery and decreased during challenges that
decreased cerebral oxygen delivery. Moreover, the ∆[oxCCO] signal demonstrated a depth
dependent response, with an increase in signal amplitude with increasing source detector
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separation. This depth dependent response of the ∆[oxCCO] signal is distinctly different
from that of the ∆[HbT] and ∆[HbDiff] signals which seldom show a gradient change in
magnitude depending on penetration depth. This is one of the first studies to support
the hypothesis that ∆[oxCCO] signal is a brain specific signal of cerebral metabolism,
superior to haemoglobin signals in this aspect.
Collectively, these studies demonstrated that the oxCCO signal may be a more reliable
measurement of cerebral changes in comparison to the traditional haemoglobin signals,
showing a superior specificity to the brain.
3.6.2 Functional activation studies
During functional activation, the increase in neuronal activity results in an increase in
oxidative metabolism that is linked to the dilation of blood vessels through the process
of neurovascular coupling. This dilation of blood vessels leads to an increase in cerebral
blood flow to the regions of neuronal activity, providing an excess supply of oxygen. This
results in regions of hyperoxygenation usually referred to as functional hyperemia.
NIRS, with the advantage of being non-invasive, has long been used as a tool to study
haemodynamic changes in response to functional activation in healthy adult volunteers.
A typical functional haemodynamic response measured by NIRS is characterised by an
increase in ∆[HbO2] and a decrease in ∆[HHb]. This has been demonstrated in several
cognitive, motor, sensory and visual studies. Obrig and Villringer provide an excellent re-
view on this topic [1]. Most studies to date have investigated functional activation via the
change in cerebral haemodynamics secondary to neuronal activity. There are certain
concerns in characterising functional activation using only vascular related changes.
One of those is the issue of false positives (the possibility of getting haemodynamic
changes similar to functional activation that are not due to neuronal activity but due
to changes in intracerebral haemodynamics caused by task-related systemic changes
and/or changes in extracerebral haemodynamics) and false negatives (the possibility of
having a neuronal-induced functional haemodynamic response being masked or atten-
uated by systemic-induced intracerebral changes or extracerebral contamination) [109].
The ∆[oxCCO], a measure of oxygen metabolism, may provide a more direct measure
of neuronal activity during functional activation. The ∆[oxCCO] signal, together with
∆[HbO2] and ∆[HHb], may offer valuable insight into understanding the mechanism of
neurovascular coupling. This is a unique feature of NIRS as a monitoring modality as it
has the ability to measure both intravascular and intracellular events simultaneously.
Despite being an appealing non-invasive marker of cellular oxygen metabolism, measur-
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ing ∆[oxCCO] signal is challenging. As a result, there are only a few studies investigating
the response of the signal during functional activation and these will be discussed here.
Using functional visual stimulation with reversing checkerboard, Heekeren et al. showed
that CCO in the occipital cortex in the adult human subjects was transiently oxidised
during functional activation and this could be measured by the ∆[oxCCO] signal using
broadband NIRS [70]. The maximum group averaged change in the concentration of ox-
CCO was 0.05 ± 0.01 µM , together with the maximum concentration changes of 0.12
± 0.03 µM and -0.10± 0.01 µM for HbO2 and HHb respectively. The authors demon-
strated that the difference attenuation spectrum between stimulation and rest could not
be fully explained by ∆[HbO]2 and ∆[HHb] alone. When ∆[oxCCO] was included in the
analysis, the difference spectrum could be fully explained and the residual of the fitting
model was randomly distributed. This is the first study of its kind showing the evidence
of an increase in the oxidation state of CCO in the adult human cortex during functional
activation. The authors suggested that this increase in ∆[oxCCO] signal was not due to
the increase in the oxygen tension but due to the decrease in the proton electrochemical
gradient that led to an increase in the rate of electron exit from CCO. Such interpretation
demonstrated evidence that the ∆[oxCCO] signal could provide an intriguing insight into
the cellular processes following functional activation.
Using two types of visual stimulation to differentially activate areas of either rich
(blob areas) or poor (interblob areas) CCO content and a layered head model to calculate
potential cross talk, Uludag et al. concluded that the changes in ∆[oxCCO] signal cannot
be modelled as a pure cross talk artefacts [71] as suggested previously using Monte
Carlo simulations on layered head model [87] and this could be taken as an argument
in favour of the existence of changes in ∆[oxCCO] in response to functional activation.
The observed change in the first part of this study for both stimuli was similar to that in
the study published previously by Heekeren et al. [70].
Kolyva et al. used a dual channel FD system and two single-channel multi-distance
CW broadband system to interrogate the same tissue segment simultaneously, and hence
determine µa and µs′ during a frontal lobe activation task. The authors reported a het-
erogeneous response of ∆[oxCCO] signal to functional activation between subjects, in the
presence of the typical haemodynamic responses. Although there was not a significant
change in the ∆[oxCCO] signal in the group average during the anagram solving task, a
majority of the subjects showed a significant increase in ∆[oxCCO] but some showed a
significant decrease. The maximum magnitude changes in ∆[oxCCO] are + 0.6 µM and -
0.4 µM for the positive and the negative changes respectively. The authors suggested that
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the heterogeneity observed in the ∆[oxCCO] signal may be due to the fact that there are
spatial and temporal variations in the response of mitochondrial redox system and that
NIR light interrogates different regions of the cortex in different subjects. This means
that observed heterogeneous responses in ∆[oxCCO] were due to the spatial sensitivity
of the measuring system rather than due to a fundamental difference in the underlying
physiology.
The result reported by Kolyva et al. raised a question of whether there is a spatial
variation in the response of ∆[oxCCO] across the cerebral cortex and whether it can be
measured using broadband spectroscopy. From our knowledge to date, a system that can
monitor ∆[oxCCO] signal across multiple regions of the cortex has not been developed
(Table 3.1). A system that has the capability of measuring ∆[oxCCO] across multiple
regions of the cortex in addition to the traditional NIRS parameters will prove useful
in providing insights into understanding mechanisms of neurovascular coupling and
oxidative metabolism in the healthy and injured brains. The existing broadband system
built by our group, the MDBBS system, will be used as a basis for the development
of a multi-channel, multi-distance broadband system. Progressive development of the
system will be discussed in chapter 4 and 5 of this thesis. Results from functional
activation experiments investigating the ∆[oxCCO] signal with the modified system will
also be discussed.
3.7 Image reconstruction methods in NIRS
Traditional NIRS devices use a small number of light sources and detectors to probe
a focal brain region of interest and provide channel-wise, time-series measurements of
changes of concentration of chromophores with good temporal resolution but with limited
spatial resolution. With an increasing number of measurement channels, it is challeng-
ing to analyse data using channel-wise analysis within a subject or among a group of sub-
jects to extract useful physiological information. Diffuse optical tomography (DOT) aims
to combine information from multi-distance, multi-channel measurements acquired in
NIRS to produce spatially resolved images [92]. These images can provide information
about specific absorption and scattering properties of biological tissues or physiological
parameters of interest and provide a different direction to analyse NIRS parameters.
Generally, DOT images can fall into two categories: topography and tomography. Al-
though the distinction between the two is blurred, topography is generally used to de-
scribe methods that produce two dimensional (2D) images with limited depth information
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while tomography is used to refer to methods that produce three dimensional (3D) im-
ages. In this thesis, images of changes in NIRS parameters will be reconstructed using
a tomographic approach, producing 3D images with depth information from measure-
ments acquired from the healthy and injured adult brains.
Recently it has been shown that distributed brain functions and networks can be
mapped with high spatial resolution using a high-density DOT system and these maps
have a strong correspondence to maps that were obtained by fMRI in the same subject
[93]. However, unlike fMRI, DOT is limited to imaging the superficial cortex and can-
not access deep subcortical brain structures. Despite this limitation, there is a strong
rationale for the use of DOT technique for its non-invasiveness and portability. It can
be used in subjects that cannot be transported into MRI machines such as neonates,
patients with implanted devices or critically ill patients in neurointensive care unit that
require bedside monitoring. Moreover, with the measurement of ∆[oxCCO], DOT has the
potential to reconstruct 3D images of cellular oxygen metabolism of the adult human
brain with high spatial resolution; this advantage has never been demonstrated before
with modalities that utilise the measurement of blood flow for imaging such as fMRI and
traditional fNIRS. This can provide an unprecedented opportunity to monitor and un-
derstand brain pathologies in which neurovascular coupling, the process that couples
changes in blood flow to changes in metabolism as discussed in chapter 2, may be dis-
turbed, resulting in an abnormal response. Such pathologies can alter the relationship
between haemodynamics and metabolism and an additional co-localised measure of cel-
lular oxygen metabolism can provide a complete picture into the pathway of pathologies
and rationale for future management strategies.
3.7.1 The process of image reconstruction
The process of reconstructing images in DOT consists of three steps: (1) acquiring a sub-
ject specific, multilayer and anatomically accurate head model; (2) modelling the process
of light transport through this head model given an array of sources and detectors (the
forward problem), (3) reconstructing images of concentration changes by solving the in-
verse problem. Each of the steps of the reconstruction process will be briefly discussed
here to provide an understanding of the reconstruction process that was utilised in this
thesis. Details of the image reconstruction method used in this thesis can be found in
[110].
To acquire a subject specific, multi-layer and anatomically accurate head model, it is
best to register a head model to subject specific anatomical MRI images. Knowledge of
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specific brain anatomy from MRI images can allow accurate registration of DOT image to
the cerebral cortex and significant improvement of the image by providing some restraints
to the ill-posed DOT image reconstruction problem. However, requiring subjects MRI
scans to perform DOT undermines the fundamental advantage of being portable and
applicable to vulnerable subjects. An alternative is to use a multilayer 3D atlas head
model that can be transformed to the specific subject space using positions of sources,
detectors and cranial landmarks of the subject’s head in 3D space, usually recorded by
electromagnetic tracking system [111], [112]. The atlas used to reconstruct images in
this thesis was built by Dr Brigadoi and Dr Cooper [113] based on the nonlinear MNI-
ICMB152 atlas [114].
To solve the forward problem, a model of how light propagates through this head model
is generated by finite-element method (FEM) approach using Toast++ [115], defining the
relationship between the changes in optical properties to changes in the measured sig-
nals. The result of this step is a grey matter sensitivity matrix or a Jacobian for any given
source detector array configuration.
To solve the inverse problem and reconstruct optical properties of tissue at each FEM
node, the solution of the forward model or the Jacobian has to be inverted and the result
is projected to a volumetric mesh and the cortical grey matter surface mesh. This step
is the most computationally expensive and under-determined.
3.7.2 Type of data needed for DOT tomography
Image reconstruction using the DOT tomography approach requires specific data sets
that have multi-distance measurement channels to probe the tissue of interest at mul-
tiple depths. Moreover, multiple overlapping channels are required to acquire sufficient
spatial resolution to distinguish localised functional brain activity. Present commercial
NIRS systems that have the capability of measuring ∆[oxCCO] do not have the capability
of acquiring multi-distance, multi-channel measurements while in-house systems de-
veloped explicitly to measure ∆[oxCCO] signal do not allow overlapping, multi-channel
measurements. In the next two chapters of this thesis, progressive development of the
MDBBS system in BORL to a multi-distance, multi-channel broadband NIRS system with
the capability of investigating ∆[oxCCO], ∆[HbO2] and ∆[HHb] over multiple regions of
the adult human brain will be discussed. Data sets collected from different stages of sys-
tem development were used to facilitate the implementation of an image reconstruction
algorithm to reconstruct concentration changes of oxCCO into tomographic images.
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Chapter 4
Development of a pseudo
broadband diffuse optical
tomography system and its
application
This chapter describes the first development of the dual-channel MDBBS system de-
scribed previously in chapter 3 into a pseudo broadband diffuse optical tomography
(DOT) system to acquire multi-channel, multi-distance broadband NIRS data sets. A
visual functional activation paradigm was used as a testing platform to test the capabil-
ity of the upgraded system to monitor ∆[oxCCO], ∆[HbO2] and ∆[HHb] across multiple
regions of the adult head. Multi-channel, multi-distance broadband NIRS data sets ac-
quired from this pilot functional activation study were used 1) to investigate the spatial
variation in the ∆[oxCCO] signal; 2) to investigate the localisation of centres of activation
and 3) to facilitate the development of an image reconstruction algorithm to reconstruct
images of ∆[oxCCO] for the first time in a human study. These analyses highlight the
benefits of having a multi-channel system for data collection in vivo.
4.1 Introduction
As discussed in the previous chapter, commercial NIRS systems do not have the capa-
bility to measure ∆[oxCCO] accurately and in-house systems developed specifically to
measure ∆[oxCCO] only have one or two channels, limiting their capability to monitor
96
4.1. INTRODUCTION
changes in one or two regions of the brain. Moreover, with only a limited number of
channels and no overlapping measurement, the method of DOT to reconstruct images
of changes in oxCCO cannot be utilised. This means that the benefits of having tomo-
graphic images that can be used for the investigation of the variation in cerebral oxygen
metabolism in the healthy brain and in brain pathologies cannot be fully realised.
There is an unmet need for a multi-channel, mutli-distance broadband NIRS system
that can monitor ∆[oxCCO] across multiple regions of the adult brain. However develop-
ing a full multi-channel broadband NIRS system requires a large investment of both time
and money. Therefore, before committing fully to the development of the new system,
a smaller step of development was taken to develop a pseudo broadband DOT system.
The system is called pseudo DOT because conventional DOT system acquires data from
multiple overlapping channels simultaneous. This system does not acquire data from
multiple overlapping channels simultaneous but rather require the physical movement
of source and detector fibres during a repeated experimental protocol, the detail of which
will be discussed in the following session. This step was crucial because it provided the
opportunity to 1) validate the feasibility of monitoring ∆[oxCCO] across multiple regions;
2) develop in vivo testing paradigms and results that can be used to benchmark future
results from the full system; 3) develop analysis algorithms for and realise the benefits
of multi-channel data sets.
In this step of development, a visual functional activation paradigm was used as a
testing platform to evaluate the capability of the system. Functional activation paradigms
have long been used as a testing platform for NIRS instruments and early NIRS studies
have established the typical haemodynamic changes in response to functional activation
[1]. Visual functional activation paradigm was chosen because it is a simple task that
only requires the subject to look at a computer screen and it can elicit a repeatable
response in the visual cortex of the human brain. Additionally, the visual cortex is
accessible for NIRS as it is a superficial brain structure in the occipital lobe of the brain.
The aims of the work presented in this chapter are to 1) develop a pseudo broadband
DOT system that can assess the feasibility of monitoring ∆[oxCCO] across multiple re-
gions of the healthy adult human brain; 2) to introduce analysis techniques that can be
used for multi-channel data sets of ∆[HbO2], ∆[HHb] and ∆[oxCCO] 3) to evaluate the
feasibility of reconstructing tomographic images of ∆[oxCCO] using the multi-distance,
multi-channel broadband NIRS data sets.
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4.2 Challenges
4.2.1 Technical challenges for oxCCO measurement
As discussed previously, monitoring ∆[oxCCO] is challenging because of the low in vivo
concentration of CCO in comparison to a much higher concentration of haemoglobin and
of the overlapping of the absorption spectra of these compounds. This makes it difficult
to separate the ∆[oxCCO] signal from the generally much larger haemoglobin signals.
However, it has been shown that broadband NIRS technology with the UCLn algorithm
can robustly resolve oxCCO signal with minimal cross talk artefacts [88]. Therefore, the
pseudo broadband DOT system was based on the the MDBBS broadband NIRS instru-
ment.
4.2.2 Challenges in experimental protocol
In order to evaluate the capability of the pseudo DOT system, a brain activation task with
a clear regional variation of the response was necessary. The task also needs to produce
a reproducible functional response. Moreover, it is of great preference to have a passive
task to minimise the effect of the variation in the level of concentration and attention of
volunteers which can introduce more complexity to the haemodynamic response. Visual
activation with a flickering checkerboard fulfils all the criteria. Moreover, Heekeren and
Uludag have demonstrated that this task can activate the visual cortex with measurable
∆[oxCCO] changes [70], [71].
4.2.3 Challenges in multi-channel measurement
Multi-channel measurement is by itself challenging because of the issues of multi-fibre-
scalp coupling, source-detector encoding, array ergonomics and data quality manage-
ment. Overcoming these issues requires integrative advances in fibre-optic cap design,
experimental design, encoding/decoding methods and analysis algorithm.
4.3 Methods
The pseudo broadband DOT system was developed using the optical components of the
MDBBS system with a slight modification in the hardware at the subject end.
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4.3.1 Basic components of the pseudo broadband DOT system
The pseudo broadband DOT system has one customised halogen bulb light source which
is connected to a light source fibre with a fibre diameter of 4 mm. The system has
two customised spectrometers, each of which is connected to four detectors fibres. The
details of these optical components were given in Chapter 3. As a result, the system
can collect data from eight NIRS measurement channels simultaneously. To achieve
a higher number of measurement channels using this configuration, the source and
detector fibres were physically moved across a probe holder fixed on the occipital cortex
while repeating the functional activation paradigm. As a result, the probe holder had to
be redesigned to have multiple slots for source fibre and detector fibres. Moreover, a new
experimental protocol was developed to facilitate the data collection process.
4.3.2 Probe holder development
A new probe holder was designed using AutoCAD (AutoDesk, USA) to incorporate four
source slots (red) and 14 detector slots (blue) as shown in Figure 4.1 and 4.2a to pro-
vide the flexibility to move the source and detector fibres to reproduce multi-channel
measurements. This design enables measurement channels with source-detector sep-
arations of 25 mm and 37.75 mm. The probe holder was 3D printed using Object500
Connex 3D printer (Stratasys, USA) using a mixture of flexible black material (TangoB-
lack) and hard white material (VeroWhite) (Figure 4.2b). This ensures that the probe
holder can hold the fibres in place and is flexible to curve around the curvature of the
head for good optical coupling.
2537.75
20
20
Source slot
Detector slot
Figure 4.1: Probe holder was redesigned to have multiple slots for source and detector
fibres to facilitate multi-distance, multi-channel measurements using one source fibre
and eight detector fibres of the pseudo DOT system.
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a) b)
Figure 4.2: a) 3D probe holder design in AutoCaD. b) 3D printed probe holder using a
mixture of hard (white) and soft (black) material.
Figure 4.3 shows the channels of measurement that can be acquired when the source
fibre is at the first source location and eight detector fibres are arranged symmetrically
above and below it. Figure 4.4 shows all 32 measurements channels that can be acquired
by repeating the functional activation paradigm four times while moving the source and
detector fibres along the fixed probe holder for each repetition.
1 2 3 4
5 6 7 8
Figure 4.3: Measurement channels acquired in the first repeat of the functional acti-
vation paradigm with the source fibre fixed in the first source slot position and eight
detector fibres arranged symmetrically above and below it.
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Figure 4.4: All 32 measurement channels acquired after four repeats of the experimental
paradigm. Measurement channels acquired during the first repeat are shown in green
while those acquired during the second, third and fourth repeats are shown in magenta,
blue and red respectively.
4.3.3 Experimental paradigm design
Visual functional activation was achieved with a 4 Hz inverting checkerboard (Figure
4.5a) coded in Matlab (Mathworks, USA) using Psychtoolbox 3. Resting condition was
achieved by a black screen with a centred white cross to keep subjects eyes in focus
(Figure 4.5b). The experimental paradigm consisted of 10 epochs, each of which had
20 s of stimulation followed by 20 s of rest. The experimental paradigm was repeated
four times for each subject. For each repeat, the source fibre and detector fibres were
positioned in one of the four sets of locations (as demonstrated in figure 4.4) to collect
an aggregate of 32 measurement channels.
101
4.3. METHODS
(a) Visual stimulation was achieved by a full field 4 Hz
flickering checkerboard. This was coded in Matlab us-
ing Psychtoolbox 3.
(b) Resting condition with black screen and a
centred white cross for keeping eyes at focus.
Figure 4.5: Functional activation paradigm. The paradigm consisted of 10 epochs, each
with 20 s of visual stimulation followed by 20 s of resting condition. The paradigm was
repeated four times for each of the four source positions of the probe holder. One source
fibre and eight detector fibres were used to collect intensity data at each repeat.
4.3.4 Participant set-up and experimental protocol
Following ethics approval and volunteer consent, four healthy adults (two males and two
females; age range from 27 to 48 years old) were studied. For each subject, the probe
holder was fixed horizontally at the back of the head using velcro straps to cover the
left visual cortex with the fourth source slot positioned over Oz (10/20 EEG position)
as shown in Figure 4.6. The location of the probe on the subject head was recorded
using a Digitiser (Pohemus, USA). With this placement of the probe holder, measurement
channels numbered 17 to 32 were expected to probe the primary left visual cortex V1
and therefore could monitor the functional response. Hair was cleared out of all slots
before the insertion of optical fibres. One source fibre was placed at the first source
slot while eight detector fibres were populated in eight nearest detector slots to collect
intensity data continuously during 10 epochs. This was repeated for each of the four
source slots by translating the fibres over the fixed probe holder, yielding an aggregate
of 32 measurement channels. The whole procedure took two hours for each subject.
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Figure 4.6: Fixation of the probe holder onto subject head using a Velcro strap. The
fourth source slot of the probe holder was positioned over Oz (10/20 EEG). The figure
shows the source fibre in the fourth source slot position with eight detector fibres ar-
ranged above and below the source fibre. The experimental paradigm was repeated four
times, one for each source slot position. Detector fibres and source fibre were translated
horizontally for each repeat.
4.3.5 Data analysis
An algorithm was developed to analyse the multi-channel data sets collected in this
study. All data analysis techniques were coded in Matlab (version R2013a, Mathworks,
USA). The intensity data were used to calculate the differential attenuation (∆A). For
each of the 32 channels, concentration changes of oxygenated haemoglobin (∆HbO2),
deoxygenated haemoglobin(∆[HHb]), and oxidised cytochrome c oxidase (∆[oxCCO]) were
calculated by fitting the attenuation spectra over the wavelength range from 780 nm to
900 nm using the UCLn algorithm as described previously in chapter 3. Source-detector
separation and DPF were used to calculate the optical path length in the UCLn algo-
rithm. The DPF at 807 nm was assumed to be 6.26 for all detectors and the wavelength
dependence of the DPF was taken into account as DPF falls with increasing wavelength.
This analysis technique is similar to what has been described previously by Kolyva et
al. [12]. The concentration changes were band-pass filtered using a fifth-order But-
terworth filter with cutoff frequencies of 0.01 and 0.25 Hz. As a result, there were 32
time-series data sets of concentration changes for each of the four subjects, each has
400 data points ( 10 x 40 s). Concentration changes for each subject were zero-baselined
and averaged across epochs producing 32 sets of 40 s traces corresponding to 20 s of
stimulation and 20 s of resting. For statistical analysis, the baseline period was defined
as the first 10 seconds after the start of the visual stimulation and the activation pe-
riod was defined as 10 seconds from 25th second to 35th second after the start of the
visual stimulation. To calculate the group response to visual stimulation, concentration
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changes of ∆HbO2, ∆[HHb] and ∆[oxCCO] from a channel with maximal oxyhaemoglobin
changes from each subject were chosen for averaging. Unpaired student t-test was used
to compare the means of the selected baseline and activation points to assess whether
there was a group significant change during the activation period in comparison with
the baseline period.
Centre of gravity (CoG) analysis was applied to the time-course data sets to investigate
the localisation of the centre of activation for each of the three chromophores using the
25 mm channels [116]. The location of the lower left detector slot constituting channel 5
(Figure 4.4) was taken as the origin for calculating x, y coordinates for this analysis and
all units were in mm. The NIRS CoG was determined using mean response amplitudes
of the changes occurring during time t=15s to 20s of each individual epoch and the
coordinates of the channels (equations 4.1 and 4.2). The NIRS CoGs were calculated for
HbO2, HHb and oxCCO separately. Ten epochs produced 10 CoGs for each chromophore.
Mean coordinates of the 10 centres were calculated to produce the final CoG for each
chromophore with 95% CI.
XCoG =
∑
aiXi/
∑
ai (4.1)
YCoG =
∑
aiYi/
∑
ai (4.2)
where ai represents the mean amplitude change of ∆[HbO2], ∆[HHb] or ∆[oxCCO] at
coordinates Xi and Yi.
4.3.6 Image reconstruction procedure
The multi-distance, multi-channel spectroscopic data sets were used to reconstruct 3D
images of concentration changes of ∆[HbO2], ∆[HHb] and ∆[oxCCO] by a multispectral
approach [110]. This part of the work was done by Dr Brigadoi and I collected and
processed the data sets into format that can be used for image reconstruction. Data
at seventeen wavelengths were selected from the measured broadband spectrum (every
10 nm from 740 nm to 900 nm) to perform the reconstruction. TOAST++ software was
used to run the forward model on the registered adult volumetric mesh and the Tikhonov
regularised least-square solution was used to solve the inverse problem. The volumetric
images were then projected on the cortical surface mesh.
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4.4 Results
4.4.1 Spectroscopic results
Figure 4.7 shows the concentration changes of the three chromophores in channel 1 from
subject 1. According to the placement of the source and detector fibres in probe holder
on the occipital cortex, this channel was off the visual cortex and as a result, concentra-
tion changes measured from this channel did not show the functional response. On the
other hand, Figure 4.8 shows the concentration changes measured by channel 20. This
channel was likely to probe the visual cortex and as a result, a clear functional response
could be seen in the concentration changes of the three chromophores from this channel.
A typical haemodynamic response was observed as an increase in ∆[HbO2] coupled with
a decrease in ∆[HHb] during each stimulation period of the 10 epochs. These signals re-
turned to the pre-activation level during the resting period. ∆[oxCCO] increased during
the activation period and returned to pre-activation level during the resting period. Over-
all, the results suggest that visual stimulation by inverting checkerboard produces a very
reproducible response in term of both haemodynamic and metabolic changes that can
be measured by NIRS. Figure 4.9 shows ∆[oxCCO] from channel 20 by itself. ∆[oxCCO]
signal demonstrated a clear increase in response to each visual stimulation period with
a highly reproducible response.
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Figure 4.7: Time series concentration changes of HbO2 (red), HHb (blue) and oxCCO
(green) in channel 1 showing no functional response. The 20 s visual stimulation period
is shaded in grey.
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Figure 4.8: Time series concentration changes of HbO2 (red), HHb (blue) and oxCCO
(green) in channel 20 showing a functional response. The 20 s visual stimulation period
is shaded in grey. Reproducible changes are evident for each single epoch of the stimu-
lation and rest. Two time points are marked as end of resting and end of stimulation for
the comparison of the raw optical signals in later figure.
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Figure 4.9: Time series concentration changes of oxCCO (green) in channel 20 from
subject 1 showing functional activation. The 20 s visual stimulation period is shaded in
grey.
Figure 4.10a shows the raw intensity measured during two time points marked as
end of resting and end of stimulation in Figure 4.8. At the end of the post-stimulus
rest period, an increase in the measured intensity spectrum was evident which may be
suggestive of a decrease in CBF. This is evident in the figure as there is a higher in-
tensity spectrum of the red trace in comparison to the blue trace. Figure 4.10b shows
the ∆A calculated from the intensity spectrum of the two time points. Attenuation of
NIR light at the end of resting was lower than that at the end of stimulation. This may
also be explained by the decrease in CBF during the resting period. Figure 4.10c shows
the measured ∆A and the back-projected ∆A for two fitting models. The red line rep-
resents ∆A back-projected from the concentration changes calculated using the three
106
4.4. RESULTS
component fitting model (including oxCCO). The blue line represents ∆A back-projected
from concentration changes calculated using the two component fitting model (exclud-
ing oxCCO). Figure 4.10d shows the residual (measured ∆A - back-projected ∆A) of the
two-component fitting model, the residual of the three-component fitting model and the
residual difference between the two. The shape of the residual difference is similar to
the ox-redCCO spectra.
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Figure 4.10: a) The measured intensity spectra at the end of resting and end of stimu-
lation in channel 20. b) Calculated delta attenuation at these two time points. c) The
measured attenuation and the back-projected attenuation from concentration changes
using the 2-component model fit and the 3-component model fit. d) The residual (the
difference between the measured attenuation and the back-projected attenuation) of the
2-component fitting model, the residual of the 3-component fitting model and the resid-
ual difference.
Figure 4.11 shows the block-averaged concentration changes of HbO2, HHb and ox-
CCO with standard deviation calculated from the time-series changes shown in Figure
4.8. Typical haemodynamic response to functional activation was evident as an increase
in ∆[HbO2] and a decrease in ∆[HHb]. ∆[oxCCO] increased during the stimulation period
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and returned the pre-activation level during the resting period.
Figure 4.11: Block averaged concentration changes of HbO2 (red), HHb (blue) and oxCCO
(green) in channel 20 of subject 1. The visual stimulation period is shown as the shaded
grey area. Typical haemodynamic response to functional activation is evident as an
increase in ∆[HbO2], a decrease in ∆[HHb]. ∆[oxCCO] increased during the stimulation
period and returned the pre-activation level during the resting period
Figure 4.12 shows the block-averaged concentration changes of HbO2, HHb and ox-
CCO for all 32 measurement channels from subject 1. The first row of plots (channel
1 to 8) in the figure shows the concentration changes measured by channels when the
source fibre was at source position 1 of the probe holder. The second (channel 9 to
16), third (channel 17 to 24) and fourth rows (channel 25 to 32) show the concentration
changes measured by channels when the source fibre was at source positions 2, 3 and
4 respectively. Channels are displayed such that 16 channels on the left half of the plot
have the same separations of 37.75 mm and 16 channels on the right half have the same
separation of 25 mm. Overall, functional activation response is evident in 21 out of 32
channels, probing a localised brain area underneath source position 3 and 4. Figure
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4.13 shows the blocked averaged concentration changes of oxCCO by itself. An increase
in the concentration of oxCCO was evident in almost all channels originating from source
position 3 and 4. This maybe because at those two source locations, the source fibre
was directly on top of the left primary visual cortex and as a result, functional activation
could be seen in all the channels.
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Figure 4.12: Block averaged concentration changes of HbO2 (red), HHb (blue) and oxCCO
(green) in all 32 channels of subject 1. Changes in concentration of HbO2, HHb and
oxCCO corresponding to functional activation are highlighted by red border.
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Figure 4.13: Block averaged concentration changes oxCCO in all 32 channels of subject
1.
Table 4.1 shows the mean, standard deviation and the maximum value of the ∆[HbO2],
∆[HHb] and ∆[oxCCO] for all 32 channels of subject 1 in µM.
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Table 4.1: Mean, standard deviation and the max value of ∆[HbO2], ∆[HHb] and
∆[oxCCO] from the block-averaged changes for all 32 channels for subject 1.
∆[HbO2] (µM) ∆[HHb] (µM) ∆[oxCCO] (µM)
Ch. mean std max ∆ mean std max ∆ mean std max ∆
1 0.057 0.051 0.160 -0.012 0.040 -0.072 0.008 0.016 0.036
2 0.078 0.063 0.185 0.026 0.030 -0.053 -0.014 0.016 0.029
3 0.044 0.053 0.146 0.049 0.037 -0.014 -0.002 0.018 0.038
4 0.133 0.088 0.255 -0.033 0.055 -0.124 0.012 0.028 0.067
5 0.073 0.044 0.149 0.008 0.017 -0.026 0.000 0.011 0.018
6 0.088 0.060 0.202 -0.014 0.017 -0.048 -0.002 0.006 0.011
7 0.047 0.061 0.160 -0.007 0.045 -0.092 0.012 0.020 0.065
8 0.070 0.058 0.151 -0.026 0.027 -0.080 0.016 0.016 0.040
9 0.087 0.069 0.200 -0.048 0.056 -0.158 0.010 0.019 0.053
10 0.031 0.054 0.125 -0.066 0.056 -0.158 0.035 0.027 0.084
11 0.095 0.110 0.245 -0.157 0.101 -0.306 0.049 0.033 0.107
12 0.260 0.210 0.500 -0.291 0.207 -0.528 0.101 0.070 0.191
13 -0.008 0.035 0.069 -0.053 0.044 -0.124 0.012 0.011 0.031
14 -0.009 0.062 0.128 -0.062 0.051 -0.149 0.010 0.014 0.040
15 0.064 0.077 0.195 -0.042 0.065 -0.190 0.008 0.018 0.039
16 0.057 0.072 0.168 -0.090 0.098 -0.215 0.038 0.035 0.089
17 0.210 0.162 0.402 -0.171 0.136 -0.332 0.040 0.037 0.088
18 0.232 0.204 0.451 -0.179 0.156 -0.367 0.048 0.038 0.095
19 0.432 0.337 0.827 -0.279 0.196 -0.521 0.072 0.045 0.145
20 0.361 0.275 0.690 -0.238 0.207 -0.471 0.073 0.066 0.149
21 0.115 0.124 0.257 -0.175 0.111 -0.310 0.055 0.041 0.112
22 0.119 0.142 0.274 -0.158 0.102 -0.293 0.055 0.037 0.101
23 0.234 0.208 0.470 -0.120 0.098 -0.257 0.043 0.038 0.106
24 0.134 0.139 0.296 -0.105 0.089 -0.229 0.055 0.042 0.120
25 0.387 0.236 0.626 -0.206 0.200 -0.453 0.077 0.073 0.172
26 0.393 0.254 0.738 -0.283 0.180 -0.495 0.064 0.038 0.118
27 0.134 0.109 0.398 -0.120 0.070 -0.212 0.050 0.034 0.110
28 0.414 0.236 0.715 -0.206 0.149 -0.378 0.064 0.060 0.145
29 0.202 0.107 0.327 -0.124 0.096 -0.263 0.051 0.044 0.113
30 0.083 0.066 0.250 -0.063 0.047 -0.152 0.026 0.024 0.062
31 0.044 0.066 0.198 0.027 0.030 -0.044 -0.003 0.017 0.033
32 0.092 0.050 0.178 -0.045 0.037 -0.106 0.031 0.023 0.067
Similarly, Figure 4.14 shows the block-averaged concentration changes of HbO2, HHb
and oxCCO and Figure 4.15 shows the concentration changes of oxCCO for the second
subject. Table 4.2 provides a summary of mean changes, standard deviation and maxi-
mum changes of the three chromophores from the block-averaged changes from subject
2. In this subject, changes in HbO2, HHb and oxCCO corresponding to functional acti-
vation were evident in 27 out of 32 channels.
111
4.4. RESULTS
0 20 40
-0.5
0
0.5
1
Ch1
0 20 40
-0.5
0
0.5
1
Ch4
0 20 40
-0.5
0
0.5
1
Ch5
0 20 40
-0.5
0
0.5
1
Ch8
0 20 40
-0.5
0
0.5
1
Ch2
0 20 40
-0.5
0
0.5
1
Ch3
0 20 40
-0.5
0
0.5
1
Ch6
0 20 40
-0.5
0
0.5
1
Ch7
0 20 40
Co
nc
en
tra
tio
n 
Ch
an
ge
s (
uM
)
-0.5
0
0.5
1
Ch9
0 20 40
-0.5
0
0.5
1
Ch12
0 20 40
-0.5
0
0.5
1
Ch13
0 20 40
-0.5
0
0.5
1
Ch16
0 20 40
-0.5
0
0.5
1
Ch10
0 20 40
-0.5
0
0.5
1
Ch11
0 20 40
-0.5
0
0.5
1
Ch14
0 20 40
-0.5
0
0.5
1
Ch15
0 20 40
-0.5
0
0.5
1
Ch17
0 20 40
-0.5
0
0.5
1
Ch20
0 20 40
-0.5
0
0.5
1
Ch21
0 20 40
-0.5
0
0.5
1
Ch24
0 20 40
-0.5
0
0.5
1
Ch18
0 20 40
-0.5
0
0.5
1
Ch19
0 20 40
-0.5
0
0.5
1
Ch22
0 20 40
-0.5
0
0.5
1
Ch23
Time(s)
0 20 40
-0.5
0
0.5
1
Ch25
Time(s)
0 20 40
-0.5
0
0.5
1
Ch28
Time(s)
0 20 40
-0.5
0
0.5
1
Ch29
Time(s)
0 20 40
-0.5
0
0.5
1
Ch32
Time(s)
0 20 40
-0.5
0
0.5
1
Ch26
Time(s)
0 20 40
-0.5
0
0.5
1
Ch27
Time(s)
0 20 40
-0.5
0
0.5
1
Ch30
Time(s)
0 20 40
-0.5
0
0.5
1
Ch31
Channels with SDS = 37.75 mm Channels with SDS = 25 mm 
Figure 4.14: Block averaged concentration changes of HbO2 (red), HHb (blue) and oxCCO
(green) in all 32 channels of subject 2.
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Figure 4.15: Block averaged concentration changes oxCCO in all 32 channels of subject
2.
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Table 4.2: Mean, standard deviation and the maximum value of ∆[HbO2], ∆[HHb] and
∆[oxCCO] from the block-averaged changes for all 32 channels for subject 2.
∆[HbO2] (µM) ∆[HHb] (µM) ∆[oxCCO] (µM)
Ch. mean std max ∆ mean std max ∆ mean std max ∆
1 0.156 0.082 0.292 -0.034 0.041 -0.095 -0.004 0.014 0.022
2 0.212 0.112 0.392 -0.013 0.041 -0.099 0.001 0.014 0.031
3 0.300 0.154 0.523 -0.106 0.091 -0.273 0.027 0.026 0.076
4 0.345 0.200 0.608 -0.155 0.156 -0.357 0.022 0.032 0.079
5 0.102 0.077 0.243 -0.015 0.027 -0.056 0.003 0.008 0.017
6 0.086 0.080 0.241 -0.009 0.024 -0.058 0.002 0.009 0.023
7 0.176 0.109 0.372 -0.049 0.053 -0.136 0.039 0.025 0.086
8 0.299 0.195 0.560 -0.166 0.133 -0.337 0.049 0.037 0.100
9 0.096 0.120 0.294 -0.120 0.111 -0.286 0.030 0.028 0.071
10 0.110 0.121 0.302 -0.152 0.109 -0.304 0.032 0.029 0.084
11 0.097 0.148 0.336 -0.192 0.150 -0.388 0.060 0.042 0.114
12 0.210 0.208 0.514 -0.248 0.234 -0.553 0.057 0.058 0.150
13 0.164 0.164 0.395 -0.119 0.133 -0.298 0.037 0.040 0.091
14 0.200 0.199 0.459 -0.138 0.144 -0.327 0.041 0.040 0.099
15 0.226 0.230 0.552 -0.208 0.181 -0.412 0.062 0.052 0.125
16 0.369 0.341 0.819 -0.399 0.331 -0.826 0.135 0.110 0.290
17 0.336 0.335 0.904 -0.281 0.303 -0.674 0.088 0.093 0.216
18 0.241 0.262 0.760 -0.240 0.228 -0.502 0.076 0.076 0.173
19 0.301 0.310 0.852 -0.279 0.251 -0.620 0.087 0.074 0.188
20 0.387 0.371 1.008 -0.357 0.328 -0.748 0.104 0.091 0.221
21 0.264 0.241 0.637 -0.292 0.251 -0.596 0.097 0.084 0.205
22 0.216 0.198 0.543 -0.226 0.236 -0.527 0.088 0.082 0.206
23 0.312 0.303 0.799 -0.246 0.255 -0.569 0.085 0.087 0.209
24 0.337 0.326 0.844 -0.282 0.277 -0.628 0.120 0.104 0.268
25 0.358 0.414 0.839 -0.307 0.308 -0.682 0.120 0.107 0.273
26 0.392 0.465 0.885 -0.314 0.281 -0.644 0.082 0.060 0.163
27 0.226 0.315 0.557 -0.198 0.178 -0.399 0.064 0.040 0.126
28 0.248 0.309 0.597 -0.223 0.220 -0.456 0.084 0.064 0.164
29 0.173 0.239 0.429 -0.205 0.170 -0.404 0.095 0.085 0.202
30 0.180 0.318 0.521 -0.181 0.152 -0.374 0.085 0.061 0.171
31 0.074 0.208 0.292 -0.126 0.105 -0.267 0.072 0.048 0.136
32 0.115 0.180 0.320 -0.101 0.076 -0.211 0.040 0.033 0.097
Figure 4.16 shows the block-averaged concentration changes of HbO2, HHb and ox-
CCO and Figure 4.17 shows the concentration changes of oxCCO for the third sub-
ject. Table 4.3 provides a summary of mean changes, standard deviation and maximum
changes of the three chromophores from the block-averaged changes from subject 3. In
this subject, changes in HbO2, HHb and oxCCO corresponding to functional activation
are observed in 15 out of 32 channels.
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Figure 4.16: Block averaged concentration changes of HbO2 (red), HHb (blue) and oxCCO
(green) in all 32 channels of subject 3.
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Figure 4.17: Block averaged concentration changes oxCCO in all 32 channels of subject
3.
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Table 4.3: Mean, standard deviation and the maximum value of ∆[HbO2], ∆[HHb] and
∆[oxCCO] from the block-averaged changes for all 32 channels for subject 3.
∆[HbO2] (µM) ∆[HHb] (µM) ∆[oxCCO] (µM)
Ch. mean std max ∆ mean std max ∆ mean std max ∆
1 0.015 0.030 0.098 -0.057 0.063 -0.166 0.020 0.021 0.067
2 -0.025 0.034 0.026 -0.028 0.058 -0.145 0.003 0.022 0.066
3 0.069 0.064 0.188 -0.109 0.043 -0.168 0.031 0.013 0.052
4 0.141 0.124 0.307 -0.099 0.099 -0.241 0.028 0.035 0.085
5 -0.026 0.017 0.002 0.002 0.016 -0.031 -0.002 0.005 0.010
6 -0.040 0.028 0.018 0.006 0.012 -0.011 0.001 0.007 0.014
7 -0.063 0.036 0.007 0.011 0.028 -0.030 0.005 0.012 0.030
8 -0.048 0.024 0.003 0.027 0.034 -0.038 -0.003 0.011 0.016
9 0.255 0.174 0.463 -0.135 0.100 -0.278 0.024 0.025 0.065
10 0.275 0.195 0.519 -0.221 0.161 -0.428 0.061 0.047 0.130
11 0.390 0.293 0.736 -0.261 0.190 -0.501 0.099 0.070 0.191
12 0.647 0.509 1.271 -0.336 0.275 -0.693 0.101 0.080 0.209
13 0.022 0.021 0.072 0.002 0.009 -0.017 0.000 0.004 0.007
14 0.026 0.024 0.064 0.002 0.027 -0.036 0.000 0.008 0.014
15 -0.005 0.030 0.051 -0.002 0.017 -0.035 0.013 0.008 0.027
16 0.021 0.019 0.056 -0.010 0.017 -0.044 0.008 0.008 0.024
17 0.527 0.449 1.095 -0.304 0.244 -0.597 0.065 0.067 0.152
18 0.515 0.481 1.116 -0.278 0.286 -0.635 0.052 0.069 0.145
19 0.405 0.393 0.891 -0.263 0.229 -0.583 0.063 0.053 0.144
20 0.252 0.250 0.588 -0.152 0.133 -0.350 0.041 0.036 0.108
21 0.081 0.154 0.301 -0.117 0.099 -0.241 0.048 0.044 0.109
22 -0.014 0.100 0.139 -0.093 0.082 -0.202 0.046 0.047 0.119
23 -0.023 0.102 0.116 -0.072 0.083 -0.214 0.048 0.043 0.117
24 0.021 0.083 0.161 -0.099 0.065 -0.197 0.033 0.027 0.086
25 0.226 0.203 0.497 -0.162 0.122 -0.319 0.066 0.047 0.127
26 0.077 0.092 0.187 -0.038 0.073 -0.171 0.015 0.022 0.058
27 0.092 0.094 0.261 0.019 0.069 -0.122 -0.003 0.024 0.038
28 0.217 0.166 0.428 -0.186 0.127 -0.383 0.051 0.041 0.117
29 -0.049 0.031 0.001 -0.027 0.023 -0.072 0.009 0.005 0.019
30 -0.069 0.042 0.012 -0.030 0.031 -0.122 0.019 0.012 0.041
31 -0.014 0.027 0.017 -0.032 0.022 -0.070 0.001 0.007 0.014
32 -0.020 0.020 0.015 -0.015 0.025 -0.068 -0.001 0.006 0.015
Figure 4.18 shows the block-averaged concentration changes of HbO2, HHb and ox-
CCO and Figure 4.19 shows the concentration changes of oxCCO for the fourth sub-
ject. Table 4.4 provides a summary of mean changes, standard deviation and maximum
changes of the three chromophores from the block-averaged changes from subject 4. In
this subject, changes in HbO2, HHb and oxCCO corresponding to functional activation
were evident in 11 out of 32 channels. Especially in this subject, there was a decrease
in ∆[HbO2] in some measurement channels such as channel 11. This may be caused
by contamination due to extracerebral changes. In the same channel, concentration
changes of oxCCO showed a clear increase in response to the functional activation task.
115
4.4. RESULTS
0 20 40
-0.5
0
0.5
1 Ch1
0 20 40
-0.5
0
0.5
1 Ch4
0 20 40
-0.5
0
0.5
1 Ch5
0 20 40
-0.5
0
0.5
1 Ch8
0 20 40
-0.5
0
0.5
1 Ch2
0 20 40
-0.5
0
0.5
1 Ch3
0 20 40
-0.5
0
0.5
1 Ch6
0 20 40
-0.5
0
0.5
1 Ch7
0 20 40
Co
nc
en
tra
tio
n 
Ch
an
ge
s (
uM
)
-0.5
0
0.5
1 Ch9
0 20 40
-0.5
0
0.5
1 Ch12
0 20 40
-0.5
0
0.5
1 Ch13
0 20 40
-0.5
0
0.5
1 Ch16
0 20 40
-0.5
0
0.5
1 Ch10
0 20 40
-0.5
0
0.5
1 Ch11
0 20 40
-0.5
0
0.5
1 Ch14
0 20 40
-0.5
0
0.5
1 Ch15
0 20 40
-0.5
0
0.5
1 Ch17
0 20 40
-0.5
0
0.5
1 Ch20
0 20 40
-0.5
0
0.5
1 Ch21
0 20 40
-0.5
0
0.5
1 Ch24
0 20 40
-0.5
0
0.5
1 Ch18
0 20 40
-0.5
0
0.5
1 Ch19
0 20 40
-0.5
0
0.5
1 Ch22
0 20 40
-0.5
0
0.5
1 Ch23
Time(s)
0 20 40
-0.5
0
0.5
1 Ch25
Time(s)
0 20 40
-0.5
0
0.5
1 Ch28
Time(s)
0 20 40
-0.5
0
0.5
1 Ch29
Time(s)
0 20 40
-0.5
0
0.5
1 Ch32
Time(s)
0 20 40
-0.5
0
0.5
1 Ch26
Time(s)
0 20 40
-0.5
0
0.5
1 Ch27
Time(s)
0 20 40
-0.5
0
0.5
1 Ch30
Time(s)
0 20 40
-0.5
0
0.5
1 Ch31
Channels with SDS = 37.75 mm Channels with SDS = 25 mm 
Figure 4.18: Block averaged concentration changes of HbO2 (red), HHb (blue) and oxCCO
(green) in all 32 channels of subject 4.
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Figure 4.19: Block averaged concentration changes oxCCO in all 32 channels of subject
4.
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Table 4.4: Mean, standard deviation and the maximum value of ∆[HbO2], ∆[HHb] and
∆[oxCCO] from the block-averaged changes for all 32 channels for subject 4.
∆[HbO2] (µM) ∆[HHb] (µM) ∆[oxCCO] (µM)
Ch. mean std max ∆ mean std max ∆ mean std max ∆
1 0.132 0.107 0.390 -0.003 0.086 -0.317 0.003 0.017 0.046
2 0.142 0.102 0.317 0.026 0.036 -0.050 0.000 0.013 0.028
3 0.374 0.184 0.725 -0.153 0.115 -0.429 0.015 0.035 0.091
4 0.139 0.084 0.251 0.089 0.059 -0.006 -0.017 0.026 0.037
5 0.157 0.092 0.284 0.035 0.035 -0.034 -0.001 0.005 0.011
6 0.190 0.129 0.381 0.049 0.037 -0.016 0.010 0.012 0.032
7 0.209 0.129 0.392 0.027 0.059 -0.089 0.024 0.015 0.047
8 0.148 0.092 0.289 0.042 0.049 -0.023 0.019 0.016 0.054
9 -0.099 0.159 0.188 -0.125 0.085 -0.250 0.048 0.028 0.084
10 -0.226 0.233 0.164 -0.099 0.103 -0.256 0.050 0.035 0.117
11 -0.228 0.203 0.122 -0.094 0.106 -0.258 0.069 0.050 0.153
12 -0.049 0.117 0.173 -0.080 0.109 -0.226 0.033 0.043 0.098
13 -0.173 0.168 0.147 0.003 0.026 -0.036 -0.014 0.018 0.022
14 -0.234 0.220 0.113 -0.051 0.041 -0.117 0.003 0.019 0.042
15 -0.262 0.211 0.053 -0.039 0.029 -0.090 -0.005 0.035 0.068
16 -0.218 0.179 0.084 0.009 0.032 -0.059 -0.012 0.016 0.032
17 0.346 0.260 0.688 -0.167 0.193 -0.415 0.086 0.089 0.198
18 0.357 0.237 0.695 -0.135 0.190 -0.388 0.067 0.085 0.195
19 0.326 0.208 0.655 -0.152 0.183 -0.408 0.087 0.080 0.199
20 0.252 0.159 0.500 -0.105 0.158 -0.334 0.044 0.062 0.125
21 0.082 0.087 0.300 -0.001 0.027 -0.042 0.006 0.008 0.020
22 0.065 0.112 0.335 -0.002 0.040 -0.079 0.003 0.010 0.023
23 0.097 0.124 0.416 0.006 0.033 -0.047 -0.001 0.012 0.018
24 0.055 0.086 0.274 0.060 0.036 -0.012 -0.007 0.017 0.025
25 0.280 0.203 0.632 -0.031 0.052 -0.107 0.026 0.033 0.082
26 0.293 0.252 0.804 0.011 0.031 -0.039 0.005 0.013 0.036
27 0.260 0.227 0.715 -0.021 0.055 -0.129 0.014 0.024 0.060
28 0.251 0.163 0.534 0.006 0.040 -0.051 0.009 0.024 0.049
29 0.286 0.233 0.789 0.036 0.048 -0.073 0.003 0.008 0.015
30 0.359 0.274 0.897 0.040 0.040 -0.034 -0.007 0.013 0.018
31 0.461 0.323 1.104 0.137 0.110 -0.077 -0.051 0.037 0.032
32 0.249 0.205 0.682 0.057 0.044 -0.036 0.005 0.014 0.038
Figure 4.20 shows the group average concentration changes of HbO2, HHb and oxCCO
for the visual stimulation experiment. There were significant changes (p < 0.05) in the
concentration of these chromophores during the functional activation period.
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Figure 4.20: Group averaged concentration changes of HbO2 (red), HHb (blue) and ox-
CCO (green) and standard error of means calculated using changes from a channel with
maximal concentration changes in each subject. The visual stimulation period is shown
as the shaded grey window. There were significant changes (p < 0.05) in the concentra-
tion of the three chromophores during the functional activation period.
4.4.2 Centre of gravity analysis
Figure 4.21 shows the locations of the CoGs for each chromophore relative to the location
of the probe holder. Fourteen solid blue circles indicate fourteen locations of detector
slots. Four solid red circles indicate the locations of four source slots. Solid black circles
indicate the locations of the measurement channels. Individual red, blue and green ring
circles denote the x-y location of the calculated CoGs for each of the 10 epochs for HbO2,
HHb and oxCCO respectively. The final CoG for each chromophore is indicated by the
crosses. As can be seen from the figure, centres of activation for all three chromophores
lie between source slots 2 and 3.
Figure 4.22 shows a close-up view of Figure 4.21 to assess the overlapping between
CoGs of different chromophores. As can be seen from the figure, the final CoGs of HbO2
and oxCCO show some degree of overlapping while the CoG of HHb lies separated from
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the other two.
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Figure 4.21: The CoGs for each chromophore for subject 1. Fourteen solid blue circles
indicate fourteen locations of detector slots. Four solid red circles indicate the locations of
four source slots. Solid black circles indicate the locations of the measurement channels.
Individual red, blue and green ring circles denote the x-y location of the calculated CoGs
for each of the 10 epochs for HbO2, HHb and oxCCO respectively. The final CoG for each
chromophore is indicated by the crosses.
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Figure 4.22: A close-up view of the CoGs of three chromophores for subject 1 revealing
the overlapping between the centres of HbO2 and oxCCO.
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Similar results were obtained for three other subjects. See Figures 4.23, 4.24 for
subject 2, Figures 4.25, 4.26 for subject 3 and Figures 4.27, 4.28 for subject 4. Overall,
in all four subjects, the locations of CoGs are between source slots 2 and 3. The final
CoGs of HbO2 and oxCCO are located in close proximity in all subjects. In two subjects,
those overlap each other. The CoG of HHb remains separate from others in all subjects,
suggesting a distinct spatial localisation.
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Figure 4.23: CoGs for each chromophore and the final CoGs for subject 2.
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Figure 4.24: A close-up view of the CoGs of three chromophores for subject 2.
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Figure 4.25: CoGs for each chromophore and the final CoGs for subject 3.
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Figure 4.26: A close-up view of the CoGs of three chromophores for subject 3.
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Figure 4.27: CoGs for each chromophore and the final CoGs for subject 4.
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Figure 4.28: A close-up view of the CoGs of three chromophores for subject 4.
4.4.3 Reconstructed images of concentration changes
Figure 4.29 shows the reconstructed images of the block-averaged change of ∆[HbO2],
∆[HHb] and ∆[oxCCO] from the left occipital cortex of subject 1 at four time points t = 10s,
20s, 30s and 40s after the onset of the visual stimulation. The visual stimulation finished
at t= 20s. There were clear, localised changes corresponding to functional activation as
evident in an increase in ∆[HbO2], a decrease in ∆[HHb] and an increase in ∆[oxCCO]
during the functional stimulation period (from t= 0 s to t = 20 s). These changes returned
back to baseline level during the resting period.
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t = 10 s
t = 20 s
t = 30 s
t = 40 s
Figure 4.29: Reconstructed images of concentration changes of HbO2, HHb and oxCCO
in subject 1. Four selected time points (10 s , 20 s, 30s and 40s ) are shown.
Similar results can be evident in reconstructed images of subject 2 (Figure 4.30),
subject 3 (Figure 4.31) and subject 4 (Figure 4.32).
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t = 10 s
t = 20 s
t = 30 s
t = 40 s
Figure 4.30: Reconstructed images of concentration changes of HbO2, HHb and oxCCO
in subject 2. Four time points are shown to demonstrate the changes over time corre-
sponding to functional activation.
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t = 10 s
t = 20 s
t = 30 s
t = 40 s
Figure 4.31: Reconstructed images of concentration changes of HbO2, HHb and oxCCO
in subject 3. Four time points are shown to demonstrate the changes over time corre-
sponding to functional activation.
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t = 10 s
t = 20 s
t = 30 s
t = 40 s
Figure 4.32: Reconstructed images of concentration changes of HbO2, HHb and oxCCO
in subject 4. Four time points are shown to demonstrate the changes over time corre-
sponding to functional activation.
Figure 4.33 shows the images of block-averaged ∆[oxCCO] at the time point t = 20 s
for all four subjects. Clear and focused functional activation response is seen in all four
reconstructed images.
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Figure 4.33: Reconstructed images of concentration changes of oxCCO in all four sub-
jects at the peak of the response to visual stimulation.
4.5 Conclusion and discussion
In this chapter, by combining a new probe holder, a new analysis algorithm and a new
experimental protocol with optical components of an existing broadband system, we have
developed a pseudo broadband DOT system that has the capability of collecting broad-
band NIRS data from 32 measurement channels. We used the system to explore 1) the
feasibility of monitoring ∆[oxCCO] across multiple regions of the brain during visual
functional activation; 2) the use of centre of gravity analysis to examine the centre of ac-
tivation of three NIRS chromophores during functional activation and 3) the feasibility of
reconstructing images of ∆[oxCCO] using the multi-distance, multi-channel broadband
data.
From the result of the visual functional activation, we believe that the pseudo broad-
band DOT system could monitor changes in ∆[oxCCO] across multiple regions of the
brain. More importantly, it demonstrated that it is feasible to monitor these changes
using a broadband approach and there is a spatial variation in the signal. The spatial
variation was confirmed by channel-wise block-averaged spectroscopic results from all
four subjects showing a clear localised increase in ∆[oxCCO] together with an increase in
∆[HbO2] and a decrease in ∆[HHb] from a selected number of channels. The changes cor-
responding to functional response were mostly evident in channels 17 to 24 originating
from source slot 3, most likely probing the primary visual cortex based on the location
of the probe on the head. Channels that were positioned more laterally (channel 1 to
8, unlikely to probe the visual cortex) did not show the haemodynamic and metabolic
responses corresponding to functional activation. Our results of ∆[HbO2], ∆[HHb] and
∆[oxCCO] are consistent with those of other publications investigating changes in the
visual cortex during visual stimulation [70], [71]. However, the intra-subject spatial
variation in the measured signal needs further investigation before relating it to actual
variation in cerebral physiology. This is because of the partial volume effect in NIRS
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which means that different measurement channels may probe different volume of the
activated brain region, creating a variation in the amplitude of the measured signal. In
other words, different measurement channels may have different sensitivity to the acti-
vated brain volume. This issue can be explored further using modelling of light transport
in the adult head model. However, it is beyond the scope of this thesis.
Centre of gravity analysis for all four subjects revealed the spatial difference in the
CoGs among the three chromophores. While the CoGs of HbO2 and oxCCO showed some
degree of overlapping (in three out of four subjects), the CoG of HHb remained separate
from the other two chromophores in all subjects. This may suggest that these chro-
mophores have distinctly separate centres of activation. Moreover, all the CoGs were
located in between source slot 2 and source slot 3 in all four subjects. This shows a de-
gree of agreement with the spectroscopic results as changes in chromophore concentra-
tion corresponding to functional activation were seen mostly in measurement channels
acquired when the source fibre was placed at slot positions 2 and 3 ( row 2 and 3 in
spectroscopic result figures).
The reconstructed images confirmed the feasibility of using the multi-distance, multi-
channel data sets to reconstruct images of ∆[oxCCO]. This is extremely encouraging as
for the first time, we have the ability to represent and evaluate the changes in cellular
oxygen metabolism using 3D tomographic images. Reconstructed images during func-
tional activation showed a clear and localised activation for all three chromophores in
the left occipital cortex during the period of maximum changes in response to functional
activation (t= 20 s) in all four subjects. Images at different time points demonstrated
an increase in ∆[HbO2], a decrease in ∆[HHb] and an increase in ∆[oxCCO] during the
stimulation period ( t = 0 s to t = 20 s). These changes returned to baseline level during
the resting period ( t= 20 s to t = 40 s). These results are in line with the channel-wise
spectroscopic results. Moreover, in term of localisation, the results from image recon-
struction and from spectroscopy showed a high degree of agreement, both demonstrating
functional changes localising around source slot locations 2 and 3. However, in one of
the subjects (subject 4), the focalised centre of activation in the reconstructed images
was localised more laterally in comparison to the expected visual cortex. This may be
due to errors in the digitising of the coordinates of the probes on the subject head. This
can be prevented in future studies by digitising the locations of the probe on the subject
head before and after the studies.
Previous studies have demonstrated the transient oxidation of CCO during visual
stimulation characterised by the increase in ∆[oxCCO] signal [70], [71]. The results of
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this pilot functional study reported in this chapter show similar findings. However, in
this study, we have extended the measurement of ∆[oxCCO] into 32 channels to map a
much larger area of the left visual cortex using a pseudo broadband DOT system. With
multi-channel, multi-distance data sets, we have demonstrated the spatial variation and
spatial localisation ∆[oxCCO] using the centre of gravity analysis and image reconstruc-
tion algorithm. The importance of this study does not only lie in the actual results but
also in the confidence that the spatial variation in ∆[oxCCO] could be monitored and it
could be used to reconstruct tomographic images of the changes in metabolism. This
study represents a big step towards monitoring ∆[oxCCO] across multiple regions of the
adult human brain.
4.6 Limitations and future improvements
The pseudo broadband DOT system presented in this chapter has certain limitations.
The biggest limitation is that the system cannot acquire multi-channel measurements
simultaneously. The whole experimental paradigm had to be repeated four times for
each subject to acquire a full data set of 32 measurement channels. During each repeat,
the source and detector fibres had to be physically moved to different slot positions.
This could introduce technical differences among repeats with issues such as slight
changes in the hair clearance, slight movement of the probe holder on the head of the
subject. Moreover, although visual stimulation is known to elicit reproducible functional
changes, subject level of concentration and attention can be different among repeats and
this can introduce differences among channels. In addition, it took a long time ( around
two hours) to collect one full data set which made data collection in a large number of
subjects impractical. The only way to tackle all of these limitations at once is to develop a
multi-distance, multi-channel optimised broadband NIRS system that has the capability
of monitoring ∆[oxCCO] across multiple regions of the brain simultaneously. In the next
chapter, further developments will be presented to transform the pseudo broadband DOT
system into a truly multi-channel, multi-distance broadband NIRS system.
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Chapter 5
Development of a multi-channel
multi-distance broadband NIRS
system with the capability of
monitoring changes in oxCCO
signal across multiple brain
regions
This chapter describes the development of a multi-channel, multi-distance broadband
NIRS system based on the pseudo broadband DOT system described earlier in chapter
4. Developments in hardware, software and the analysis algorithm will be described as
well as the preliminary testing and in vivo experiments.
5.1 Overview
To develop the pseudo DOT system into a truly multi-channel, multi-distance system
with the capability of monitoring multiple areas of the brain, the number of measurement
channels had to be increased. This required developments in the hardware, the software
and the resolving algorithm. In terms of the hardware, the same light sources and
spectrographs from the pseudo DOT system that was described earlier in chapter 4 were
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used. The number of source and detector fibres was increased in order to probe multiple
regions of the head simultaneously. The probe holder was redesigned to accommodate
the changes in source and detector fibres. The shutter controllers system was changed
to sequentially illuminate source fibres. In terms of software development, a new control
code was developed and integrated into the existing LabVIEW software to control the
order of illumination of sources. A new resolving algorithm based on the UCLn algorithm
was developed to accommodate multi-distance, multi-channel arrangement.
An overview of the instrument is provided in Figure 5.1.
Figure 5.1: Schematic diagram showing the components of the multi-distance, multi-
channel broadband NIRS system. The system has two light sources, each has a solenoid
shutter that is controlled by an electronic shutter controller with a time multiplexing
mechanism. Light from the sources (filtered to 504 nm - 1068 nm) is directed to the
subject by means of bifurcated optical fibre bundles, creating four source fibre bundles
at the subject end. The diffused light from the subject head is collected using 12 detector
fibre bundles branched from two fibre bundles, each of the two is connected to a spec-
trograph and a CCD camera. Both spectrographs are controlled by another electronic
shutter controller. The system is run by LabVIEW software from a computer.
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5.2 Hardware
5.2.1 Light sources and spectrograph
The new system employs two halogen bulb light sources, each with a gold plated mir-
ror and a 50 W halogen bulb (Phillips) with an axial filament to emit a broadband NIR
enhanced spectrum. The output spectrum is filtered to remove wavelengths below 504
nm and above 1068 nm to reduce UV exposure and heating effects. Each of the two
light sources has a solenoid shutter (Melles Griot, USA) that is controlled by an elec-
tronic shutter controller (Melles Griot, USA). Light from each light source is directed to
the subject via a custom-built bifurcated optical fibre (Loptek, Germany). This effectively
creates two pairs of source fibre bundles at the subject end. A time multiplexing mecha-
nism is used to control the opening and closing of the shutters of the light sources hence
allowing one light source to be on every 1.4 s, delivering light to the pair of source fibre
bundles connected to it. This will be discussed in detail in section 5.2.3.
To collect, separate and measure the intensity of light from the tissue at each wave-
length, the instrument has two custom-built spectrographs, each of which is connected
to a front illuminated CCD camera (PIXIS: 512f, Princeton Instruments). The spectro-
graph is lens-based rather than mirror-based to provide higher light throughput. The
spectrograph contains Minolta MC Rokkor lenses with the focal length of f = 58 mm and
an f-number of f/# = 1:1.2. The grating of the spectrograph (GR50-0310, Thorlabs) has
dimensions of 50 x 50 x 9.5 mm with 300 grooves per mm blazed at 1000 nm to optimise
reflection in the NIR region. The light spectrum is detected by two CCD cameras (PIXIS:
512f, Princeton Instruments). each with chip dimension of 12.3 x 12.3 mm correspond-
ing to 512 x 512 pixels with a pixel size of 24 x 24 µm. The CCD cameras are cooled to
-70oC to reduce thermal noise and increase sensitivity. Each spectrograph is connected
to a 3 m long detector fibre bundle which branches into six individual fibre bundles at the
subject end. Overall, at the subject end, the system has four source fibre bundles and
12 detector fibre bundles resulting in a total maximum of 24 measurement channels.
5.2.2 Optical fibres
The new source and detector fibre bundles were custom-built by Loptek (Glasfasertech-
nik GmbH, Germany) using glass fibres with an individual fibre diameter of 70 µm and
numerical aperture values of 0.54 and 0.57 for detector and source fibres respectively.
The system has two sets of detector fibre bundles, each of which is connected to one
spectrograph (Figure 5.2a). Each detector fibre bundle has six individual fibre bundles
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for the subject-end, five of which have a bundle diameter of 1.5 mm and one with a di-
ameter of 0.6 mm. The ferule of the bundle at the system-end has six openings (Figure
5.2b) aligned along a straight line to fit into the slit of the spectrograph to transmit the
light collected from the subject into the spectrograph for spectral analysis.
The system has two sets of source fibre bundles, each splits into two source fibres at
the subject-end (Figure 5.3a). The bundle diameter at the system-end is 4.5 mm and the
bundle diameter of individual source fibre at the subject-end is 3.2 mm. This effectively
creates two pairs of source fibres, where each pair is turned on and off at the same time
at the system-end.
(a) Two set of detector fibre bundles, each has a
spectrograph-end and a subject-end.
(b) Spectrograph end of a detector fibre
bundle has six openings.
Figure 5.2: Specifications of detector fibre bundles.
(a) The bifurcation of source fibre bundles to in-
crease the number of sources from two halogen
bulbs.
(b) The system end and the subject end of source
fibre bundles.
Figure 5.3: Specifications of source fibre bundles.
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5.2.3 Mechanical shutter controller boxes and its operation
One shutter controller box was used to control the solenoid shutter of each of the two light
sources. A time multiplexing mechanism was developed to control the shutter controllers
to alternately open and close the shutters of the two light sources, allowing one light
source to be on every 1.4 s, delivering light to the pair of source fibre bundles connected
to it (Figure 5.4). It is important to ensure that the CCD cameras finish capturing the
data before the multiplexing of the light source occurs (Figure 5.5). This was achieved
by introducing a multiplexing control code into the existing LabVIEW software. The
LabVIEW software was modified such that after both CCD cameras finish capturing data,
they return a local Boolean variable, GotFrame, indicating the process of capturing data
has finished. That variable was used to control the time multiplexing of the sources. A
counter variable, Pcounter, was created to increase its value after the both CCDs finish
one cycle of capturing data. When Pcounter is even, simulated squared wave signals are
sent to a DAQ assistance module to send an analogue output to shutter box controllers
to open the shutter for light source 1 (fibres 1 & 3) and close the shutter for light source
2 (fibres 2 & 4). When Pcounter is odd, a similar process occurs to close the shutter
for light source 1 and open the shutter for light source 2. This process produces a time
multiplexing mechanism for sources, sequentially delivering light to the paired source
fibres connected to them (Figure 5.4).
(a) Light is delivered from light source 1 to source
fibre 1 and 3.
(b) Light is delivered from light source 2 to source
fibre 2 and 4
Figure 5.4: The time multiplexing of the light sources to sequentially deliver light to the
paired source fibres connected to them.
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both CCD capturing
source on
source o
both CCD capturing
Light source 1
  Fibre 1 & 3
Light source 2
  Fibre 2 & 4
Time
Figure 5.5: Diagram to demonstrate the integration of the time-multiplexing mechanism
of the light sources to the capturing of CCD cameras.
5.2.4 Probe holder
The optical interface between optical fibre bundles and the subject is provided by a probe
holder. Two types of probe holder were developed for application at the frontal and visual
cortices. For the former, optical coupling can be achieved with ease as the forehead is
hairless and double sided medical tape can be used to keep the probe holder with optical
fibres in place. For the latter, it is more challenging as hair needs to be cleared out of the
interface between optical fibres and the scalp for good optical coupling. Special headgear
design with an integrated probe holder is needed for this application. In the next section,
probe holder designs for both applications will be presented.
5.2.4.1 Holder for visual experiment
The probe holder for visual experiments was designed with an objective of having a good
area of coverage to detect visual functional activation. The schematic shown in Figure 5.6
demonstrates the desired locations for sources and detectors. The design incorporated
four sources and ten detectors with all source detector separations of 30 mm (Figure
5.6). This source detector separation has been used previously for NIRS measurement
of the visual cortex [70], [71]. The distance between neighbour sources is 45 mm, which
ensures that individual detector will not receive light from any two sources at the same
time using a dual illumination switching mechanism.
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ch1 ch2
ch3 ch4
ch5 ch6
ch7 ch8
ch9 ch10
ch11 ch12
ch13 ch14
ch15 ch16
Detectors Sources
30mm channels between 
source and detector
Figure 5.6: Simple diagram to demonstrate the probe holder
There were specific requirements for the probe design to facilitate NIRS measurements
in the visual cortex:
• It must be integrated into a headgear so that it can be fixated on the subject head.
• It must enable clearance of hair for good optical coupling between the scalp and
optical fibres.
• It must have a fixation mechanism so that it can hold optical fibres in place.
• It must maintain a constant separation between sources and detectors.
To fulfil those requirements, a modular design of probe holder integrated into a head-
gear was developed. The design for the probe holder has three basic modules: source
block, detector block and base block (Figure 5.7). The base block was designed to have a
clearance hole with a diameter of 10 mm that is large enough for convenient hair clear-
ance. Fourteen base blocks were 3D printed using TangoBlack hard material and were
attached to a neoprene head cap as shown in Figure 5.8a. To prevent the location of
the base blocks from shifting while the head cap is stretched, plastic pieces with fixed
distance were used to provide constraints in multiple stretching directions as shown in
Figure 5.8b. Four source blocks and ten detector blocks were 3D printed and incorpo-
rated onto the subject ends of optical fibres (Figure 5.9a and 5.9b) so that they can be
locked into the base blocks in the headgear. The final probe holder incorporated in the
headgear and its accompanying fibres are shown in Figure 5.10. This design of probe
holder and headgear enables 16 NIRS measurement channels to be collected simultane-
ously.
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(a) Source block to be attached to
source fibre.
(b) Detector block to be attached
to detector fibre.
(c) Base block to be attached to
the head cap.
Figure 5.7: Three modules to hold optical fibres for visual cortex monitoring.
(a) Fourteen base blocks attached to the headgear. (b) The constraint mechanism inside the headgear
to prevent stretching of the fabric.
Figure 5.8: Overview of the headgear design for monitoring of the visual cortex.
(a) Detector blocks attached to the subject ends of
the detector fibres.
(b) Source blocks attached to the subject ends of
the source fibres.
Figure 5.9: The subject ends of optical fibres for monitoring of the visual cortex.
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Figure 5.10: Demonstration of the monitoring of the visual cortex using the new probe
holder and headgear.
5.2.4.2 Holder for frontal experiment
As mentioned earlier, it is less challenging to design the probe holder for the frontal
lobe application. However, with the objective of collecting multi-distance, multi-channel
measurements that are compatible for image reconstruction, a novel design for probe
holder was conceptualised. This probe holder was designed in AutoCad (AutoDesk) to
have four source locations (numbered 1 to 4) with inter-source distance of 45 mm and
multiple detector locations to enable 24 multi-distance NIRS channels and six TOI mea-
surements using four source fibres and 12 detector fibres (numbered 1 to 12) (Figure
5.13). The holder was 3D printed with a combination of hard (Vero White) and flexible
(Tango Black) materials (Figure 5.12) using Connex 500 3D printer (Stratasys, USA) to
accommodate the curvature of the adult human forehead. The source detector separa-
tions set out by the probe holder range from 20 to 35 mm. During operation, source
fibres bundles were fixed in the holder such that the two source fibre bundles that are
operating simultaneously have a separation of 90 mm. This was to ensure that detector
fibre bundles only receive light from one light source bundle at a time.
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Figure 5.11: Design for probe holders to fix optical fibres in place for frontal experiments
Figure 5.12: 3D printed probe holder with a combination of hard and flexible material
Figure 5.13: Frontal probe holder with optical fibres
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5.3 Software Developments
The LabVIEW software of the pseudo DOT system was upgraded to control the multi-
channel, multi-distance broadband NIRS system. The main modifications to the original
software involved enabling the software to handle a larger number of detectors and to
time-multiplex the light sources. The main operation of the LabVIEW software is sum-
marised in Figure 5.14. The system starts when the start button indicated by the arrow
in the LabVIEW software is pressed. Both CCD cameras start to cool down to the set
temperature ( usually -70◦C) which can take up to ten minutes. The time multiplex-
ing process of the light source that was integrated into the LabVIEW software starts to
multiplex the light source. A cycle of acquisition starts when one source is turned on
and stops when both CCD cameras finish capturing the data. Then another cycle starts
when the other source is turned on while the previous source is turned off and both
CCD cameras start capturing intensity data again. The process repeats until the stop
button of the software is activated. After each time the CCD cameras finish capturing the
intensity data, the data are displayed and used together with other inputs to calculate
the concentration changes. This process will be discussed in detail in a later section.
SETTING SOURCE 1ON
CCD1 
capture 
intensity
CCD 2 
capture 
intensity
SOURCE 2
ON
CCD1 
capture 
intensity
CCD 2 
capture 
intensity
Start
captured
captured
captured
captured
Display 
intensity
&
Calculate 
concentration
&
Save data
Display 
intensity
&
Calculate 
concentration
&
Save data
Wavelength 
calibration
Recording 
reference 
spectrum
Figure 5.14: Block diagram of the main functions of the LabVIEW software.
5.3.1 Setting
The setting tab is the first panel to appear when starting the LabVIEW software (Figure
5.15). In this panel, all the variables needed for the operation of the system are set.
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Figure 5.15: The setting tab of the LabVIEW software.
5.3.1.1 Temperature
The setting has a panel to set the temperature to cool the CCD cameras. This is normally
set to -70 ◦C. The actual temperature of the camera is displayed next to that setting panel.
5.3.1.2 Timing parameters
Cycle time and exposure time are two parameters to control the timing of the system.
Exposure time determines the duration of acquisition of the CCD camera. The longer
the exposure time, the higher the intensity count detected. The cycle time determines
the duration of one whole run through the software.
5.3.1.3 Wavelength range
The wavelength range is set to be from 780 nm to 900 nm. These parameters are used for
the calculation of the concentration changes. Despite settings of the wavelength range,
the system collects the whole intensity spectrum from 500 to 1000 nm.
5.3.1.4 Background subtraction
With the shutter of the spectrographs closed, the CCD cameras collect background
counts dependent on the exposure time, the camera temperature and the number of
binned pixels. These background counts are subtracted from the measured intensity to
minimise the error in the measurement.
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5.3.1.5 Source-detector distances
The value of the source-detector separations for each detector can be input for the cal-
culation of concentration change.
5.3.1.6 Binning
Data binning describes the process of adding the data of adjacent pixels in the CCD
camera to form a single value. In this software, the data is binned in the y-direction to
yield an array with 512 values in the x-direction for each individual detector. Each pixel
in the x-direction corresponds to a wavelength value(see Figure 5.16).
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Figure 5.16: A snapshot of one of the two CCD cameras that shows the areas illuminated
by the six detectors. Individual detectors are separated in the y-direction of the CCD
chip. Binning is the process to add pixels in the y-direction in each detector to produce
an intensity spectrum.
5.3.2 Intensity data collection
One of the main modifications to the system is the increased number of measurement
channels resulting from an increase in the number of detectors, sources and a time
multiplexing mechanism for the light sources. As a result, each of the twelve detectors
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collects intensity spectra from two individual measurement channels and these needs to
be separated before resolving the concentration changes. This process will be discussed
in detail in the algorithm section.
5.3.3 Concentration calculation
The concentration change is calculated from the measured intensity spectra for each
measurement channel using the UCLn algorithm as described earlier in chapter 3. Inten-
sity data are used to calculate the change in attenuation (∆A). ∆A spectra, DPF spectra
(corrected for the wavelength dependency), source-detector distances and the specific ex-
tinction spectra of three chromophores are used to calculate the concentration changes.
5.4 Analysis algorithm development
A new resolving algorithm was developed using MATLAB (MathWorks, USA) to calculate
the concentration changes from the raw intensity data collected by the modified system.
As both CCD cameras capture intensity data while the light sources are turned on and
off alternately, the intensity data captured by each individual detector contains intensity
spectrum for two measurement channels. As a result, the intensity spectra from each
detector need to be separated, sorted and allocated into individual measurement chan-
nels. This process is demonstrated in Figure 5.17 for one example detector. As shown in
the figure, detector 1 receives light originating from source 1 at one cycle and source 2
at the next cycle (Figure 5.17a). As a result, there are two intensity spectra collected by
detector 1 and these were separated and allocated to the corresponding channels. More-
over, these intensity spectra are at different levels due to the difference in source-detector
separation. This difference can be used to identify the location of the working sources.
This information is then used to allocate the intensity spectra of all the detectors to the
correct channels as the example demonstrated in Figure 5.17b.
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intensity -channel a
intensity -channel b
Figure 5.17: Diagram to demonstrate the process of allocating intensity spectra .a) De-
tector 1 receives the diffusely reflected light through tissue which originally comes from
source 1 for measurement channel a and from source 2 for measurement channel b. b)
The collected intensity spectra from detector 1 has two individual spectra, each of which
is allocated to the corresponding measurement channel.
The sorted intensity spectra for each individual channel is then used to calculate the
delta attenuation ∆A and then the concentration changes of chromophores ∆c applying
the MBLL via the UCLn algorithm (Figure 5.18).
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Figure 5.18: Block diagram of the implemented differential spectroscopy technique using
the MBLL.
5.5 Preliminary testing
5.5.1 Power output
The power output at the end of the source fibre was measured using a slim photodiode
power sensor (Thorlab. S130C) to ensure that it is within the safety standards. The
average power output of the four source fibres is 5.0 mW. With a fibre diameter of 3.2
mm, the power density is 0.625 mW per square millimetre, which is within the UK tissue
safety limits for an incoherent source of 2 mW per square millimetre. Figure 5.19 shows
the power distributed across wavelengths for one typical light source fibre.
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Figure 5.19: Power spectrum of one of the light source fibre.
5.5.2 Phantom Testing
Studies on phantoms were done to assess the stability of the system over time. The
frontal probe holder with optical fibres was attached to a solid phantom with tissue-like
optical properties as shown in Figure 5.13. The intensity measurements of 24 channels
were collected for a one hour period to assess the stability of the system. Figure 5.20
shows the intensity spectra plotted together of one example channel over the one hour
measurement period. There was a small variation of intensity over time with maximum
variation falling into the region of 0.5 to 1 % of the intensity count.
147
5.5. PRELIMINARY TESTING
Figure 5.20: Intensity measurement of one channel for one hour stability test. Data were
collected once every 2.8 s, and the plot shows each intensity spectrum over the one hour
period.
5.5.3 Muscular Cuff Occlusion
Muscular cuff occlusion experiments were done on three healthy volunteers to assess the
ability of the multi-channel system to monitor concentration changes of chromophores in
vivo. The volunteer was seated comfortably with their forearm resting on a table. Optodes
were fixated over the forearm muscle using the frontal probe holder as demonstrated in
Figure 5.21. A baseline period was recorded for two minutes before the cuff was inflated
to 200 mmHg for another two minutes to occlude both the artery and the vein. This was
followed by deflation of the cuff and baseline measurement for another few minutes.
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Figure 5.21: Muscular cuff occlusion experiment using the frontal probe. This experi-
ment is to test the response of the three chromophores using the new modified system.
During arterial cuff occlusion which stops blood flow into and away from the forearm,
desaturation is expected, producing an increase in ∆[HHb] and a virtually equal decrease
in ∆[HbO2]. ∆[oxCCO] is expected to show a little or no change due to the large oxygen
reserve bound to muscle myoglobin and the low oxygen consumption in resting muscle.
Figure 5.22 shows the intensity spectra at two time points during the experiment, one
in the baseline period and one at the peak changes. At the time of peak changes, there
were two characteristic changes in the shape of the intensity spectrum: a lower intensity
measurement within the spectral range from 780 to 800 nm and a higher intensity mea-
surement above 820 nm in comparison to the intensity spectrum at the baseline time
point. The former characteristic could be explained by the increase in ∆[HHb] as this
chromophore has a high absorption level in this spectral region characterised by a peak
around 760 nm. The latter characteristic could be explained by the decrease in ∆[HbO2]
as this chromophore has high absorption in the spectral region above 800 nm.
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Figure 5.22: Intensity spectra through arm during baseline (red) and arterial cuff occlu-
sion(blue) showing difference in spectral shape in response to changes in concentration
of chromophores.
Figure 5.23, shows the resolved concentration changes of three NIRS chromophores
from a 35 mm measurement channel using the newly developed resolving algorithm
mentioned earlier. During the arterial occlusion period, there was an increase in the
∆[HHb] (blue) and a decrease in ∆[HbO2] (red). ∆[oxCCO] (green- multiplied by 10 for
visualisation) increased in a small amount during the occlusion period and decreased
back to the baseline level after the occlusion period. This result agrees with the general
expectations of the physiological processes that occur during arterial cuff occlusion and
with the results of our previous system developed in-house [117]. Moreover, the result
of this experiment also suggests that the ∆[oxCCO] is independent of the haemoglobin
signals as large changes in the haemoglobin concentration did not create a corresponding
change in the ∆[oxCCO] signal. Overall, this demonstrated that the upgraded system
with the new probe holder, the new software and the new resolving algorithm is able to
monitor concentration changes of NIRS chromophores in vivo.
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Figure 5.23: Concentration changes of chromophores during arterial cuff occlusion on
the forearm. Note that the oxCCO changes are plotted on a x10 scale.
5.6 Visual functional activation
The visual functional activation paradigm presented in chapter 4 was repeated with the
upgraded multi-channel, multi-distance broadband NIRS system to test the capability
of the new system to monitor simultaneously changes in concentrations of NIRS chro-
mophores across multiple regions of the adult human brain.
5.6.1 Methods
The probe holder and the headgear designed for this visual experiment was presented
in section 5.2.4. In brief, the holder allowed easy clearance of hair and fixation of four
source fibres and ten detector fibres onto the subject scalp as shown in Figure 5.24. The
headgear was positioned such that the midpoint between source slots 2 and 3 was 2 cm
above the inion, a small bony protuberance of the occipital bone at the back of the head.
This position of the headgear ensured that both the left and right visual cortices located
underneath the occipital bone were probed by the system. Notice that the two small
detector fibres were not used for the visual functional experiment. Figure 5.25 shows the
measurement channels acquired when the paired source fibres were time-multiplexed.
This set-up allowed the 16 NIRS measurement channels monitoring different regions of
the visual cortex to be collected simultaneously.
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Figure 5.24: The probe holder, headgear and the final subject set-up for the visual func-
tional activation. a) The headgear fixated on the subject head, allowing clearance of hair
to provide a good optical interface between the subject scalp and the optical fibres. b)
Fixation of optical fibres onto the headgear, allowing the monitoring of changes in the
visual cortex.
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Figure 5.25: NIRS measurement channels collected when the paired source fibres were
time-multiplexed. a) Source fibres at location 1 and 3 were illuminated to collect channels
1 to 4 and 9 to 12. b) Source fibres at location 2 and 4 were illuminated to collect channels
5 to 8 and channels 13 to 16.
Visual functional activation was achieved as previously described in chapter 4. The
experimental paradigm consisted of 10 epochs, each with 20 s of stimulation achieved by
a 4 Hz inverting checkerboard followed by 20 s of resting achieved by a black screen with
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a centred white cross. Change in the intensity of diffusely reflected NIR light through
the visual cortices was monitored continuously in 16 NIRS measurement channels us-
ing 4 source fibres and 10 detector fibres of the multi-channel broadband system. This
change in intensity was used to calculate the change in concentration of NIRS chro-
mophores using the algorithm described earlier. The calculated concentration changes
were resampled to 1 Hz and were processed with a low-pass second order Butterworth
filter with cut-off frequency of 0.08 Hz. There were 16 sets of data for each subject. Each
set had the time-series concentration changes of three chromophores ∆[HbO2] ∆[HHb]
and ∆[oxCCO]. These time-series changes were blocked averaged according to stimula-
tion epoch to produce 16 sets of 40 s block-averaged data for each chromophore. The
baseline and the activation periods were defined as in the visual experiment presented
previously in chapter 4. Group averaging and statistical tests were performed using the
same method as mentioned in chapter 4.
5.6.2 Results
Following ethics approval and volunteer consent, six healthy adult volunteers were stud-
ied. Figure 5.26 shows the intensity spectra and the delta attenuation spectra at two
time points from one channel probing the visual cortex during the experiment: at the
end of a resting period and at the end of a stimulation period. Intensity at the end of the
resting period was higher than that at the end of the stimulation period. This may be be-
cause during the stimulation period, there was a net increase in CBF, bringing a surplus
supply of HbO2 into the part of the visual cortex probed by the channel. This increase in
HbO2 attenuated the NIR light across the spectral range from 780 to 900 nm. The delta
attenuation data also supported this hypothesis as there was higher attenuation at the
end of the stimulation period in comparison to that at the end of resting period (Figure
5.26b).
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Figure 5.26: a) Intensity of two time points marked as end of resting and end of stimu-
lation b) Delta attenuation at those two time points.
Figure 5.27 shows the raw concentration changes of three chromophores from chan-
nel 10 from one subject during functional visual stimulation. The stimulation period is
shaded in grey and ∆[HbO2], ∆[HHb] and ∆[oxCCO] are plotted in red, blue and green
respectively. A typical haemodynamic response was evident with an increase in ∆[HbO2],
a decrease in ∆[HHb]. ∆[oxCCO] increased during the stimulation period and came back
to baseline during the resting period. This result is similar to the previous results pre-
sented in chapter 4 using the pseudo DOT system and it agrees with results published
by other authors investigating the changes of CCO during visual stimulation [70], [71].
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Figure 5.27: Raw concentration changes of three NIRS chromophores in channel 10
measured in an example subject during full field visual stimulation.
Figure 5.28 shows the block-averaged concentration changes of all 16 measurement
channels in the same subject. The X in the middle of the plot indicates the centre point of
the probe holder which was positioned at 2 cm above the inion. Concentration changes
of HbO2, HHb and oxCCO corresponding to functional activation were seen in a subset
of channels. According to the location of these channels, they were likely to probe the
visual cortex in this subject. A spatial variation in the concentration changes of the
haemoglobin signal and of oxCCO signal could be observed. Large changes in response
154
5.6. VISUAL FUNCTIONAL ACTIVATION
to functional activation were seen mostly in the upper channels. This may be due to the
position of the probe holder that could be too low in relation to the activated cortices.
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Figure 5.28: Block averaged concentration changes of three NIRS chromophores in 16
channels in the same subject. Typical haemodynamic response and cytochrome c oxi-
dase response with a spatially varying amplitude corresponding to functional activation
were evident in a subset of channels localising in proximity to the left and right visual
cortices.
The results for five other subjects are similar and is as followed:
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Figure 5.29: Block averaged concentration changes of ∆[HbO2], ∆[HHb] and ∆[oxCCO]
during visual functional activation in subject 2.
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Figure 5.30: Block averaged concentration changes of ∆[HbO2], ∆[HHb] and ∆[oxCCO]
during visual functional activation in subject 3.
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Figure 5.31: Block averaged concentration changes of ∆[HbO2], ∆[HHb] and ∆[oxCCO]
during visual functional activation in subject 4.
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Figure 5.32: Block averaged concentration changes of ∆[HbO2], ∆[HHb] and ∆[oxCCO]
during visual functional activation in subject 5.
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Figure 5.33: Block averaged concentration changes of ∆[HbO2], ∆[HHb] and ∆[oxCCO]
during visual functional activation in subject 6.
Figure 5.34 shows the group-averaged concentration changes across six subjects.
There was a significant increase in the ∆[HbO2], decrease in ∆[HHb] and increase in
∆[oxCCO] during the activation period in comparison to the baseline period.
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Figure 5.34: Group averaged concentration changes of HbO2 (red), HHb (blue) and ox-
CCO (green) and standard error of means across six subjects following visual functional
activation. The visual stimulation period is shown as the shaded grey window.
5.6.3 Conclusion and discussion
In this study, we have demonstrated the capability of the multi-channel, multi-distance
broadband NIRS system to monitor the concentration change of oxCCO simultaneously
across multiple regions in the healthy adult human brain during a functional visual ac-
tivation task. This study provides evidence that the system developed during the course
of this PhD has the capability to resolve changes in ∆[oxCCO] alongside traditional NIRS
parameters of haemodynamics (∆[HbO2] and ∆[HHb]).
In the previous visual functional experiment presented in chapter 4, the multi-channel
NIRS measurements were not acquired simultaneously. They required the physical move-
ment of source and detector fibres to cover a large enough area of the visual cortex.
These issues made the measurements not truly simultaneous and presented technical
and practical difficulties in collecting data from a larger pool of subjects. With the de-
velopments presented in this chapter, multi-channel measurements of ∆[oxCCO] can be
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collected simultaneously across multiple regions of the adult human brain without the
need for physically moving source and detector fibres, thus reducing the data acquisition
time from two hours to twenty minutes and opening up opportunities for the investiga-
tion of the spatial variation in the changes of metabolism in the adult human brain in a
variety of scenarios.
5.7 Prefrontal Activation
To test the capability of the system to measure more than one region of the brain, the
system was used to monitor functional activation over the prefrontal cortex. This was
important for future clinical studies investigating changes in the brain of patients with
brain injury because the frontal region is the one of the few regions in the head of brain
injured patients that NIRS can be used to monitor changes.
5.7.1 Methods
The interface between the optical fibres of the system and the subject was provided by the
frontal probe holder, the design of which has been described previously in this chapter.
Figure 5.35 demonstrates the interface between the system and the subject (a,b), the
working of the time-multiplexed source fibres (c) and the fixation of the optical fibres
onto the forehead using double-sided medical tape and a Velcro headband.
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Figure 5.35: The interface between the system and the subject. a) The 3D printed probe
holder used for frontal functional activation experiment. b) Four source fibre and 12
detector fibre bundles fixed on the probe holder on a solid phantom. c) Illustration
showing one complete acquisition cycle during which each of the two pairs of the source
fibre bundles delivers light one after the other. d) the probe holder with fibre bundles is
fixed on a subject forehead using a headband.
For prefrontal cortex monitoring, all four source fibres and 12 detector fibres were
placed in the probe holder as shown in Figure 5.36a, so that two 0.6 mm diameter
detector fibre bundles occupy location 1 and 12 and the other locations were filled with
1.5 mm diameter detector fibre bundles. Detector fibre bundles from location 1 to 6 were
from one common bundle connected to the first spectrograph, and detector fibre bundles
from location 7 to 12 were from the other common bundle connected to the second
spectrograph. The source-detector separations of the 24 measurement channels set out
by this arrangement of optical fibres range from 20 mm to 35 mm. During operation,
source fibre bundles were fixed in the holder such that the two source fibre bundles that
were operating simultaneously had a separation of 90 mm as demonstrated in Figure
5.36c, ensuring that detector fibre bundles only received light from one source fibre
bundle at a time. Figure 5.36b shows measurement channels that were acquired when
the paired sources are on and Figure 5.36c shows the spatial locations of all 24 possible
measurement channels. Figure 5.36d shows the locations of detector fibre bundles that
were used for the calculation of TOI. Overall, the system with this fibre arrangement has
the capacity to acquire data from 24 NIRS measurement channels using the method of
differential spectroscopy to calculate the ∆[HbO2], ∆[HHb] and ∆[oxCCO] and from six
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TOI channels using the method of spatially resolved spectroscopy from multiple regions
of the prefrontal cortex.
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Figure 5.36: a) Probe design showing the locations of four source fibre bundles numbered
from 1 to 4 (red circles) and 12 detector fibre bundles numbered from 1 to 12 (cyan
circles). The distance between neighbour source bundles is 45 mm and the SDS ranges
from 20 mm to 35 mm. b) Measurement channels acquired when alternate paired source
bundles are on. Red circles indicate the locations of the working source bundles and cyan
circles indicate the locations of the detector fibre bundles. Dark green, magenta and light
blue arrows indicate channels with SDS of 35 mm, 30 mm and 20 mm respectively. c) The
spatial distribution of all 24 measurement channels. Colour coding for SDS is similar to
b. Circle size is proportional to SDS. d) Detector bundles used for each TOI calculation.
TOI 1 uses detector bundles 2 and 3, TOI 2 uses detector bundles 3 and 4, TOI 3 uses
detector bundles 5 and 6, TOI 4 uses detector bundles 7 and 8. TOI 5 uses detector
bundles 9 and 10 and TOI 6 uses detector bundles 10 and 11.
Following ethics approval and volunteer consent, nine healthy adult volunteers were
studied with the probe holder positioned across the mid line of the forehead such that
source locations 2 and 3 were located at Fp2 and Fp1 according to 10/20 EEG elec-
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trode placing system. Prefrontal lobe activation was achieved using a modified version
of the Stroop task. The subject was presented with a series of coloured words written
in coloured ink and asked to name the colour of the individual word while ignoring its
meaning. There were four options for words (RED, GREEN, BLUE AND MAGENTA) and
four options for colours (red, green, blue and magenta). A random combination of one
of these four words painted in one of the four colours was presented to the subject one
after another during the stimulation period. The subject responded by pressing one of
the keys R, G, B and M in response to the colour of the presented word. An example
of the task is shown in Figure 5.37 and the subject should press G to respond to this
example. The block design consisted of 10 epochs, each with a 30 s black screen followed
by 60s Stroop task and then a 30 s black screen. Total acquisition time was 1200 s.
RED
Figure 5.37: An example of one of the combinations presented in the Stroop task. In
this case, the subject should press G as the answer.
The system collected the intensity spectra from 12 detector fibre bundles while the
light source fibres were illuminated alternately. Time-series concentration changes of
HbO2, HHb and oxCCO were calculated using the algorithm described earlier. The con-
centration changes were filtered using a fifth order Butterworth low-pass filter with cut-
off frequency of 0.08 Hz, linearly detrended and resampled to 1 Hz. For each subject,
concentration changes were block-averaged according to stimulation epoch to produce
three 120 s traces for each of the 24 measurement channels. The mean concentration
changes in individual channels were then averaged across nine subjects to produce the
grand average activation response across the frontal lobe for the Stroop task. In this
study, cortical activation was defined by an increase in ∆[HbO2], a decrease in ∆[HHb]
and an increase in ∆[oxCCO]. To identify channels with significant changes in response
to the functional stimulation, the response of each channel for each subject was defined
as the difference between the mean of the first 10 s window of activation and the mean of
the first 10 s window during the black screen period. Paired t-tests were used to compare
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the responses of each channel across nine subjects to zero (i.e no response). p <0.05
was considered statistically significant.
TOI values were calculated as described earlier for six sites of measurements indicated
in Figure 5.35d. Using the slope of the attenuation between the closest detector (20 mm
SDS) and the furthest detector (35 mm SDS) for sites 2, 3, 5, between the 30 mm and
the 35 mm detectors for sites 1 and 6 and between the 20 mm and the 30 mm detectors
for site 4, scaled absorption coefficients (kµa) were calculated and then used to estimate
the scaled absolute concentration of HbO2 and HHb (k[HbO2 and k[HHb]) for each site.
These values were then used to calculate TOI for different sites. To investigate the spatial
variation in TOI in different regions, mean TOI was calculated by taking the average of
TOI values across the whole experiment period for each of the six sites.
5.7.2 Results
5.7.2.1 Differential spectroscopic results
Figure 5.38 shows the concentration changes of three NIRS chromophores from an ex-
ample channel in a subject during the Stroop paradigm. The Stroop task periods are
indicated by the grey areas. Repeatable changes in concentration of three chromophores
(an increase in ∆[HbO2], a decrease in ∆[HHb] and an increase in ∆[oxCCO]) were ob-
served. However, the increase in the haemodynamic signals seems to precede the actual
stimulation. This may be caused by the expectation of the subject to the task.
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Figure 5.38: Concentration changes from an example channel during the Stroop task.
Figure 5.39a shows the intensity spectra at the baseline and at the peak changes of
concentration and Figure 5.39b shows the measured delta attenuation and the fitted
delta attenuation using the three component fitting procedure.
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Figure 5.39: a)The measured intensity at baseline and at the peak of concentration
changes. b) The measured and the fitted ∆A at peak changes.
Channels 1, 4, 19, 22 and 24 were excluded from further analysis due to low inten-
sity. Figure 5.40a presents the positions of 19 channels on the forehead. Figure 5.40b
presents the grand averaged concentration changes and the standard error of mean of
the three chromophores during the Stroop task across nine subjects with different SDS
indicated by the borders of the plots. The concentration change of oxCCO was multiplied
by 10 for ease of visualisation. There was a spatial variation of the oxCCO response to
frontal lobe activation among channels with 35 mm SDS induced by the Stroop task
with maximum changes in ∆[oxCCO] varying from +0.015 µM (channel 21) to +0.073 µM
(channel 23) in the presence of haemodynamic changes correlating to functional activa-
tion (increase in ∆[HbO2], decrease in ∆[HHb]). Figure 5.40c presents locations of the
channels with significant response in ∆[HbO2], ∆[HHb] and ∆[oxCCO]. Out of 12 chan-
nels with SDS of 35 mm, 11 channels (92%) showed significant increase in ∆[HbO2];
nine channels (75%) showed a significant decrease in ∆[HHb] and five channels (42%)
showed a significant increase in ∆[oxCCO]. A significant change in ∆[oxCCO] was only
present in channels where there were significant changes in both ∆[HbO2] and ∆[HHb].
A significant change in ∆[oxCCO] was not present in 30 mm or 20 mm SDS channels.
However, significant changes in ∆[HbO2] were present in the 30 mm SDS (two out of
three channels) and in 20 mm SDS (three out of four channels). Table 5.1 presents the
mean response across nine subjects for ∆[HbO2], ∆[HHb] and ∆[oxCCO] and the corre-
sponding p value in channels with significant ∆[oxCCO] change as indicated in Figure
5.40c.
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Figure 5.40: Summary result for prefrontal cortex functional activation study.
a)Locations of 19 channels on the head. b) Grand averaged concentration changes across
nine subjects. c) Locations of channels with significant response in∆[HbO2], ∆[HHb] and
∆[oxCCO].
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Table 5.1: The mean response in µM (Resp.) across nine subjects for each chromophore
and the corresponding p value in channels with significant oxCCO changes.
Ch.7 Ch.8 Ch.9 Ch.13 Ch.14
Resp. p Resp. p Resp. p Resp. p Resp. p
HbO2 0.135 0.026 0.176 0.018 0.185 0.022 0.163 0.033 0.193 0.026
HHb -0.059 0.007 -0.116 0.005 -0.110 0.014 -0.060 0.032 -0.093 0.020
oxCCO 0.024 0.005 0.033 0.009 0.024 0.036 0.028 0.027 0.029 0.035
5.7.2.2 The variation of TOI
There was no observable TOI response during functional activation. Table 5.2 presents
the mean TOI values during the experiment across six sites of measurement on the
frontal lobe of each individual subject and the mean, standard deviation (SD), maximum
and minimum values of TOI across nine subjects.
Table 5.2: TOI (%) across 6 measurement sites of nine subjects
Sub. Site 1 Site 2 Site 3 Site 4 Site 5 Site 6 Mean SD
1 79 73 74 77 80 73 76 3
2 81 73 70 72 76 N/A 74 4
3 65 69 67 69 70 66 68 2
4 89 74 73 78 80 87 80 6
5 66 70 70 73 73 69 70 2
6 78 74 75 73 77 76 76 2
7 81 73 76 82 76 83 78 4
8 61 69 69 71 72 75 69 4
9 79 76 78 77 79 73 77 2
Mean 76 72 72 75 76 75
SD 9 2 4 4 4 6
Min 61 69 67 69 70 66
Max 89 76 78 82 80 87
5.7.3 Conclusion and discussion
We have demonstrated the use of the multi-channel broadband NIRS system in monitor-
ing the changes of HbO2, HHb, oxCCO and TOI across multiple locations of the frontal
region of healthy adult volunteers during a prefrontal cortex functional activation task.
The group average results confirmed that changes of ∆[HbO2] and ∆[HHb] were consis-
tent with typical functional activation with an increase in ∆[HbO2] and a decrease in
∆[HHb] during the stimulation period. However, the changes started slightly before the
stimulation, peaked and declined rapidly during the stimulation period. These results
agreed with the results of our previous Stroop task study using another fNIRS system
(Oxymon Mk III, Artinis Medical System, the Netherlands). The early changes may be
explained by the changes in CBF caused by the expectation of the subject due to the
nature of the block design study on the frontal lobe.
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The maximum and minimum TOI values for six sites were within the range from 61%
to 89 %. This ranges of TOI values are within reasonable physiological range. Given
that the measurement of TOI is a challenging one to collect and there is no gold stan-
dard to compare it to, it is encouraging that the system was able to collect TOI values
across multiple sites. In our study, there were a small variation in TOI values across
different sites within the same subject and a small variation of TOI values within the
same site across different subjects. TOI does not have sufficient signal to noise ratio to
detect changes in oxygenation during functional activation; however, it may be used to
assess the variation in oxygenation in clinical scenarios where there is large changes in
oxygenation.
Significant changes in haemoglobin signals were seen in both channels with short
SDS (20 mm) and with long SDS (35 mm) while significant changes in ∆[oxCCO] were
seen in only five channels with long SDS (35 mm) where there were concurrent significant
change in both ∆[HbO2] and ∆[HHb]. This may be due to the fact that changes in the
haemoglobin signals are easily contaminated by the changes in extracerebral circulation
caused by systemic changes and anxiety level [118], [119]. This is one of the rationales
to investigate the possibility of using the oxCCO signal for functional brain imaging to
identify the specific location of the functional activation as the oxCCO signal is less
susceptible to changes in systemic variables and more brain specific [12].
The Stroop task is known to activate bilateral dorsolateral prefrontal cortex (DLPFC)
[120], [121]. As we have explicitly stated, we identified functional activation as a signifi-
cant increase in ∆[HbO2], a significant decrease in ∆[HHb] and a significant increase in
∆[oxCCO]. With our array positioned on the prefrontal cortex where source locations 2
and 3 were positioned at Fp2 and Fp1 of the 10/20 EEG electrode placement system, our
results identified bilateral activation of the DLPFC. Using the oxCCO signal in addition to
the traditional haemoglobin signals, we could identify a more localised activation area in
response to the Stroop task. The increase in oxygen consumption is previously suggested
to be more localised than the increase in blood flow [122] and our data might suggest
that. Larger studies are required to differentiate regional variation in the magnitude of
the oxCCO and confirm the findings.
To our knowledge, this is the first study demonstrating the difference in the oxCCO
response to functional activation across multiple areas of the frontal cortex that are dis-
tinct from the haemoglobin responses. Using the multi-channel broadband NIRS system
described in this chapter, multi-channel measurements of changes in haemodynamics
and metabolism as well as tissue oxygen saturation can be acquired simultaneously.
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5.8 Conclusion and discussion
In this chapter, we have described the development of the pseudo DOT system into a
multi-channel, multi-distance broadband NIRS system with changes introduced to the
hardware, the software and the resolving algorithm. The new system has the capability
to monitor changes in the visual and prefrontal cortices with two different types of probe
holder and headgear. The system can collect data from 16 NIRS measurement channels
monitoring the visual cortex or 24 NIRS measurement channels monitoring the pre-
frontal cortex. Moreover, the system also has the capability to monitor TOI changes for
six regions of the prefrontal cortex. This system is among the first of its kind to have the
capability of monitoring changes in ∆[oxCCO] across multiple regions of the adult head.
Most commercial CW-NIRS devices rely on the dual wavelength approach, limiting
their capability to the measurement of concentration changes of HbO2 and HHb [3].
Under the assumption of intact neurovascular coupling, these measurements are an in-
direct measure of brain activity. However, issues have been raised about the possibility
of inadvertently measuring fNIRS haemodynamic responses that are not the result of
neurovascular coupling and these can be misinterpreted as brain activity (false posi-
tives) or masked brain activity (false negatives). These issues are caused by changes in
systemic variables such as heart rate, blood pressure, CO2 concentration in the blood
etc. which can lead to non-neuronal driven changes in haemodynamics and oxygena-
tion in the cerebral and extracerebral compartments. The measurement of ∆[oxCCO],
a biomarker of cellular oxygen metabolism, with its brain specificity characteristic [12]
may overcome these issues. Moreover, in cases of brain pathology, the assumption of
intact neurovascular coupling in the measurement of the haemoglobin signals is usu-
ally violated. In these scenarios, an additional colocalised measure of cerebral oxygen
metabolism can help elucidate the changes caused by the pathology. In the specific case
of acute brain injury, where cerebral energy failure usually occurs, a method for mon-
itoring cerebral energy metabolism may provide useful insight into the injury pathway.
However, most NIRS instruments that have the capability to measure ∆[oxCCO] only have
a limited number of channels, limiting the measurement to a small area of the cortex,
which poses the difficulty of finding the ’right’ location to place the probes. Therefore,
there is a clinical need for a NIRS system that can monitor changes in ∆[oxCCO] together
with ∆[HbO2] and ∆[HHb] from several regions of the brain simultaneously. The multi-
channel, multi-distance broadband NIRS system developed as part of this PhD provides
that much-needed capability.
The development of the multi-channel broadband NIRS system has resulted in several
168
5.8. CONCLUSION AND DISCUSSION
advancements in the field of NIRS. First and foremost, for the first time, a system with
the capability of monitoring ∆[oxCCO] across multiple regions of the brain is developed.
As a result of that development, spatially dependent changes in ∆[oxCCO] induced by
functional activation tasks could be investigated and characterised in the adult human
brain. Having characterised the response of the signal in the healthy adult brain during
functional activation task, the next step was to demonstrate the use of the system in
the clinical setting of a neurointensive care unit to monitor brain injured patients. This
transitional step of bringing the technology developed in a lab environment to a clinical
environment is challenging but it is an important step to prove the clinical usefulness
of the new instrument. The next chapter will describe several case studies where the
instrument was used to investigate the changes of ∆[oxCCO] together with ∆[HbO2] and
∆[HHb] in the injured brain.
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Chapter 6
Monitoring patients with acute
brain injury with the
multi-channel, multi-distance
broadband NIRS system
The capability of the multi-channel, multi-distance broadband NIRS system to moni-
tor changes in cerebral haemodynamics and metabolism in multiple brain regions has
been demonstrated in the previous two chapters through the use of functional activation
paradigms in the healthy brain. Moving away from the healthy brain, this chapter will
describe the use of the system to monitor regional variations in the injured brain. The
overall aim of this chapter is to demonstrate the increased capability of the system to con-
tribute to our understanding of the pathophysiology of brain injury. This chapter begins
with a brief overview of brain injury and the rationale of monitoring regional variations in
cerebral haemodynamics and metabolism before outlining the clinical study to demon-
strate the capability of the multi-channel broadband system in monitoring patients with
brain injury.
6.1 Introduction
As discussed in chapter 2, the normal brain has several mechanisms to ensure that oxy-
gen and substrates supply meet metabolic demand. Two of the most important mecha-
nisms are cerebral pressure autoregulation and flow metabolism coupling. These mech-
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anisms ensure that in the normal healthy brain, there is a balance between oxygen
supply and demand. This balance is usually disturbed in brain injury, resulting in cere-
bral hypoxia/ischemia, a common injury pathway of different types of brain injury that
is associated to poor outcome [18]. It is not within the scope of this thesis to discuss the
detailed pathophysiology of brain injury; however, it is important to highlight some key
aspects of it so as to put the role of cerebral monitoring into perspective.
Brain injury can be traditionally classified into two processes: primary and secondary
injuries. Primary injury occurs at the moment of impact for traumatic injury or at the
moment of ischaemic/haemorrhagic events for acute injury. Cerebral disturbances from
the primary injury can prolong hours after the injury. Primary injury is believed to be
irreversible and changes introduced to the anatomy and physiology of the brain as a
result of the primary injury lead to secondary damage. The processes involved in sec-
ondary damage is still under active investigation. However, several processes have been
identified to play key roles and these are characterised by disturbances in the neuronal
ionic exchange processes and by metabolic and inflammatory changes. These processes
result in cerebral ischemia/hypoxia and the failure of the neuronal cell to maintain its
cross membrane ionic gradient and eventually cell death. Cell death in a limited region
of the brain may create a more widespread state of metabolic dysfunction in other remote
areas characterised by depressed aerobic metabolism and metabolic crisis even in the
absence of ischemia. However, it is widely believed that processes that lead to secondary
injury may be prevented or minimised given the correct physiological environment that
optimises cerebral perfusion to maintain the balance between oxygen supply and de-
mand.
Although the pathophysiology of brain injury is complex and different for different
types of injury, two components have been identified as of significant importance: fail-
ure of substrate delivery below critical thresholds and failure of mitochondrial substrate
utilization leading to cerebral cellular energy failure. The latter has been characterised
by a histochemistry study demonstrating a diffuse decrease in the level of CCO activity in
rats with lateral fluid percussion injury - a commonly used experimental model of trau-
matic brain injury [123]. More importantly, this failure of energy metabolism may occur
without cerebral ischemia and has regional variation. It was reported in a combined
microdialysis and PET study that metabolic crisis without ischaemia was a common
finding [19], [124]. It was evident in cats with fluid percussion injury that derangement
in brain energy metabolism in the absence of substrate limitations could occur and it had
regional heterogeneity [125]. These studies highlight the fact that monitoring cerebral
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energy metabolism across multiple regions of the injured brain is crucially important to
provide insights into the pathophysiology of brain injury and its analysis may hold the
keys to predicting the status of the injury and provide information to assist the modifi-
cation of systemic physiology to optimise cerebral perfusion to improve clinical outcome.
CCO, as mentioned in chapter 3, is the terminal complex of the ETC and is respon-
sible for more than 95% of cellular oxygen metabolism. Its oxidation status reflects the
balance between mitochondrial oxygen supply and demand. The NIRS-derived concen-
tration change of oxidised CCO has been validated in a preclinical study as a measure of
change in cerebral energy metabolism [126] and it can offer insight into understanding
cerebral energy metabolism in brain injury. The oxCCO signal has been shown to have a
significant correlation with cerebral oxygen delivery in the healthy brain [5], [12] and it
has also been demonstrated to have a higher specificity to brain tissue than NIRS-derived
haemoglobin measures [12]. Moreover, it has been used successfully used to investigate
mechanisms of depressed aerobic metabolism in brain injury [6], [127]. These stud-
ies highlight the clinical relevance of this biomarker. However, in these studies, due to
the limitation of the NIRS instrumentation, only one or two regions of the brain were
monitored, neglecting the fact that there is regional heterogeneity in cerebral energy
metabolism following brain injury. With the development of the multi-channel broad-
band NIRS system, we now have the capability to investigate the regional heterogeneity
of cerebral energy metabolism following brain injury.
This chapter of the thesis will describe the first attempt to use the multi-channel,
multi-distance broadband NIRS system developed as part of this PhD to monitor patients
with brain injury to assess regional variation in cerebral energy metabolism and relate
it to variation in haemodynamics and non-NIRS neuromonitoring variables.
6.2 Challenges and objectives
This is the first time that a multi-channel, multi-distance broadband NIRS system has
been used in the clinical environment to monitor changes in cerebral haemodynamics
and metabolism in the frontal region of patients with acute brain injury. There were
several challenges to be overcome to enable multi-modal data sets to be acquired from
brain injured patients:
• The first challenge was to use the system in the clinical environment without dis-
rupting normal clinical care. The study required monitoring the brain of ABI pa-
tients during periods of stability and free from clinical interventions without inter-
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ruption for at least 60 minutes in a busy intensive care unit. Moreover, contamina-
tion from the changing ambient lighting condition had to be minimised. As a result,
studies were done at night after nursing handover to minimise possible disruption
and ambient light contamination.
• The other challenge was that the system and its accompanied optical fibres, probe
holder have to be designed with the patient in mind. The process of designing
took place long before the actual study with testing on phantoms and on healthy
volunteers to ensure the safety of the patient and reliability of the data collected.
During the actual study, the probe holder and the optical fibres had to be used in
conjunction with various probes from other monitoring systems being used to guide
clinical care of the patients.
With these challenges in mind, the objectives of this pilot clinical study were:
• To demonstrate the possibility of using the multi-channel, multi-distance broad-
band NIRS system in a clinical environment along side existing multi-modal moni-
toring systems.
• To use the oxCCO signal, biomarker for cellular energy metabolism, in combination
with other NIRS, non-NIRS and systemic parameters to understand more about
regional heterogeneity in cerebral autoregulation in the injured brain.
• To reconstruct tomographic images of ∆[oxCCO] in patients with ABI using the
multi-channel broadband data and demonstrate the potential use of these images.
6.3 Methods and Analysis Techniques
Four patients with acute brain injury were studied as part of an ongoing study to in-
vestigate metabolic disturbances following brain injury. This study was approved by the
Research Ethics Committee of the National Hospital for Neurology and Neurosurgery and
the Institute of Neurology. Written consent was obtained from a family representative as
all patients were unconscious at the time of the study. All patients were managed using
standardised protocol-based therapy specific to their brain injury type.
6.3.1 Systemic and cerebral monitoring
Muti-modal monitoring was recorded during an undisturbed 60-minute of clinical sta-
bility while the patients were ventilated, sedated and positioned with 30-degree head
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tilt. Cerebral variables included intraparenchymal intracranial pressure (ICP) (Codman
microsensor, Johnson & Johnson, USA), transcranial Doppler (TCD) flow velocity flow
velocity (FV) of the left and right middle cerebral arteries (Vmca1 and Vmca2) (DWL
Doppler Box, Compumedics, Singen Germany) and NIRS parameters. Systemic vari-
ables included mean arterial blood pressure (ABP) and arterial partial pressure of carbon
dioxide (PaCO2). All physiological data were captured at 125Hz using TrendFace software
(ixellence Gmbh, Germany).
NIRS parameters were acquired with the multi-distance, multi-channel broadband
NIRS system described earlier in chapter 5 using the frontal probe. This system with the
frontal probe allowed 24 NIRS measurement channels using the technique of differential
spectroscopy and six TOI measurement channels using the technique of SRS as de-
scribed earlier in chapter 2. The source detector separations (SDS) for 24 NIRS channels
range from 20 to 35 mm. The location of all measurement channels is shown in Figure
6.1. The frontal probe was positioned symmetrically on the forehead using double-sided
medical tape to minimise movement artefacts. All optical data were captured using the
LabView software that runs the broadband system.
Figure 6.1: Locations of 24 channels on the forehead. Light blue circles indicate the
location of channels with SDS of 20 mm, pink circles indicate the location of channels
with SDS of 30 mm and green circles indicate the location of channels with SDS of 35
mm.
6.3.2 Data preprocessing and analysis
Concentration changes of HbO2, HHb and oxCCO were calculated using the UCLn algo-
rithm over the wavelength range of 780 - 900 nm as described in details in chapter 5. The
wavelength dependency of DPF was applied to take into account the fact that DPF falls
with increasing wavelengths. Six TOI values were derived from six spatially resolved pairs
of channels using the SRS principle as described earlier. Systemic and cerebral variables
were synchronised using computer time stamps and resampled to 1 Hz through cubic
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spline interpolation. The processed multi-distance, multi-channel broadband NIRS data
were sent to Dr Brigadoi for image reconstruction.
For each of the patients, the multimodal data set included systemic variables, non-
NIRS cerebral parameters, 24 channels of NIRS measurements, six channels of TOI and
3D tomographic images. To analyse and extract useful insights about the pathophys-
iology of brain injury, multiple analysis techniques were utilised. In this thesis, data
analysis began with visualising all the data together to summarise the details for each
patient. The analysis was done using NIRS parameters, non-NIRS parameters, systemic
variables as well as the reconstructed images to extract potentially useful information to
inform about the heterogeneity of the brain injury.
6.3.2.1 Standard autoregulation index analyses
For each patient case, standard autoregulation indices were calculated. Pressure reac-
tivity index (PRx) was derived using the moving Pearson correlation coefficient between
ABP and ICP [128] on 10-second time-averaged data points over a 300 s window. Im-
paired cerebral pressure autoregulation is indicated by a positive PRx value, showing
that there is a passive transmission of the slow waves of ABP to ICP. With intact cerebral
pressure autoregulation, ICP is inversely correlated with ABP, resulting in a negative PRx
value. Clinical studies showed evidence of the association between an abnormally high
mean PRx value ( >0.35) and high mortality rate ( >50%). PRx values could be used
to differentiate patients with a good outcome, moderate disability, severe disability and
death [128]. More importantly, PRx could be used to define optimal CPP range for an
individual patient [129]. Similar to PRx, the mean velocity index (Mx) was derived using
the moving Pearson correlation coefficient between ABP and TCD-FV. However, the dif-
ference between PRx and Mx is that Mx assesses the global autoregulatory state while
PRx indicates the autoregulatory state of a specific region monitored by the ICP probe.
6.3.2.2 Slow wave analyses
Slow wave oscillations (0.05-0.003 Hz) of cerebral haemodynamics are believed to be
the result of myogenic, neurogenic and metabolic regulatory mechanisms on the cere-
brovasculature [130]. These oscillations reflect the physiological adaptation of the brain
to changes in systemic physiology and metabolic demand. Therefore, the analysis of
these oscillations may hold the key to the assessment of the state of cerebral autoregu-
lation in ABI patients. For each patient case, slow wave analysis was conducted using
wavelet-based techniques to compare the similarity and the phase difference between
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cerebral slow wave oscillations measured by NIRS and non-NIRS neuromonitoring and
systemic variables. The wavelet-based analysis technique is an advanced signal process-
ing technique that can offer high time-frequency resolution and is frequently applied to
measure the similarity and phase relationship between highly dynamic signals, varying
in both the time and frequency domains. This technique is superior to standard signal
processing methods in that it does not only provide excellent time and frequency resolu-
tion but also does not assume the frequency content of a data set is constant with time
and therefore allows changes in frequency to be analysed. In short, continuous wavelet
transform with the Morlet-wavelet was applied to each of the two signals of interest using
the wavelet scale factor of 150, investigating the frequency between 0.05 and 0.003 Hz.
Wavelet coherence [131] and wavelet semblance [132] were calculated to compare the
similarity and the phase difference between the two signals of interest. The technique
has been previously applied to assess the relationship between ABP and NIRS-derived
parameters in brain injury patients [133].
6.3.2.3 NIRS-based autoregulation indices
Systemic variables and non-NIRS parameters can be used to calculate indices to as-
sess cerebral autoregulation. However, the calculation of these indices requires invasive
monitoring (for the case of ICP) or technically challenging method and not suitable for
long-term monitoring (for the case of TCD). NIRS with its non-invasive nature and its
ease of use may provide another tool to monitor the injured brain. Moreover, for the
first time, using the multi-channel broadband NIRS, measures of haemodynamics and
metabolism can be derived regionally over multiple regions. These regional NIRS pa-
rameters can be correlated with systemic variables to derive NIRS-based autoregulation
indices that can be used to assess the autoregulation status of multiple regions of the
injured brain simultaneously.
6.3.2.4 Image reconstruction and calculation of indices in the image space
A 1000 s period of non-contaminated data was chosen for image reconstruction. The
multi-channel attenuation data was extracted and sent to Dr Brigadoi to run through
the image reconstruction algorithm developed specifically for oxCCO [110]. This algo-
rithm uses the multi-channel, multi-distance broadband NIRS data sets to reconstruct
images of ∆[HbO2], ∆[HHb] and ∆[oxCCO] every 10 s using the multi-spectral approach
as discussed early in chapter 3. All the images were used to make an animated video
showing the changes for each patient. The video was sped up 10 times for visualisation.
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Individual points in the images of [HbO2], [HHb] and [oxCCO] were correlated with ABP
using a moving Pearson correlation coefficient with a window length of 30 data points to
derive NIRS-based cerebrovascular and cerebrometabolic reactivity indices in the image
space.
6.4 Results
This section presents the results of the pilot clinical study. Due to time limitation, only
four patients with different types of brain injury were studied. This makes it inappro-
priate to formulate group observation and analysis. Therefore, the analysis was done on
the individual level and the results are presented as patient case studies. The summary
of all the findings for all four patients is presented in Table 6.1. This table provides the
complete overview of the results for each patient including details of the brain injury, the
details of non-NIRS monitoring and NIRS monitoring, the results of standard autoregu-
lation index calculation, the results of the wavelet-based analysis and the details of the
reconstructed tomographic images. Figures 6.2, 6.3, 6.4, 6.5 provides the summary of
the multi-modal data set collected for each of the four patients which provides the basis
for all the data analysis.
6.4.1 Summary results for all four patient cases
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Table 6.1: The complete overview of the results for all four patients
patient 1 (age 70,
GCS:11, GOS:2)
patient 2 (age 40,
GCS:14, GOS:4)
patient 3 (age 58,
GCS:10, GOS:2)
patient 4 (age 44, GCS:4,
GOS:0)
Injury type post-operative right
frontal intraparenchymal
haemorrhage
subarachnoid
haemorrhage
intraventricular
haemorrhage
left basal ganglia bleed
intraparenchymal
haemorrhage
Monitoring Non-NIRS ABP, ICP, VmCa ABP, ICP, VmCa ABP, VmCa ABP, ICP, VmCaNIRS multi-channel broadband multi-channel broadband multi-channel broadband multi-channel broadband
Results
PRx 0.37 0.18 N/A 0.15
Mx1 0.51 0.09 0.09 0.32
Mx2 0.34 0.28 -0.07 0.38
ABP & ICP
semblance
presence of in-phase
relationship
intermittent periods of
in-phase and anti-phase
relationship
N/A intermittent periods of
in-phase and anti-phase
relationship
Presence or
absence of
slow wave
oscillations
slow waves present in
NIRS and non-NIRS
variables in frequency
range 0.01 - 0.02Hz
slow waves present in
NIRS and non-NIRS
variables in frequency
range 0.01 - 0.02 Hz
absence of slow waves in
frequency range 0.01 -
0.02 Hz
absence of slow waves in
frequency range 0.01 -
0.02 Hz
NIRS &
non-NIRS
variables
correlation
spatially varied coherence
and semblance between
ABP and NIRS parameters
spatially varied coherence
and semblance between
ABP and NIRS parameters
spatially varied coherence
and semblance between
ABP and NIRS parameters
spatially varied coherence
and semblance between
ABP and NIRS parameters
TOI & VmCa
comparison
slow waves present in TOI
that correlate with that in
Vmca
slow waves present in TOI
that correlate with that in
Vmca
No slow wave present in
TOI
No slow wave present in
TOI
Tomographic
Images
localised increase in
∆[oxCCO] in the left
hemisphere; localised
decrease in ∆[HHb] in the
left hemisphere;
distributed localised
response in ∆[HbO2]
localised decrease in
∆[oxCCO] in left
hemisphere; localised
decrease in ∆[HHb] in the
right hemisphere;
distributed localised
response in ∆[HbO2]
localised decrease in
∆[oxCCO] in both
hemispheres; localised
decrease in ∆[HHb] in the
left hemisphere;
distributed response in
∆[HbO2]
localised increase in
∆[oxCCO] in the left
hemisphere; distributed
localised response of
∆[HHb] and ∆[HbO2]
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Figure 6.2: Summary of data from patient 1 having a post-operative right frontal intra-
parenchymal haemorrhage. a) CT scan showing the location of the injury. b) Averaged
reconstructed images of ∆[HbO2], ∆[HHb] and ∆[oxCCO] over a period of 1000 s of clin-
ical stability showing regional variation in cerebral haemodynamics and metabolism. c)
The locations of six 35 mm NIRS measurement channels (in green circles) and six TOI
channels across the forehead of the patient. d)∆[HbO2], ∆[HHb] and ∆[oxCCO] in six
NIRS channels. Clear spontaneous slow wave oscillations are evident in NIRS param-
eters in channels 15 and 21 monitoring the left brain regions e) Time-series plots of
systemic variables including ABP and PaCO2 and of non-NIRS cerebral parameters in-
cluding ICP, Vmca1, Vmca2. f) Six TOI measurements across the forehead. Slow-wave
oscillations are evident in two TOI channels 5 and 6 monitoring the left brain regions.
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Figure 6.3: Summary of data from patient 2 having subarachnoid haemorrhage due to
rupture of an aneurysm on the left anterior communicating artery. The panels are pre-
sented in the same order as in the previous patient. Spontaneous slow wave oscillations
are evident in NIRS parameters in channels 23, 15, 21 monitoring the left brain regions
in this patient. Slow wave oscillations are also evident in two TOI channels 5 and 6
monitoring the left brain regions.
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Figure 6.4: Summary of data from patient 3 having an intraventricular haemorrhage.
The panels are presented in the same order as in previous patients. In this patient, ICP
was not monitored as part of routine care. No obvious slow wave oscillations are evident
in both NIRS parameters and TOI channels.
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Figure 6.5: Summary of data from patient 4 having intraparenchymal haemorrhage as
a result of a left basal ganglia bleed. The panels are presented in the same order as in
previous patients. No obvious slow wave oscillations are evident in both NIRS parameters
and TOI channels.
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6.4.2 Full results
Patient 1 is a 70-year-old female with a post-operative right frontal intraparenchymal
haemorrhage. Her Glasgow Coma Scale (GCS) at admission was 11/15 and her Glasgow
Outcome Scale (GOS) was 2/5. Multimodal monitoring variables were collected within
24 hours after admission. Figure 6.2 gives the summary of the multimodal data set from
this patient. This includes a) a CT scan showing the location of the injury. b) averaged re-
constructed images of ∆[HbO2], ∆[HHb] and ∆[oxCCO] over a period of 1000 s of clinical
stability showing regional variation in cerebral haemodynamics and metabolism. c) the
locations of six 35 mm NIRS measurement channels (in green circles) and six TOI chan-
nels across the forehead of the patient. d) ∆[HbO2], ∆[HHb] and ∆[oxCCO] in six NIRS
channels, two of which (channels 15 and 21 monitoring the left brain regions) show clear
spontaneous slow wave oscillations e) time-series plots of systemic variables including
ABP and PaCO2 and of non-NIRS cerebral parameters including ICP, Vmca1, Vmca2. f)
six TOI measurements across the forehead, two of which (channels 5 and 6 monitoring
the left brain regions) show slow-wave oscillations. Slow wave oscillations are evident in
NIRS parameters and TOI measurements monitoring the left brain region. They are also
evident in non-NIRS cerebral parameters (ICP and Vmca1).
Patient 2 is a 40-year-old male with subarachnoid haemorrhage due to rupture of an
aneurysm on the left anterior communicating artery. His GCS was 14/15 and his GOS
was 4/5. The same multimodal monitoring method was used to monitor this patient
three days after brain injury. Figure 6.3 gives the summary of the multimodal data
set from this patient. Slow wave oscillations are evident in NIRS parameters and TOI
measurements monitoring the left brain regions in this patient. They are also evident in
non-NIRS cerebral parameters (ICP and Vmca1).
Patient 3 is a 58-year-old male with posterior fossa intracranial haemorrhage. His
GCS was 10/15 and his GOS was 2/5. The same multimodal monitoring method was
used to monitor this patient three days after brain injury. ICP was not monitored in this
patient as part of routine clinical care. Figure 6.4 gives the summary of the multimodal
data set from this patient.
Patient 4 is a 44-year-old male with left basal ganglia intracranial haemorrhage. His
GCS was 4/15 and his GOS was 0/5. The same multimodal monitoring method was
used to monitor this patient two days after brain injury. Figure 6.5 gives the summary
of the multimodal data set from this patient.
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6.4.2.1 Analysis using standard autoregulation indices
Patient 1 PRx was calculated for this patient in the standard manner as described
earlier. Mean PRx value for the whole period was 0.37 ( > 0.3), indicating impaired
cerebral pressure autoregulation. Continuous PRx calculation shows evidence of a long
period of highly positive PRx value (Figure 6.6). Similar results are evident in the Mx
calculation (Figure 6.7) with mean Mx1 for the whole period was 0.51.
50 100 150 200 250 300 350
80
85
90
95
AB
P 
(m
mH
g)
Pressure reactivity index
50 100 150 200 250 300 350
5
10
15
20
25
IC
P 
(m
mH
g)
50 100 150 200 250 300 350
Time (10 s)
-0.5
0
0.5
1
PR
x
Figure 6.6: ABP, ICP and PRx of patient 1. Mean PRx for the whole duration is 0.37 >
0.3 indicating impaired autoregulation. Continuous PRx trace shows a sustained period
of positive PRx indicating impaired cerebral pressure autoregulation.
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Figure 6.7: ABP, Vmca1 and Mx1 of patient 1. Mean Mx1 for the whole duration is 0.51
> 0.3 indicating impaired autoregulation. Continuous Mx trace shows a long sustain
positive period of impaired cerebral pressure autoregulation.
Pressure passive slow wave oscillations transferred between ABP and ICP are evident
in the semblance plot within the frequency range from 0.05 to 0.003 Hz (Figure 6.8)
with most areas having wavelet semblance values close to 1 (red), indicating an in-phase
relationship between ABP and ICP correlating to pressure passive response of impaired
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cerebral autoregulation.
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Figure 6.8: Wavelet semblance between ABP and ICP for patient 1. Wavelet plot shows
large red areas where semblance is close to 1 in the time frequency domain, indicat-
ing zones of in-phase relationship between ABP and ICP, suggesting pressure passive
responses.
Patient 2 Mean PRx is 0.18 and mean Mx1 is 0.09. Continuous PRx shows large vari-
ation (Figure 6.9), starting at high level and decreasing to below 0 at the end of the mea-
surement period. Vmca1 measured by TCD in this patient suffered a large drop indicated
by the spike in the middle plot of Figure 6.10. Wavelet semblance plot for the relationship
between ABP and ICP shows large blue areas across time and frequency domain, indi-
cating anti-phase relationship between the two variables correlating to pressure active
response of intact cerebral autoregulation (Figure 6.11).
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Figure 6.9: ABP, ICP and PRx of patient 2. Mean PRx for the whole duration is 0.18,
indicating impaired autoregulation. Continuous PRx shows large variation starting at
high level and decreasing to below 0 at the end of the measurement period.
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Figure 6.10: ABP, Vmca1 and Mx1 of patient 2. Mean Mx1 for the whole duration is 0.09.
Vmca1 (middle plot) suffered from a large drop during the initial period of monitoring.
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Figure 6.11: Semblance between ABP and ICP for patient 2. Wavelet plot shows more
large blue areas where semblance is close to -1 across the time frequency domain, indi-
cating zones of anti-phase relationship between neuromonitoring variable correlating to
pressure-active response.
Patient 3 As ICP was not monitored in patient 3, PRx could not be calculated. Stan-
dard autoregulation index based on TCD-measured flow velocity was calculated. Mean
Mx values derived from the correlation between ABP and TCD-flow velocity from the left
(Vmca1) and right (Vmca2) middle cerebral arteries were 0.09 and -0.07 respectively.
This does not indicate impaired autoregulation. However, as can be seen from the con-
tinuous measures of these indices (Figure 6.12 and 6.13) there were periods where con-
tinuous Mx values were highly positive, indicating periods of impaired autoregulation.
Figure 6.14 shows the semblance plot between ABP and Vmca1. Several blue areas in
the frequency range between 0.05-0.003 Hz show anti-phase relationship between Vmca
and ABP, indicating intact cerebral pressure autoregulation. This result is in agreement
with the standard autoregulation indices calculation.
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Figure 6.12: ABP, Vmca1 and flow velocity reactivity index Mx1 of patient 3. Mean Mx1
for the whole during of monitoring is 0.09. Continuous Mx1 trace shows periods of
positive Mx indicating impaired vascular reactivity.
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Figure 6.13: ABP, Vmca2 and flow velocity reactivity index Mx2 of patient 3. Mean Mx2
for the whole during of monitoring is -0.07. Continuous Mx2 trace shows shorter periods
of positive value in comparison to Mx1 trace.
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Figure 6.14: Semblance analysis between ABP and Vmca1 for patient 3. Blue areas in
the frequency range (0.05-0.003 Hz) indicate anti-phase relationship between the two
signals, suggesting intact vascular reactivity.
Patient 4 Mean PRx, Mx1 and Mx2 are 0.15, 0.32 and 0.38 respectively. These values
indicates impaired cerebral pressure autoregulation. Large changes in ABP as well as
instability in Vmca measurements were evident in this patient case (Figure 6.15, 6.16
and 6.17).
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Figure 6.15: ABP, ICP and continuous PRx for patient 4. Mean PRx for the whole during
of monitoring is 0.15. Continuous PRx trace shows periods of fluctuation around 0,
indicating periods of impaired vascular reactivity.
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Figure 6.16: ABP, Vmca1 and continuous Mx1 for patient 4. Mean Mx1 for the whole
during of monitoring is 0.32, indicating impaired vascular reactivity.
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Figure 6.17: ABP, Vmca2 and Mx2 for patient 4. Mean Mx2 for the whole during of
monitoring is 0.38, indicating impaired vascular reactivity.
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Figure 6.18: Semblance analysis between ABP and ICP for patient 4. Red areas in the
frequency range (0.05-0.003 Hz) indicate in-phase relationship between the two signals,
suggesting impaired vascular reactivity.
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6.4.2.2 Comparing NIRS and non-NIRS neuromonitoring parameters
Patient 1 Figure 6.19 shows the variation in blood pressure, non-NIRS parameters and
NIRS parameters of channel 15 monitoring the left hemisphere of patient 1. Slow wave
oscillations are evident in both non-NIRS cerebral parameters and NIRS parameters in
this patient. Power spectral density analysis shows that those oscillations in non-NIRS
and NIRS parameters have the same frequencies (Figure 6.20). These slow wave oscilla-
tions in NIRS parameter may contain information regarding the state of cerebral autoreg-
ulation and this will be investigated in more detail using wavelet analysis techniques in
a later section.
500 1000 1500 2000 2500 3000
80
90
M
AB
P
(m
mH
g)
Physiological monitorings and changes in NIRS parameters of channel 15
500 1000 1500 2000 2500 3000
10
15
20
IC
P
(m
mH
g)
500 1000 1500 2000 2500 3000
80
100
TC
D 
1
(au
)
500 1000 1500 2000 2500 3000
0
0.2
0.4
[H
bO
2]
(
M
)
500 1000 1500 2000 2500 3000
-0.4
-0.2
0
0.2
[H
Hb
]
(
M
)
500 1000 1500 2000 2500 3000
Time (s)
0
0.2
0.4
[ox
CC
O]
(
M
)
Figure 6.19: Slow wave oscillations in non-NIRS and in NIRS parameters from channel
15 monitoring the left hemisphere (non-injured region) of patient 1.
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Figure 6.20: Power spectral density analysis to compare the distribution of power across
the low-frequency range in non-NIRS cerebral variables and NIRS parameters in patient
1. Similar spectral features are evident among these variables.
Figure 6.21 shows the time-series changes of TCD-measured flow velocity from the left
middle cerebral artery (Vmca1) and TOI-5 from patient 1. High coherence was evident
between TOI parameter measured by NIRS and Vmca1 parameter measured by TCD.
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Figure 6.21: TCD-measured Vmca1 and TOI from channel 5 demonstrating strong co-
herence.
Coherence analysis confirmed the high coherence between NIRS parameters and non-
NIRS variables in the slow frequency range. Figure 6.22 and 6.23 show the coherence
between NIRS and non-NIRS cerebral parameters in channel 3 monitoring the injured
region and in channel 15 monitoring the non-injured region in patient 1. Yellow areas
indicate periods of high coherence in the time frequency domain. Much higher coher-
ence was evident between signals derived from the non-injured region of the brain in
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comparison to those derived from the injured region of the brain.
Figure 6.22: Squared cross-wavelet coherence between non-NIRS and NIRS parameters
in channel 3 monitoring the injured brain region of patient 1 in the time-frequency do-
main. The x-axis represents time; the y-axis represents frequency and the colour scale
represents the squared magnitude of the cross-wavelet coherence with yellow areas in-
dicating high coherence and blue areas indicating low coherence. The white dashed line
indicates the cone of influence.
Figure 6.23: Squared cross-wavelet coherence between non-NIRS and NIRS parameters
in channel 15 monitoring the non-injured brain region of patient 1 in the time-frequency
domain.
Patient 2 Similar to the results presented for patient 1, Figure 6.24 shows systemic
variables, non-NIRS cerebral parameters and changes in NIRS parameters of channel 10
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monitoring right hemisphere of patient 2. Slow wave oscillations were evidenced in both
non-NIRS neuromonitoring and NIRS parameters in this patient. Power spectral den-
sity analysis shows that the oscillations in those parameters have the same frequencies
(Figure 6.25)
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Figure 6.24: Slow wave oscillations in non-NIRS cerebral variables and in NIRS parame-
ters from channel 10 monitoring the right hemisphere (non-injured region) of patient 2.
Significant correlations were evident between NIRS parameters and Vmca1 and ICP.
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Figure 6.25: Power spectral density analysis to compare the distribution of power across
the low frequency range in non-NIRS and NIRS parameters in patient 2. Similar spectral
features were evident between these parameters.
For patient 2, similar agreement between Vmca measured by TCD and TOI are evident
(Figure 6.26)
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Figure 6.26: TCD-measured Vmca1 and TOI from channel 5 monitoring the oxygenation
of a region on the left hemisphere in patient 2.
In patient 2 with subarachnoid haemorrhage, the difference in coherence among sig-
nals between the left and the right frontal regions was less apparent in the haemoglobin
signals. However, using the oxCCO signals, difference in coherence was evident (Figure
6.27 and 6.28).
Figure 6.27: Squared cross-wavelet coherence between systemic and NIRS parameters
in channel 23 monitoring right frontal region of patient 2.
196
6.4. RESULTS
Figure 6.28: Squared cross-wavelet coherence between systemic and NIRS parameters
in channel 10 monitoring the left frontal region of patient 2.
Patient 3 Figure 6.29 shows systemic, non-NIRS cerebral variables and changes in
NIRS parameters of channel 3 monitoring the right hemisphere of the patient. Slow
wave oscillations were not apparent in non-NIRS and NIRS parameters.
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Figure 6.29: Non-NIRS and NIRS parameters in channel 3 from patient 3. There is no
apparent relationship between these monitoring variables.
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Figure 6.30: Power spectral density analysis to compare the distribution of power across
the low frequency range in systemic variables and NIRS parameters in patient 3. Similar
spectral features were evident between these parameters.
Slow wave oscillations in TCD-measured Vmca and TOI values were not as obvious
as in the first two patients for patient 3 (Figure 6.31).
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Figure 6.31: TCD-measured Vmca1 and TOI from channel 1 monitoring the oxygenation
of a region on the right hemisphere in patient 3.
In patient 3 with intraventricular haemorrhage, the coherence between non-NIRS
cerebral parameters and NIRS parameters was higher on the right brain region than on
the left brain region. (Figure 6.32 and 6.33)
198
6.4. RESULTS
Figure 6.32: Squared cross-wavelet coherence between non-NIRS and NIRS parameters
in channel 9 monitoring the right frontal region of patient 3.
Figure 6.33: Squared cross-wavelet coherence between non-NIRS and NIRS parameters
in channel 15 monitoring the left frontal region of patient 3.
Patient 4 Similarly in patient 4, slow wave oscillations are not apparent in all param-
eters. An example channel was shown in Figure 6.34. Slow wave oscillations in TCD-
measured Vmca and TOI values were not as obvious as in the first two patients for patient
4 (Figure 6.36).
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Figure 6.34: Non-NIRS neuromonitoring and NIRS parameters in channel 15 from pa-
tient 4. There is no apparent relationship between these monitorings
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Figure 6.35: Power spectral density analysis to compare the distribution of power across
the low frequency range in non-NIRS and NIRS parameters in patient 4. Similar spectral
features were evident between these parameters.
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Figure 6.36: TCD-measured Vmca1 and TOI from channel 4 monitoring the oxygenation
of a region on the left hemisphere in patient 4.
In patient 4 with left basal ganglia intraparenchymal haemorrhage, the coherence
between non-NIRS cerebral parameters and NIRS parameters was higher on the right
brain region than on the left brain region. (Figure 6.37 and 6.38)
Figure 6.37: Squared cross-wavelet coherence between non-NIRS and NIRS parameters
in channel 3 monitoring the right frontal region of patient 4.
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Figure 6.38: Squared cross-wavelet coherence between non-NIRS and NIRS parameters
in channel 15 monitoring the left frontal region of patient 4.
6.4.2.3 Semblance analysis between NIRS and non-NIRS parameters
Patient 1 As can be appreciated from the previous comparison, slow wave oscillations
in NIRS parameters are highly correlated with those in non-NIRS neuromonitoring vari-
ables. As a result, NIRS parameters may be used as surrogates for neuromonitoring
and autoregulation indices can be derived using NIRS parameters by correlating them
with ABP. With the advance of the multi-channel broadband NIRS system, regional vari-
ation in cerebral autoregulation can be evaluated using regional NIRS measurements of
∆[HbO2],∆[HHb] and ∆[oxCCO]. Semblance analysis was applied to calculate the phase
relationship between NIRS parameters and ABP to derive the NIRS-based reactivity in-
dices in the time-frequency domain. These could be used to assess cerebral autoregu-
lation status of the brain, similar to the idea of using semblance analysis between ABP
and ICP to derive the state of cerebral autoregulation [133].
Figure 6.39 shows the semblance between ABP and HbO2 and Figure 6.40 shows the
semblance between ABP and oxCCO using data from 12 NIRS channels with SDS of 35
mm across the forehead in patient 1. In-phase and anti-phase relationship are indicated
in red and blue areas respectively. There was a strong agreement between semblance
plots for HbO2 reactivity (Figure 6.39) and for CCO reactivity (Figure 6.40) which may
be explained by the coupling between oxygenation and metabolism. However, there were
distinct differences in the low frequency range (0.003 -0.008 Hz) between the HbO2 re-
activity map and the CCO reactivity map in channels populating the right hemisphere
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( channels 3, 9, 10, 4, 7, 8) which was the brain injured area in this patient. These
differences may be due to the nature of the two signals, one reflects the haemodynamic
changes while the other reflects the changes in cerebral oxygen metabolism.
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Figure 6.39: Semblance between ABP and ∆[HbO2] in 12 channels across the forehead
of patient 1. In-phase oscillations are indicated in red and antiphase oscillations are
indicated by blue areas.
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Figure 6.40: Semblance between ABP and ∆[oxCCO] in 12 channels across the forehead
of patient 1.
Semblance analysis was applied between HbO2 and oxCCO signals. The rationale
behind this analysis is that in the healthy brain, intact flow-metabolism coupling cre-
ates in-phase changes in the concentration changes of HbO2 and oxCCO. This is usually
evident in functional activation study where concentration change of HbO2 and oxCCO
increase together. This relationship may be altered in pathology with variation in flow-
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metabolism coupling in different regions of the brain, creating areas of anti-phase re-
lationship between the two signals. However, this relationship may be more complex
in brain injury as the oxCCO signal is influenced by many other factors [69]. Figure
6.41 shows the semblance plots for the phase relationship between HbO2 and oxCCO
from 12 channels across the forehead from patient 1. Blue areas are prevalent in most
channels except channels 16 and 21 monitoring the left hemisphere. These blue areas
may indicate impaired flow-metabolism coupling in the brain regions monitored by these
channels.
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Figure 6.41: Semblance between HbO2 and ∆[oxCCO] in 12 channels across the forehead
in patient 1.
The correlation between Vmca and TOI has been used as a dynamic index of cerebral
autoregulation [134]. Using the multi-channel NIRS system, TOI can be measured at six
different regions and regional variation in the relationship between TOI and TCD may be
used to assess the state of cerebral autoregulation. Semblance analysis between Vmca1
and six TOI measurements is shown in Figure 6.42. A strong in-phase relationship was
evident between Vmca1 and TOI from channels monitoring the non-injured left hemi-
sphere (TOI 4 to 6) whereas large variation in phase relationship in the time-frequency
domain is observed in the semblance plots from the injured hemisphere.
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Figure 6.42: Wavelet semblance plots between TCD measured flow velocity in the left
cerebral artery and TOI values across the forehead. This demonstrates that TOI mea-
surements from channels 4, 5 and 6 monitoring the left hemisphere (non-injured brain
region) are closely correlated with TCD flow measure.
Patient 2 Figure 6.43, 6.44 show the semblance between ABP and HbO2 and oxCCO
signals at 12 NIRS measurement channels with SDS of 35 mm across the forehead in
patient 2. No distinct difference could be seen in semblance plots for oxyhaemoglobin
and CCO reactivity indices of this patient. Figure 6.45 shows the semblance plots for the
phase relationship between HbO2 and oxCCO from 12 channels across the forehead of
patient 2. Channels at higher location (9, 10, 23, 15, 21) have predominantly red areas
indicating normal flow-metabolism coupling whereas other channels have predominantly
blue areas indicating impaired flow metabolism coupling.
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Figure 6.43: Semblance between ABP and ∆[HbO2] in 12 channels across the forehead
of patient 2.
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Figure 6.44: Semblance between ABP and ∆[oxCCO] in 12 channels across the forehead
of patient 2.
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Figure 6.45: Semblance between ∆[HbO2] and ∆[oxCCO] in 12 channels across the fore-
head in patient 2.
Semblance analysis between Vmca1 and six TOI measurements demonstrated a strong
agreement between the two measures (Figure 6.46). In this case , Vmca was largely in
agreement with TOI parameters in all six regions monitored.
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Figure 6.46: Semblance plots between Vmca1 and six TOI measuring monitoring dif-
ferent regions of the frontal lobe. Strong in-phase relationship is seen in all six plots,
demonstrating strong agreement between Vmca1 and TOI values.
Patient 3 Figure 6.47, 6.48 show the semblance between ABP and HbO2 and oxCCO
signals at 12 NIRS measurement channels with SDS of 35 mm across the forehead in
patient 3. No distinct difference could be seen in semblance plots for oxyhaemoglobin
and CCO reactivity indices of this patient.
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Figure 6.47: Semblance between ABP and HbO2 in 12 channels across the forehead of
patient 3. Pressure passive oscillations of ABP and HbO2 are evident and are reflected
by large red areas, reflecting in-phase oscillations between the two variables.
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Figure 6.48: Semblance between ABP and oxCCO in 12 channels across the forehead of
patient 3. There is evidence of passive oscillations between ABP and oxCCO.
The semblance analysis between HbO2 and oxCCO signal in patient 3 (Figure 6.49)
shows a similar pattern to that of patient 1. However, in this patient, anti-phase rela-
tionship between HbO2 and oxCCO only existed in channels monitoring the lower area of
the frontal region, suggesting impaired flow-metabolism coupling in these brain regions
monitored by these channels.
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Figure 6.49: Semblance between HbO2 and oxCCO in patient 3.
Patient 4 Figure 6.50, 6.51 show the semblance between ABP and HbO2 and oxCCO
signals at 12 NIRS measurement channels with SDS of 35 mm across the forehead in
patient 4. No distinct feature could be seen in semblance plots for oxyhaemoglobin and
CCO reactivity indices of this patient.
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Figure 6.50: Semblance between ABP and HbO2 in 12 channels across the forehead of
patient 4. Pressure passive oscillations of ABP and HbO2 are evident and are reflected
by large red areas, reflecting in-phase oscillations between the two variables.
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Figure 6.51: Semblance between ABP and oxCCO in 12 channels across the forehead of
patient 4.
The semblance analysis between HbO2 and oxCCO signal in patient 4 (Figure 6.52)
shows a similar pattern to that of patient 1. However, in this patient, anti-phase rela-
tionship between HbO2 and oxCCO was only evident in channels monitoring the lower
area of the frontal region, suggesting impaired flow-metabolism coupling in these brain
regions monitored by these channels.
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Figure 6.52: Semblance between HbO2 and oxCCO in patient 4.
Semblance analysis between Vmca1 and six TOI measurements demonstrate a large
variation in the time frequency domain (Figure 6.53). This may indicate impaired cerebral
autoregulation.
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Figure 6.53: Semblance plots between Vmca1 and six TOI measuring monitoring differ-
ent regions of the frontal lobe in patient 4.
6.4.2.4 Reconstructed images of changes in haemodynamics and metabolism in
patient 1
One of the most important advances presented in this thesis is the ability to reconstruct
images of changes in cerebral oxygen metabolism. This was enabled by the develop-
ment of the multi-channel, multi-distance broadband NIRS system and the collection
of in vivo data from human subjects. Figure 6.54 shows the reconstructed images of
∆[HbO2],∆[HHb] and ∆[oxCCO] at five time points demonstrating the temporal and re-
gional variation in haemodynamics and metabolism in the frontal region of patient 1.
The full reconstructed video can be found in the URL https://goo.gl/o8vD64.
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Figure 6.54: Reconstructed images of ∆[HbO2],∆[HHb] and ∆[oxCCO] for five time points
in patient 1. Large temporal and spatial variations in haemodynamics and metabolism
can be evident from the images.
As can be appreciated by the figure and the video, there was a distinct difference in the
spatial variation in the oxCCO image in comparison to the haemoglobin images. Increase
in metabolic activity appeared to be localised in specific localised areas in the left and
right hemisphere, with much higher amplitude in the left hemisphere, the non-injured
brain region. Figure 6.55 shows images of ∆[oxCCO] at two time points to demonstrate
the regional and temporal variation in metabolism in the patient 1. The distinct differ-
211
6.4. RESULTS
ence in the distribution of the ∆[oxCCO] signal at different time points was evident.
a) b))
Figure 6.55: Image of ∆[oxCCO] at a) t = 550 s and b) t= 860 s in patient 1.
Figure 6.56 shows the mean NIRS-based cerebrovascular (HbOx, HHbx) and the cere-
brometabolic (oxCCOx) reactivity indices in the image domain calculated by correlating
the changes in ABP and the individual voxel-based concentration changes of ∆[HbO2],
∆[HHb] and ∆[oxCCO]. Red regions indicate a high correlation between ABP and concen-
tration changes of NIRS parameters. oxCCOx reactivity image suggested a large region
of impaired cerebral autoregulation on the left hemisphere.
Figure 6.56: NIRS-based cerebrovascular (HbOx and HHbx) and cerebrometabolic (oxC-
COx) reactivity indices calculated by correlating the voxel-based concentration changes
and ABP in patient 1.
6.4.3 Reconstructed images of changes in haemodynamics and metabolism
in patients 2, 3 and 4
6.4.3.1 Patient 2
Figure 6.57 shows the reconstructed images of ∆[HbO2], ∆[HHb] and ∆[oxCCO] at five
time points for patient 2 having subarachnoid haemorrhage. The full reconstructed video
can be found in the URL https://goo.gl/o8vD64. Changes in ∆[oxCCO] signal were again
localised to certain areas of the brain. In this case, a localised decrease in the left hemi-
sphere and a slight increase in the right hemisphere were evident. ∆[HHb] images also
show some localised features whereas ∆[HbO2] images appeared to have more scattered
changes.
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Figure 6.57: Reconstructed images of ∆[HbO2], ∆[HHb] and ∆[oxCCO] for five time points
in patient 2 having subarachnoid haemorrhage.
Figure 6.58 shows the mean NIRS-based reactivity indices in the image domain for
patient 2. oxCCOx reactivity image suggests a focal region of impaired cerebral autoreg-
ulation on the right hemisphere.
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Figure 6.58: NIRS-based cerebrovascular reactivity indices calculated by correlating the
voxel-based concentration changes and ABP in patient 2.
6.4.3.2 Patient 3
Figure 6.59 shows the reconstructed images of ∆[HbO2], ∆[HHb] and ∆[oxCCO] for five
time points for patient 3 having intraventricular haemorrhage. The full reconstructed
video can be found in the URL https://goo.gl/o8vD64. There was a distinct difference in
the spatial variation present in the oxCCO image in comparison to that present in the
haemoglobin images. A decrease in metabolic activity appeared to be localised in specific
areas in the left and right hemispheres.
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Figure 6.59: Reconstructed images of ∆[HbO2],∆[HHb] and ∆[oxCCO] for five time points
in patient 3.
Figure 6.60 shows the mean NIRS-based reactivity indices in the image domain for
patient 3. oxCCOx reactivity image suggested a small region of impaired cerebral au-
toregulation on the left hemisphere.
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Figure 6.60: Autoregulation reactivity indices calculated by correlating ABP and
∆[HbO2],∆[HHb] and ∆[oxCCO] from patient 3
6.4.3.3 Patient 4
Figure 6.61 shows the reconstructed images of ∆[HbO2],∆[HHb] and ∆[oxCCO] for five
time points for patient 4 having left intraparenchymal haemorrhage. The full recon-
structed video can be found in the URL https://goo.gl/o8vD64. There was a distinct
difference in the spatial variation present in the oxCCO image in comparison to that
present in the haemoglobin images. Increase in metabolic activity appeared to be lo-
calised in specific areas in the left hemisphere.
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Figure 6.61: Reconstructed images of ∆[HbO2],∆[HHb] and ∆[oxCCO] for five time points
in patient 4.
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Figure 6.62: Autoregulation reactivity indices calculated by correlating ABP and
∆[HbO2],∆[HHb] and ∆[oxCCO] from patient 4
6.5 Conclusion and discussion
We have investigated the use of the multi-distance, multi-channel broadband NIRS sys-
tem developed as part of this PhD in the neurocritical care unit, together with other neu-
romonitoring systems used as part of routine care for patients with acute brain injury.
The use of this system in the clinical environment was feasible and allowed multi-site
monitoring of the frontal region of patients with ABI. Overcoming the challenges of ac-
quiring data in this clinical environment is an achievement in itself. This has enabled the
collection of four multi-modal data sets including systemic physiological variables, non-
NIRS cerebral variables and multi-distance, multi-channel broadband NIRS measure-
ments across multiple regions of the frontal region of brain injury patients. These data
sets have been analysed using multiple techniques to provide a better understanding of
the regional heterogeneity of cerebral haemodynamics and more importantly, metabolism
during brain injury.
Regarding the reliability of the system, we have demonstrated the ability of the sys-
tem to collect complete 24-channel NIRS data on all patients without any interruption.
This is not a trivial matter because (standard) neuromonitoring modalities may fail to
collect data due to technical difficulties (e.g. TCD), or may be invasive and not indicated
(e.g. ICP). Multi-channel NIRS monitoring with its non-invasive nature and ease of ap-
plication may provide another element to improve the understanding of the state of the
brain in specific clinical scenarios where there is an increased risk of cerebral ischaemia.
Moreover, this has demonstrated the reliability of multi-channel broadband NIRS for
long-term monitoring of brain injury patients. Unlike TCD which may have problems in
long-term monitoring due to probe dislocation or drying of gel, multi-channel NIRS does
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not have practical limitations in long-term monitoring.
In terms of analysis, we have demonstrated the use of existing analysis techniques
on physiological variables in these four data sets and then expanded the use of these
techniques to NIRS parameters to calculate regional NIRS-based reactivity indices. Us-
ing a moving Pearson correlation coefficient with 300 s time window, autoregulation
indices were derived from non-NIRS variables for each of the four data sets to assess
the degree of impaired cerebral autoregulation. The wavelet-based analysis was then
applied to further investigate the variation in the phase relationship of these variables in
the time-frequency domain. This analysis was then applied to investigate the similarity
and the phase relationship between NIRS and non-NIRS variables to assess the regional
heterogeneity in brain injury. With the reliability of NIRS measurements, NIRS autoreg-
ulation indices can be derived with confidence for the whole period of recording. With
the advance of multi-channel broadband NIRS, autoregulation indices can be derived for
specific regions from the regional measures of haemodynamics and metabolism.
Interestingly, as part of this pilot study, we have observed synchronised oscillations
of slow frequency in cerebral blood flow, oxygenation (0.05-0.003 Hz) measured by non-
NIRS neuromonitoring and NIRS parameters in a number of channels in two out of four
patient cases with acute brain injury. These oscillations are suggested to be the result of
the combined influences of myogenic, metabolic and neuronal mechanisms on the cere-
bral vascular tone [130]. Analysis of those slow wave oscillations using coherence and
semblance analyses reveals a stronger correlation between non-NIRS cerebral variables
and NIRS parameters in the non-injured regions of the brain than in the injured regions.
However, more data are needed to elucidate these findings.
TOI measurement in the adult brain has always been challenging due to technical
complexity in the optical interface design and the SRS resolving algorithm. The multi-
channel, multi-distance broadband NIRS system with the novel system design has en-
abled monitoring of TOI across multiple sites in the frontal region of the adult head. In
this pilot study, we have demonstrated the measurement of TOI across multiple locations
in the frontal region of patients with ABI. Within all four patients, TOI values were within
the physiological range and they were highly correlated with Vmca measure of blood flow
in the middle cerebral artery in two out of four patients. Using TOI as a surrogate mea-
sure of TCD-FV for the assessment of cerebral autoregulation is a promising direction
because of its reliability and ease of application. However, more data in both the healthy
and injured brains having both TCD-FV and TOI measurements are needed to elucidate
this finding.
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We have demonstrated the feasibility of using semblance analysis between HbO2 and
oxCCO to assess flow-metabolism coupling across multiple regions of the frontal region of
patients with ABI. There is evidence that areas with impaired flow-metabolism coupling
may demonstrate an anti-phase relationship between the two parameters. This finding
is in agreement with a previous study investigating the phase relationship between NIRS
parameters in patients with subarachnoid haemorrhage [135].
Multi-distance, multi-channel broadband NIRS data sets collected in this study have
allowed image reconstruction algorithm to be developed to assess changes in haemody-
namics and metabolism in the image space following ABI. With the use of multi-channel
broadband NIRS, images of ∆[oxCCO] together with ∆[HbO2] and ∆[HHb] were recon-
structed in ABI patients for the first time, revealing the temporal and spatial variation
in haemodynamics and metabolism across different brain regions. These images can be
used to assess the regional variation and the localisation of changes in haemodynam-
ics and metabolism. Using these images, we have demonstrated the ability to derive
NIRS-based cerebrovascular and cerebrometabolic indices in the image domain which
may provide insights into the regional variation in impaired cerebral autoregulation and
depressed oxygen metabolism. Although further work is required to optimise the image
reconstruction technique, this has opened up new opportunities for the investigation
of the spatial haemodynamic response to changes in blood pressure and its effect on
mitochondrial metabolic activity.
Previous studies have demonstrated the use of systemic, non-NIRS and NIRS param-
eters to assess cerebral autoregulation [6], [127], [133]. However, these authors only
monitored one or two locations of the injured brain, neglecting the presence of hetero-
geneity in brain injury. This study has brought the advances of multi-channel broadband
NIRS to assess changes in tissue oxygenation, cerebral haemodynamics and metabolism
at multiple regions across the frontal region of patients with ABI. These NIRS parameters
can be correlated to non-NIRS cerebral and systemic variables to derive autoregulation
status of the injured brain. Monitoring multiple brain regions in combination with ad-
vanced data analysis techniques can help elucidate relationships between oxygen deliv-
ery and metabolism to understand more about regional heterogeneity in impaired cere-
bral autoregulation and flow-metabolism coupling, two key processes underlying cerebral
ischaemia.
This study has given the first insights into the regional variation in oxygen metabolism
and flow-metabolism coupling and has allowed different analysis techniques to be as-
sessed for future clinical studies. One of the most important contributions of this study
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to NIRS research community is validating the feasibility of reconstructing tomographic
images of ∆[oxCCO] in brain injured patients. Together with tomographic images of
∆[HbO2] and ∆[HHb], these can be used to investigate regional heterogeneity of impaired
cerebral pressure autoregulation and deranged flow-metabolism coupling not only in ABI
but in other clinical scenarios where there is a high risk of cerebral ischaemia.
This pilot study is the first step in investigating the spatial variation in cellular oxygen
metabolism in the injured brain using a non-invasive optical method. As a result, there
are certain limitations. The first limitation is the number of patients monitored. Due
to time constraints, it was only possible to study four patients. Moreover, we could only
monitor patients without any intervention because of the limitation in ethical approval.
Another limitation is the fact that these four patients have different brain injury types,
which made it inappropriate to attempt any grouped results. These issues can be miti-
gated in future clinical studies with specific protocol design in a large cohort of patients
with a specific type of brain injury. Physiological challenges such as hyperoxia can be
used to investigate spatial variation in depressed oxygen metabolism following ABI as
this challenge has been used successfully by Ghosh and Tisdall ([7], [127] to investigate
cellular oxygen metabolic processes in brain injury.
Despite these limitations, it is important to realise that achieving the monitoring and
the analysis of these four patient data sets with different types of brain injury marks a
significant milestone. We now have a monitoring system and analysis techniques that
can monitor the variations in cerebral haemodynamics and more importantly cerebral
oxygen metabolism that is applicable across the whole spectrum of brain injury. Given
that metabolic failure underlies all type of brain injury, we now have a new non-invasive
tool to investigate it.
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Chapter 7
Conclusion, discussion and
future work
This thesis has presented lots of advances in the field of NIRS both in terms of instrumen-
tation development and in vivo results in the healthy and injured adult human brain.
This last chapter will summarise the work presented in this thesis, discuss various re-
sults as a whole and suggest future areas of research that have arisen from this work.
7.1 Conclusion
7.1.1 Summary
This PhD thesis describes the progressive development and applications of a multi-
channel, multi-distance broadband NIRS system with the capability of measuring changes
in haemoglobin concentrations, the oxidation state of cytochrome c oxidase and tissue
oxygenation in the adult human brain.
7.1.2 Instrumentation
The main components of the multi-channel broadband NIRS system are two customised
spectrographs and two light sources. Each spectrograph receives light input from a
custom-built fibre bundle comprised of six individual fibres. Each light source is con-
nected to a custom-built bifurcated fibre bundle to create two source fibre bundles. The
light sources are time-multiplexed to alternately deliver light to the pair of fibres con-
nected to them. Two probe holders were designed and 3D printed, one for frontal lobe
application and the other for visual cortex application. Overall, the system can monitor
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the frontal cortex over 24 NIRS measurement channels and the visual cortex over 16
NIRS measurement channels with the frequency of 0.36Hz (one full measurement cycle
in 2.8 s).
7.1.3 Functional activation studies
The system was used to measure the response of ∆[oxCCO] over multiple channels prob-
ing the visual and the prefrontal cortices during functional activation tasks. ∆[oxCCO]
signal showed an increase during the stimulation period followed by a decrease dur-
ing the resting period while the haemoglobin signals showed the typical haemodynamic
response to functional activation. This response of the ∆[oxCCO] signal was seen in mul-
tiple channels probing a localised brain area, presumably responding to the functional
activation task. Moreover, there is a spatial variation in the response of the ∆[oxCCO]
signal with channels probing different areas showing different amplitudes of the sig-
nal. More modelling work is needed for further interpretation of these data, taking into
account the relative sensitivity of the system to different regions of the cortex.
7.1.4 Acute brain injury patient case studies
The system with the frontal probe holder was used in a pilot study to monitor the frontal
region of four patients with acute brain injury over 24 measurement channels. This
was to demonstrate that the system could be used in a clinical environment alongside
other monitoring systems and there is potential that clinically useful insights can be de-
rived from the combination of multi-channel NIRS data and systemic physiological data.
Multiple analysis techniques were applied to showcase the potential benefits of having
multi-channel ∆[oxCCO] data from brain injured patients. As discussed in Chapter 6,
the pilot study presented had limitations; however, its result can be used to guide fu-
ture clinical studies with multi-channel CCO measurements. More details of this will be
discussed in the future work section.
7.1.5 Reconstructed images of ∆[oxCCO]
Multi-channel, multi-distance broadband data sets collected during this PhD has en-
abled the development of an image reconstruction algorithm that was used to recon-
struct the very first sets of tomographic images of concentration changes of oxCCO. This
has enabled the visualisation and the analysis of the spatial variation in the ∆[oxCCO]
signal in the healthy adult brain during functional activation and in the injured brain
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during periods of clinical stability without intervention.
Reconstructed images of ∆[oxCCO] during visual functional activation showed clear
localised changes in all subjects. These changes were localised to the same functional
area as evident in the reconstructed images of ∆[HbO2] and ∆[HHb]. This technique pro-
vides a unique opportunity to investigate the cerebral energy metabolism during func-
tional activation in addition to the traditional haemodynamic response.
Reconstructed images ∆[oxCCO], ∆[HbO2] and ∆[HHb] in patients with acute brain
injury during periods of clinical stability without clinical intervention showed large vari-
ation in both the haemodynamics and metabolism in various localised areas of the pre-
frontal region. The calculated NIRS-based reactivity indices in the image domain show
some degree of heterogeneity. Some regions have a highly positive reactivity index, corre-
lating to impaired cerebral autoregulation whereas other regions have a negative reactiv-
ity index, correlating to intact cerebral autoregulation. This demonstrates the feasibility
of calculating autoregulation indices of haemodynamics and metabolism using the re-
constructed images of ∆[HbO2], ∆[HHb] and ∆[oxCCO] in patients with brain injury.
Although further work is required to optimise the technique, there is considerable po-
tential to use this technique to characterise the spatial haemodynamic and metabolic
response to changes in blood pressure in patients with acute brain injury.
7.2 Discussion
The work presented in this PhD thesis has introduced lots of advances to the field of NIRS.
A broadband NIRS instrumentation has been developed with advances introduced to the
hardware, software and resolving algorithm. This instrument was used to investigate
the changes in the visual and the prefrontal cortices during functional activation tasks,
producing the first spatially resolved changes of the oxCCO signal, a measure of cerebral
oxygen metabolism across various areas of the adult human brain. After these functional
experiments in the healthy adult brain, the system was then used to monitor the frontal
brain region of patients with ABI, producing the first spatially resolved changes of the
oxCCO signal from the injured brain. Moreover, using the multi-channel, multi-distance
broadband NIRS data, tomographic images of ∆[oxCCO] were reconstructed for the first
time in the healthy brain during a functional activation task and in the injured brain
during periods of clinical stability. These images reveal an interesting spatial pattern of
changes in cerebral oxygen metabolism alongside the traditional pattern of changes in
haemodynamics and oxygenation.
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7.3 Future work
The development introduced by this work has also opened up opportunities for future
areas of research which will be discussed in this section.
7.3.1 Ongoing studies
Following the success of the functional activation studies on the visual cortex, the multi-
channel, multi-distance broadband NIRS system is currently being used to monitor the
visual cortex of subjects in a more challenging neuroscience experiment to test the role of
perceptual load in visual awareness. The hypothesis is that visual distractors (inverting
checkerboard) will intrude upon awareness in low load experimental conditions resulting
in an increase in oxCCO whereas awareness will be restricted to the content of focused
attention when the attended information involves high perceptual load, resulting in little
change in oxCCO. The results of this experiment could shine a light onto the neuro-
science of visual awareness and provide supporting evidence to answer the question of
to what degree do distractor stimuli get process.
7.3.2 NIRS system upgrades
Despite being used successfully in two functional activation studies and in a pilot clinical
study, the multi-channel broadband NIRS system can be improved in several aspects.
The number of light sources can be increased to increase the number of measurement
channels. This can be done by building and integrating a new multiplexing unit into the
system to multiplex the output of the light source. This multiplexing unit could use a 1D
axis galvanometer-based scanning mirror, focusing optics and a source plug disk holding
multiple optical fibres. The angle of the incident beam can be changed by changing the
orientation of the galvanometer mirrors. It is, therefore, possible to sequentially inject
the incident beam into one of the output source fibres. If four source fibres are connected
to the each source plug disk, from the two halogen bulb light sources, the system can
have eight sequentially illuminated source fibres.
Larger CCD cameras can be used to increase the number of detector fibres that can
be fitted into the CCD camera imaging area. Currently, the system uses the PIXIS:512f
CCD camera that has an imaging area of 12.3 mm x 12.3 mm. Princeton Instruments
now has a larger CCD camera, the PIXIS:1300 with imaging area of 26.8 mm x 26 mm.
This potentially can fit a double number of detector fibres.
These changes in hardware need corresponding changes in the software to control the
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system and collect the intensity spectra from an increased number of channels. However,
full head coverage with overlapping multi-channel, multi-distance NIRS measurements
can be acquired and this can present a huge advance in the field of fNIRS.
7.3.3 Clinical studies
The main advancement introduced by this thesis is the ability to monitor the ∆[oxCCO]
signal across multiple regions of the brain and visualise these changes using a tomo-
graphic image reconstruction algorithm. Regional monitoring of cerebral oxygen metabolism
from multiple brain areas in patients can provide more information to help identify re-
gions with profound cerebral energy failure and therefore target management therapy
to prevent it. These are important for patient groups where there is an increased risk
of cerebral ischemic injury and a resulting metabolic crisis. These patient groups in-
clude but are not limited to patients undergoing cardiac surgery, carotid endarterec-
tomy, general anaesthesia and patients with brain injury. In the case of brain injury
where metabolic failure has been recognised as a key component of the pathophysiology,
the benefits of monitoring ∆[oxCCO] signal across multiple regions are considerable. In
this thesis, ∆[oxCCO] has been monitored over multiple regions of patients with ABI.
However, due to time limitation, we could only monitor four patients, each with a differ-
ent type of injury. As for future work, a full clinical study where the system is used to
monitor the changes of oxCCO in a large group of brain injury patients with a specific
type of injury is recommended. This can contribute greatly to the understanding of the
pathophysiology of brain injury.
A more complex study can be done using the system to investigate the spatial varia-
tion in the injury pathway following brain injury. In brain injury, as mentioned earlier,
metabolic dysfunction without ischaemia is a common finding. This may be implicated
by diffusion-limited oxygen transport or mitochondrial dysfunction. These pathways can
be investigated using hyperoxia challenges. Hyperoxia can induce an increase in cerebral
oxygen availability which would lead to an increase in oxCCO in regions where diffusion-
limited oxygen transport is the injury pathway whereas no significant change would be
observed in regions where mitochondrial dysfunction is the injury pathway.
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